{"id": 41871312, "time": "2024-11-11 00:33:28", "headline": "Reported Earlier, Japan Adjusted Current Account For September 1.27T Vs. 2.80T Est.; 3.15T (Revised) Prior", "summary": "", "symbols": ["BBJP", "DXJ", "EWJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41871312/reported-earlier-japan-adjusted-current-account-for-september-1-27t-vs-2-80t-est-", "tags": []}
{"id": 41871313, "time": "2024-11-11 00:33:48", "headline": "Reported Earlier, Japan Current Account n.s.a. For September 1.717T Vs. 3.263T Est.; 3.933T (Revised) Prior", "summary": "", "symbols": ["BBJP", "DXJ", "EWJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41871313/reported-earlier-japan-current-account-n-s-a-for-september-1-717t-vs-3-263t-est-3", "tags": []}
{"id": 41871390, "time": "2024-11-11 00:45:33", "headline": "Top Wall Street Forecasters Revamp Monday.com Price Expectations Ahead Of Q3 Earnings", "summary": " ", "symbols": ["MNDY"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41871390/top-wall-street-forecasters-revamp-monday-com-price-expectations-ahead-of-q3-earnings", "tags": ["earnings"]}
{"id": 41871398, "time": "2024-11-11 00:46:15", "headline": "SpaceX Aims To Launch Starship Once Every 2 Weeks By Late 2025, CEO Elon Musk Says 'We Will Be Much Faster'", "summary": "SpaceX is aiming to reach a cadence of one Starship launch every two weeks &#34;faster&#34; than late 2025, company CEO and billionaire Elon Musk said on Sunday.", "symbols": [], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/general/space/24/11/41871398/spacex-aims-to-launch-starship-once-every-2-weeks-by-late-2025-ceo-elon-musk-says-we-will-be-much-faster", "tags": ["management"]}
{"id": 41871407, "time": "2024-11-11 00:48:56", "headline": "Trump's Tariffs, Deportations, And Tax Cuts May Push Prices Higher, Experts Say: 'It's Pretty Clear'", "summary": "President-elect Donald Trump&#39;s proposed economic policies for a potential second term could trigger higher inflation, according to economic experts, despite his promises to lower prices for American consumers.", "symbols": [], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/news/24/11/41871407/trumps-tariffs-deportations-and-tax-cuts-may-push-prices-higher-experts-say-its-pretty-clear", "tags": []}
{"id": 41871434, "time": "2024-11-11 00:56:13", "headline": "Aramark, Live Nation Entertainment And 3 Stocks To Watch Heading Into Monday", "summary": " ", "symbols": ["ARMK", "HE", "IAC", "LYV", "MNDY"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/24/11/41871434/aramark-live-nation-entertainment-and-3-stocks-to-watch-heading-into-monday", "tags": []}
{"id": 41871463, "time": "2024-11-11 01:01:49", "headline": "Dow, S&P 500 Notch Best Week Of Year As Tesla Surges Post Trump Win: Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone", "summary": " ", "symbols": ["AAOI", "ARMK", "LYV", "MNDY", "TSLA"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/24/11/41871463/dow-sp-500-notch-best-week-of-year-as-tesla-surges-post-trump-win-investor-sentiment-improves-fear-greed-index-remains-in-neutral-zone", "tags": []}
{"id": 41871820, "time": "2024-11-11 01:56:52", "headline": "HIVE Digital Technologies Boosts Bitcoin Mining Capacity With 6,500 Avalon A1566 ASIC Miner Order, Launches Major Paraguay Facility", "summary": "", "symbols": ["CAN", "HIVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41871820/hive-digital-technologies-boosts-bitcoin-mining-capacity-with-6-500-avalon-a1566-asic-miner-order-la", "tags": []}
{"id": 41871829, "time": "2024-11-11 02:00:14", "headline": "VEON Expands Digital-First Strategy With RYZE App In Bangladesh, Leveraging AI For Personalized Youth Experiences", "summary": "", "symbols": ["VEON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41871829/veon-expands-digital-first-strategy-with-ryze-app-in-bangladesh-leveraging-ai-for-personalized-youth", "tags": []}
{"id": 41871857, "time": "2024-11-11 02:04:52", "headline": "Addex Therapeutics Preliminary Results Show CHF 1.5M Net Loss In Q3; Cash Position CHF 3.3M As Of September End", "summary": "", "symbols": ["ADXN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41871857/addex-therapeutics-preliminary-results-show-chf-1-5m-net-loss-in-q3-cash-position-chf-3-3m-as-of-sep", "tags": []}
{"id": 41871955, "time": "2024-11-11 02:10:27", "headline": "SpaceX's Dragon Shows Off Capability To Reboost International Space Station For The First Time", "summary": "SpaceX Dragon demonstrated its capability to reboost the International Space Station (ISS) for the first time on Friday, with the spacecraft&#39;s Draco thrusters adjusting the station&#39;s orbit.", "symbols": [], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/general/space/24/11/41871955/spacexs-dragon-shows-off-capability-to-reboost-international-space-station-for-the-first-time", "tags": []}
{"id": 41871966, "time": "2024-11-11 02:12:19", "headline": "ICL Group Q3 2024 Adj. EPS $0.11 Beats $0.08 Estimate, Sales $1.753B Miss $1.788B Estimate", "summary": "", "symbols": ["ICL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41871966/icl-group-q3-2024-adj-eps-0-11-beats-0-08-estimate-sales-1-753b-miss-1-788b-estimate", "tags": ["earnings"]}
{"id": 41872091, "time": "2024-11-11 02:15:13", "headline": "ICL Raised Its FY24 Guidance For Specialties-Driven EBITDA To $0.95B-$1.05B From $0.8B-$1B", "summary": "", "symbols": ["ICL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41872091/icl-raised-its-fy24-guidance-for-specialties-driven-ebitda-to-0-95b-1-05b-from-0-8b-1b", "tags": ["guidance"]}
{"id": 41872140, "time": "2024-11-11 02:26:06", "headline": "Caledonia Mining Q3 EPS $0.26 Down From $0.33 YoY, Sales $46.90M Up From $41.19M YoY", "summary": "", "symbols": ["CMCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41872140/caledonia-mining-q3-eps-0-26-down-from-0-33-yoy-sales-46-90m-up-from-41-19m-yoy", "tags": ["earnings"]}
{"id": 41872141, "time": "2024-11-11 02:27:25", "headline": "Sivers Semiconductors Halts Merger Talks with byNordic Acquisition, Opens Door for New Partners", "summary": "", "symbols": ["BYNO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41872141/sivers-semiconductors-halts-merger-talks-with-bynordic-acquisition-opens-door-for-new-partners", "tags": ["merger"]}
{"id": 41872171, "time": "2024-11-11 02:36:15", "headline": "ASE Technology Reported October Net Revenue Growth Of 1.2% YoY", "summary": "", "symbols": ["ASX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41872171/ase-technology-reported-october-net-revenue-growth-of-1-2-yoy", "tags": ["earnings"]}
{"id": 41872279, "time": "2024-11-11 02:38:21", "headline": "Cathie Wood Predicts Trump's White House Return Will Ignite Reagan-Era Economic Boom Through Deregulation And Tax Cuts: 'Likely To Turbocharge The US Economy'", "summary": "Cathie Wood, founder and CEO of ARK Investment Management LLC, predicts President-elect Donald Trump&#39;s return to the White House will trigger significant economic growth through deregulation and tax cuts, drawing parallels to the economic transformation during former President Ronald Reagan&#39;s administration in the 1980s.", "symbols": ["ARKK"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/24/11/41872279/cathie-wood-predicts-trumps-white-house-return-will-ignite-reagan-era-economic-boom-through-deregulation-and-tax-cuts-likely-to-turbocharge-the-us-economy", "tags": ["management"]}
{"id": 41872302, "time": "2024-11-11 02:41:56", "headline": "Taylor Swift Fans Abandon Elon Musk's X For Bluesky, Says Report: How Trump's Election Victory Triggered Swifties Uprising", "summary": "Taylor Swift&#39;s fanbase is leaving Elon Musk&#39;s social media platform X, following his endorsement of President-elect Donald Trump, with many Swifties finding a new home on Bluesky.", "symbols": [], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/24/11/41872302/taylor-swift-fans-abandon-elon-musks-x-for-bluesky-how-trumps-election-victory-triggered-swifties-uprising", "tags": []}
{"id": 41872323, "time": "2024-11-11 02:44:56", "headline": "Tradeweb And Tokyo Stock Exchange Collaborate To Strengthen Global Access And Liquidity For Japanese ETFs", "summary": "", "symbols": ["TW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41872323/tradeweb-and-tokyo-stock-exchange-collaborate-to-strengthen-global-access-and-liquidity-for-japanese", "tags": []}
{"id": 41872396, "time": "2024-11-11 02:57:15", "headline": "RadNet Q3 2024 Adj. EPS $0.18 Beats $0.15 Estimate, Sales $461.142M Beat $437.879M Estimate", "summary": "", "symbols": ["RDNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41872396/radnet-q3-2024-adj-eps-0-18-beats-0-15-estimate-sales-461-142m-beat-437-879m-estimate", "tags": ["earnings"]}
{"id": 41872410, "time": "2024-11-11 03:01:16", "headline": "Is Stock Market Open Today? A Quick Guide To Markets, Banking Hours And What's Closed On Veterans Day 2024", "summary": "Stock markets will remain active while banks close their doors this Veterans Day, marking a split in financial services operations on the federal holiday. Here&#39;s what you need to know about market trading and banking hours for Monday, Nov 11.", "symbols": ["DIA", "QQQ", "SPY"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/news/global/24/11/41872410/is-stock-market-open-today-a-quick-guide-to-markets-banking-hours-and-whats-closed-on-veterans-day-2024", "tags": []}
{"id": 41872597, "time": "2024-11-11 03:15:25", "headline": "Reported Sunday, Alteogen Secures Exclusive License Deal With Daiichi Sankyo To Develop Subcutaneous Version Of ENHERTU Using Hybrozyme Technology", "summary": "", "symbols": ["DSNKY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41872597/reported-sunday-alteogen-secures-exclusive-license-deal-with-daiichi-sankyo-to-develop-subcutaneous", "tags": ["contract"]}
{"id": 41872600, "time": "2024-11-11 03:16:38", "headline": "Reported Sunday, NOVONIX And Stellantis Forge Six-Year Offtake Agreement, Targeting 115,000 Tonnes Of Synthetic Graphite For North American Battery Production", "summary": "", "symbols": ["NVX", "STLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41872600/reported-sunday-novonix-and-stellantis-forge-six-year-offtake-agreement-targeting-115-000-tonnes-of", "tags": ["contract"]}
{"id": 41872601, "time": "2024-11-11 03:17:56", "headline": "Reported Sunday, Tenaris Begins $700M Share Buyback, Ends March 2025", "summary": "", "symbols": ["TS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41872601/reported-sunday-tenaris-begins-700m-share-buyback-ends-march-2025", "tags": ["buyback"]}
{"id": 41872644, "time": "2024-11-11 03:28:38", "headline": "Reported Saturday, LG Display Debuts Industry-First Stretchable Screen With 50% Elongation", "summary": "", "symbols": ["LPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41872644/reported-saturday-lg-display-debuts-industry-first-stretchable-screen-with-50-elongation", "tags": []}
{"id": 41872654, "time": "2024-11-11 03:30:14", "headline": "Mark Cuban Clarifies Social Media Cleanup Habits After Deleting Posts On VP Kamala Harris: 'I've Always Gone Back And Deleted Tweets'", "summary": "Entrepreneur and Dallas Mavericks owner Mark Cuban addressed questions about his social media practices after users noticed the deletion of posts related to Vice President Kamala Harris, revealing a long-standing habit of clearing his social media history.", "symbols": [], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/general/social-media/24/11/41872654/mark-cuban-clarifies-social-media-cleanup-habits-after-deleting-posts-on-vp-kamala-harris-ive-always-gone-back-and-deleted-tweets", "tags": []}
{"id": 41872672, "time": "2024-11-11 03:32:12", "headline": "Earnings Scheduled For November 11, 2024", "summary": " ", "symbols": ["AGO", "ANGI", "AP", "ARMK", "AROC", "ASRT", "ATER", "BAER", "BIOX", "CCAP", "DDI", "EGY", "FGI", "GATO", "GEO", "GRAB", "GSL", "IAC", "ICL", "ISPR", "IVAC", "JRVR", "LAZR", "LINC", "LYV", "MLYS", "MNDY", "NPWR", "NUWE", "NVRO", "QUIK", "RMR", "SPNS", "STRW", "STXS", "TALO", "TISI", "XAIR", "YALA", "ZETA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41872672/earnings-scheduled-for-november-11-2024", "tags": ["earnings"]}
{"id": 41872684, "time": "2024-11-11 03:33:33", "headline": "Amcor Secures European Patent for Innovative Paper Packaging with Recyclable Barrier", "summary": "", "symbols": ["AMCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/government/24/11/41872684/amcor-secures-european-patent-for-innovative-paper-packaging-with-recyclable-barrier", "tags": []}
{"id": 41872780, "time": "2024-11-11 03:41:45", "headline": "Reported Saturday, ALK Acquires Exclusive Rights To Launch neffy, The First Needle-Free Adrenaline Nasal Spray, In Europe And Canada", "summary": "", "symbols": ["SPRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41872780/reported-saturday-alk-acquires-exclusive-rights-to-launch-neffy-the-first-needle-free-adrenaline-nas", "tags": ["merger"]}
{"id": 41872908, "time": "2024-11-11 04:02:20", "headline": "Reported Saturday, Corvus Pharmaceuticals Presents New Data Showing Ciforadenant's Potential To Overcome Immunotherapy Resistance In Advanced Prostate Cancer", "summary": "", "symbols": ["CRVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41872908/reported-saturday-corvus-pharmaceuticals-presents-new-data-showing-ciforadenants-potential-to-overco", "tags": []}
{"id": 41872968, "time": "2024-11-11 04:12:55", "headline": "Amazon Offers Early Black Friday Deals With Up To $350 Off On Apple MacBooks: Here's More", "summary": "These early Black Friday deals come at a time when Apple is making significant strides in the tech world. ", "symbols": ["AAPL", "AMZN"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/tech/24/11/41872968/amazon-offers-early-black-friday-deals-with-up-to-350-off-on-apple-macbooks-heres-more", "tags": []}
{"id": 41872969, "time": "2024-11-11 04:13:00", "headline": "Reported Saturday, Fate Therapeutics Showcases Cancer-Selective HER2-Targeting Profile Of FT825/ONO-8250 CAR T-Cell Therapy For Advanced Solid Tumors At SITC 2024", "summary": "", "symbols": ["FATE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41872969/reported-saturday-fate-therapeutics-showcases-cancer-selective-her2-targeting-profile-of-ft825ono-82", "tags": []}
{"id": 41873057, "time": "2024-11-11 04:16:54", "headline": "Canaan Secures Major Deal with HIVE for 6,500 High-Power Crypto Miners Amid Expansion Push", "summary": "", "symbols": ["CAN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41873057/canaan-secures-major-deal-with-hive-for-6-500-high-power-crypto-miners-amid-expansion-push", "tags": ["contract"]}
{"id": 41873062, "time": "2024-11-11 04:18:13", "headline": "Piper Sandler Maintains Neutral on Toast, Raises Price Target to $35", "summary": "", "symbols": ["TOST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873062/piper-sandler-maintains-neutral-on-toast-raises-price-target-to-35", "tags": ["analyst_other", "price_target_up"]}
{"id": 41873064, "time": "2024-11-11 04:19:11", "headline": "Tesla Rival Rivian Reports Steep Loss Of About $40K Per EV In Q3 As Deliveries Hit Lowest Since Q1 2023", "summary": "EV company Rivian Automotive reported a gross loss per unit delivered in the third quarter of $39,130, following a drop in deliveries in the three months through the end of September. ", "symbols": ["RIVN"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/24/11/41873064/tesla-rival-rivian-reports-steep-loss-of-about-40k-per-ev-in-q3-as-deliveries-hit-lowest-since-q1-2023", "tags": []}
{"id": 41873077, "time": "2024-11-11 04:20:21", "headline": "Reported Saturday, Replimune Highlights IGNYTE Trial Results Of RP1 And Nivolumab Combo in Anti-PD1 Refractory Melanoma At SITC Annual Meeting", "summary": "", "symbols": ["REPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873077/reported-saturday-replimune-highlights-ignyte-trial-results-of-rp1-and-nivolumab-combo-in-anti-pd1-r", "tags": ["fda"]}
{"id": 41873079, "time": "2024-11-11 04:21:10", "headline": "Piper Sandler Maintains Neutral on Sprout Social, Lowers Price Target to $29", "summary": "", "symbols": ["SPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873079/piper-sandler-maintains-neutral-on-sprout-social-lowers-price-target-to-29", "tags": ["analyst_other", "price_target_down"]}
{"id": 41873085, "time": "2024-11-11 04:24:29", "headline": "Saturday, Ultragenyx Pharmaceutical Announced Phase 1/2 Data In Support Of The Phase 3 Aspire Study For GTX-102 For Angelman Syndrome, Which Will Be Presented At The 2024 Foundation For Angelman Syndrome Therapeutics Global Science Summit, Phase 3 Program To Begin Enrollment By End-Of-Year", "summary": "", "symbols": ["RARE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41873085/saturday-ultragenyx-pharmaceutical-announced-phase-12-data-in-support-of-the-phase-3-aspire-study", "tags": ["fda"]}
{"id": 41873112, "time": "2024-11-11 04:28:14", "headline": "Piper Sandler Assumes Block at Overweight, Announces Price Target of $83", "summary": "", "symbols": ["SQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873112/piper-sandler-assumes-block-at-overweight-announces-price-target-of-83", "tags": []}
{"id": 41873146, "time": "2024-11-11 04:32:23", "headline": "Piper Sandler Maintains Neutral on Lightspeed Commerce, Raises Price Target to $17", "summary": "", "symbols": ["LSPD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873146/piper-sandler-maintains-neutral-on-lightspeed-commerce-raises-price-target-to-17", "tags": ["analyst_other", "price_target_up"]}
{"id": 41873169, "time": "2024-11-11 04:35:52", "headline": "Ascendiant Capital Maintains Buy on Alzamend Neuro, Lowers Price Target to $35", "summary": "", "symbols": ["ALZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873169/ascendiant-capital-maintains-buy-on-alzamend-neuro-lowers-price-target-to-35", "tags": ["analyst_other", "price_target_down"]}
{"id": 41873245, "time": "2024-11-11 04:37:59", "headline": "Reported Friday, Mission Produce Launches Comprehensive Policy To Combat Illegal Deforestation In Mexico's Avocado Industry", "summary": "", "symbols": ["AVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873245/reported-friday-mission-produce-launches-comprehensive-policy-to-combat-illegal-deforestation-in-mex", "tags": []}
{"id": 41873261, "time": "2024-11-11 04:42:23", "headline": "Apple's iOS 18.1 Update Adds 'Inactivity Reboot' To Lock Down Unused iPhones \u2014 Here's How It Protects Your Privacy", "summary": "Apple&#39;s iOS 18.1 update introduces an automatic reboot feature for idle iPhones, enhancing device security by reducing risks of unauthorized access and forensic exploitation.", "symbols": ["AAPL"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/media/24/11/41873261/apples-ios-18-1-update-adds-inactivity-reboot-to-lock-down-unused-iphones-heres-how-it-protects-your-privacy", "tags": []}
{"id": 41873275, "time": "2024-11-11 04:44:39", "headline": "Ascendiant Capital Maintains Buy on Pro-Dex, Raises Price Target to $52", "summary": "", "symbols": ["PDEX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873275/ascendiant-capital-maintains-buy-on-pro-dex-raises-price-target-to-52", "tags": ["analyst_other", "price_target_up"]}
{"id": 41873376, "time": "2024-11-11 04:47:07", "headline": "Needham Reiterates Buy on CompoSecure, Maintains $16 Price Target", "summary": "", "symbols": ["CMPO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873376/needham-reiterates-buy-on-composecure-maintains-16-price-target", "tags": ["analyst_other"]}
{"id": 41873425, "time": "2024-11-11 04:51:01", "headline": "Canaccord Genuity Maintains Buy on Galaxy Digital Hldgs, Raises Price Target to C$36", "summary": "", "symbols": ["TSX:GLXY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873425/canaccord-genuity-maintains-buy-on-galaxy-digital-hldgs-raises-price-target-to-c-36", "tags": ["analyst_other", "price_target_up"]}
{"id": 41873427, "time": "2024-11-11 04:51:14", "headline": "Shiba Inu Lead Developer Shytoshi Kusama Pitches S.H.I.B In Response To Elon Musk's Call For New Roles Recommendations In Trump Administration", "summary": "Shytoshi Kusama, the pseudonymous lead of the Shiba Inu (CRYPTO: SHIB) ecosystem, proposed establishing a Strategic Hub for Innovation in Blockchain, or S.H.I.B., in response to Elon Musk\u2019s invitation to pitch potential roles in the new Donald Trump admi", "symbols": ["SHIBUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41873427/shiba-inu-lead-developer-shytoshi-kusama-pitches-s-h-i-b-in-response-to-elon-musks-call-for-new-roles-recommendations-in-trump-administration", "tags": []}
{"id": 41873458, "time": "2024-11-11 04:56:48", "headline": "Needham Reiterates Hold on Fortinet", "summary": "", "symbols": ["FTNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873458/needham-reiterates-hold-on-fortinet", "tags": ["analyst_other"]}
{"id": 41873461, "time": "2024-11-11 04:58:26", "headline": "Needham Maintains Buy on Genpact, Raises Price Target to $55", "summary": "", "symbols": ["G"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873461/needham-maintains-buy-on-genpact-raises-price-target-to-55", "tags": ["analyst_other", "price_target_up"]}
{"id": 41873476, "time": "2024-11-11 05:00:42", "headline": "Stephens & Co. Maintains Overweight on PAR Technology, Raises Price Target to $83", "summary": "", "symbols": ["PAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873476/stephens-co-maintains-overweight-on-par-technology-raises-price-target-to-83", "tags": ["analyst_other", "price_target_up"]}
{"id": 41873574, "time": "2024-11-11 05:06:56", "headline": "Needham Maintains Buy on PAR Technology, Raises Price Target to $90", "summary": "", "symbols": ["PAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873574/needham-maintains-buy-on-par-technology-raises-price-target-to-90", "tags": ["analyst_other", "price_target_up"]}
{"id": 41873627, "time": "2024-11-11 05:07:41", "headline": "Tectonic Therapeutic Announced Detailed Results From The Phase 1a Clinical Trial Of Its Lead Asset, TX45, The Poster Will Be Presented At The American Heart Association Scientific Sessions", "summary": "", "symbols": ["TECX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41873627/tectonic-therapeutic-announced-detailed-results-from-the-phase-1a-clinical-trial-of-its-lead-asse", "tags": ["fda"]}
{"id": 41873648, "time": "2024-11-11 05:08:15", "headline": "Needham Maintains Buy on Lantronix, Lowers Price Target to $5.5", "summary": "", "symbols": ["LTRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873648/needham-maintains-buy-on-lantronix-lowers-price-target-to-5-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41873650, "time": "2024-11-11 05:10:56", "headline": "Needham Maintains Buy on Teledyne Technologies, Raises Price Target to $550", "summary": "", "symbols": ["TDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873650/needham-maintains-buy-on-teledyne-technologies-raises-price-target-to-550", "tags": ["analyst_other", "price_target_up"]}
{"id": 41873663, "time": "2024-11-11 05:13:40", "headline": "Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket", "summary": " ", "symbols": ["AUTL", "CDT", "COIN", "DWTX", "DXYZ", "FF", "FOXO", "FRES", "HOVR", "JTAI", "LICY", "LWAY", "MARA", "PITA", "PWM", "REVB", "SGN", "SPPL", "TEM", "WTO"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41873663/why-revelation-biosciences-shares-are-trading-higher-by-around-49-here-are-20-stocks-moving-premarket", "tags": ["why_moving"]}
{"id": 41873767, "time": "2024-11-11 05:16:03", "headline": "Cybertruck 'Likely Won't Be Profitable' In Q4, Says Tesla Researcher", "summary": "Tesla Inc researcher\u00a0Troy Teslike is of the opinion that the Cybertruck will likely not be profitable in Q4 given the company has begun selling the regular versions of the vehicle instead of the Foundation series. ", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/tech/24/11/41873767/cybertruck-likely-wont-be-profitable-in-q4-says-tesla-researcher", "tags": []}
{"id": 41873768, "time": "2024-11-11 05:16:14", "headline": "Ascendiant Capital Maintains Buy on Travelzoo, Raises Price Target to $23", "summary": "", "symbols": ["TZOO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873768/ascendiant-capital-maintains-buy-on-travelzoo-raises-price-target-to-23", "tags": ["analyst_other", "price_target_up"]}
{"id": 41873782, "time": "2024-11-11 05:18:15", "headline": "Needham Reiterates Buy on Autolus Therapeutics, Maintains $9 Price Target", "summary": "", "symbols": ["AUTL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873782/needham-reiterates-buy-on-autolus-therapeutics-maintains-9-price-target", "tags": ["analyst_other"]}
{"id": 41873792, "time": "2024-11-11 05:21:17", "headline": "HC Wainwright & Co. Reiterates Buy on Mind Medicine, Maintains $55 Price Target", "summary": "", "symbols": ["MNMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873792/hc-wainwright-co-reiterates-buy-on-mind-medicine-maintains-55-price-target", "tags": ["analyst_other"]}
{"id": 41873795, "time": "2024-11-11 05:23:13", "headline": "BTIG Upgrades Upstart Hldgs to Neutral", "summary": "", "symbols": ["UPST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873795/btig-upgrades-upstart-hldgs-to-neutral", "tags": ["analyst_up"]}
{"id": 41873818, "time": "2024-11-11 05:27:13", "headline": "Cambridge GaN Devices Teams Up with Qorvo to Boost Motor Control Efficiency, Unveil High-Performance Evaluation Kit, Pushing Energy Efficiency in Motor Applications", "summary": "", "symbols": ["QRVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873818/cambridge-gan-devices-teams-up-with-qorvo-to-boost-motor-control-efficiency-unveil-high-performance", "tags": []}
{"id": 41873819, "time": "2024-11-11 05:28:01", "headline": "Guggenheim Downgrades Smartsheet to Neutral", "summary": "", "symbols": ["SMAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873819/guggenheim-downgrades-smartsheet-to-neutral", "tags": ["analyst_down"]}
{"id": 41873823, "time": "2024-11-11 05:29:22", "headline": "JMP Securities Downgrades Agilon Health to Market Perform", "summary": "", "symbols": ["AGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873823/jmp-securities-downgrades-agilon-health-to-market-perform", "tags": ["analyst_down"]}
{"id": 41873824, "time": "2024-11-11 05:29:38", "headline": "US Stocks Likely To Open Higher After Registering Best Week Of Year Following Trump Win: Markets Still Have Juice Left As Investors Eye CPI Data, Says Expert", "summary": "U.S. stocks could get off to a positive start on Monday after the averages registered their best week this year following the reelection of Donald Trump.", "symbols": ["ARMK", "BTCUSD", "DJT", "LYV", "MNDY", "QQQ", "SPY", "TSLA", "TSM"], "source": "benzinga", "author": "Rounak Jain", "url": "https://www.benzinga.com/markets/futures/24/11/41873824/us-stocks-likely-to-open-higher-after-registering-best-week-of-year-following-trump-win-expert-says-markets-still-have-juice-left-as-investors-eye-cpi-data", "tags": []}
{"id": 41873842, "time": "2024-11-11 05:31:00", "headline": "Hannover Rueck Q3 EPS $3.02 Up From $0.99 YoY, Sales $7.46B Up From $6.79B YoY", "summary": "", "symbols": ["HVRRY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41873842/hannover-rueck-q3-eps-3-02-up-from-0-99-yoy-sales-7-46b-up-from-6-79b-yoy", "tags": ["earnings"]}
{"id": 41873845, "time": "2024-11-11 05:31:19", "headline": "Bridgestone Q3 EPS $0.26 Misses $0.37 Estimate, Sales $7.34B Miss $7.45B Estimate", "summary": "", "symbols": ["BRDCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41873845/bridgestone-q3-eps-0-26-misses-0-37-estimate-sales-7-34b-miss-7-45b-estimate", "tags": ["earnings"]}
{"id": 41873881, "time": "2024-11-11 05:36:02", "headline": "Wolfe Research Upgrades Warner Bros. Discovery to Peer Perform", "summary": "", "symbols": ["WBD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873881/wolfe-research-upgrades-warner-bros-discovery-to-peer-perform", "tags": ["analyst_up"]}
{"id": 41873997, "time": "2024-11-11 05:38:42", "headline": "Needham Maintains Buy on Solid Power, Lowers Price Target to $2", "summary": "", "symbols": ["SLDP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41873997/needham-maintains-buy-on-solid-power-lowers-price-target-to-2", "tags": ["analyst_other", "price_target_down"]}
{"id": 41874007, "time": "2024-11-11 05:43:38", "headline": "HC Wainwright & Co. Reiterates Buy on Amprius Technologies, Maintains $10 Price Target", "summary": "", "symbols": ["AMPX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874007/hc-wainwright-co-reiterates-buy-on-amprius-technologies-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 41874155, "time": "2024-11-11 05:46:34", "headline": "HC Wainwright & Co. Reiterates Buy on Sana Biotechnology, Maintains $8 Price Target", "summary": "", "symbols": ["SANA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874155/hc-wainwright-co-reiterates-buy-on-sana-biotechnology-maintains-8-price-target", "tags": ["analyst_other"]}
{"id": 41874163, "time": "2024-11-11 05:49:23", "headline": "Pan Pacific International Q1 EPS $0.23 Down From $0.28 YoY, Sales $3.70B Up From $3.52B YoY", "summary": "", "symbols": ["DQJCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41874163/pan-pacific-international-q1-eps-0-23-down-from-0-28-yoy-sales-3-70b-up-from-3-52b-yoy", "tags": ["earnings"]}
{"id": 41874164, "time": "2024-11-11 05:49:24", "headline": "Sapiens International Reiterated FY24 Adj Revenue Of $541M-$546M (Prior $550M-$555M) Vs $552.69M Est", "summary": "", "symbols": ["SPNS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874164/sapiens-international-reiterated-fy24-adj-revenue-of-541m-546m-prior-550m-555m-vs-552-69m-est", "tags": ["earnings"]}
{"id": 41874165, "time": "2024-11-11 05:49:38", "headline": "Needham Maintains Buy on Vacasa, Lowers Price Target to $3.25", "summary": "", "symbols": ["VCSA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874165/needham-maintains-buy-on-vacasa-lowers-price-target-to-3-25", "tags": ["analyst_other", "price_target_down"]}
{"id": 41874154, "time": "2024-11-11 05:45:51", "headline": "Sapiens Intl Corp Q3 Adj EPS $0.37 Misses $0.38 Estimate, Sales $137.03M Miss $140.07M Estimate", "summary": "", "symbols": ["SPNS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41874154/sapiens-intl-corp-q3-eps-0-37-misses-0-38-estimate-sales-137-03m-miss-140-07m-estimate", "tags": ["earnings"]}
{"id": 41874177, "time": "2024-11-11 05:51:42", "headline": "Needham Reiterates Buy on DraftKings, Maintains $60 Price Target", "summary": "", "symbols": ["DKNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874177/needham-reiterates-buy-on-draftkings-maintains-60-price-target", "tags": ["analyst_other"]}
{"id": 41874182, "time": "2024-11-11 05:53:33", "headline": "Needham Reiterates Hold on Paramount Glb", "summary": "", "symbols": ["PARA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874182/needham-reiterates-hold-on-paramount-glb", "tags": ["analyst_other"]}
{"id": 41874186, "time": "2024-11-11 05:55:37", "headline": "Needham Reiterates Buy on NewAmsterdam Pharma, Maintains $36 Price Target", "summary": "", "symbols": ["NAMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874186/needham-reiterates-buy-on-newamsterdam-pharma-maintains-36-price-target", "tags": ["analyst_other"]}
{"id": 41874194, "time": "2024-11-11 05:57:57", "headline": "EHang Teams Up with Enpower to Boost eVTOL Aircraft Performance, Enhancing Electric Motor Systems", "summary": "", "symbols": ["EH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874194/ehang-teams-up-with-enpower-to-boost-evtol-aircraft-performance-enhancing-electric-motor-systems", "tags": []}
{"id": 41874196, "time": "2024-11-11 05:59:03", "headline": "Needham Reiterates Buy on RingCentral, Maintains $42 Price Target", "summary": "", "symbols": ["RNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874196/needham-reiterates-buy-on-ringcentral-maintains-42-price-target", "tags": ["analyst_other"]}
{"id": 41874251, "time": "2024-11-11 06:02:35", "headline": "Solidion Technology Inks Strategic Memorandum Of Understanding With Bluestar Materials Company Of Taiwan", "summary": "", "symbols": ["STI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874251/solidion-technology-inks-strategic-memorandum-of-understanding-with-bluestar-materials-company-of-ta", "tags": []}
{"id": 41874252, "time": "2024-11-11 06:03:01", "headline": "GE Healthcare And RadNet's Subsidiary DeepHealth, To Collaborate For AI In Imaging, The Companies Aim To Develop SmartTechnology Solutions", "summary": "", "symbols": ["GEHC", "RDNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874252/ge-healthcare-and-radnets-subsidiary-deephealth-to-collaborate-for-ai-in-imaging-the-companies-aim-t", "tags": []}
{"id": 41874253, "time": "2024-11-11 06:03:19", "headline": "IDEAYA Licenses Biocytogen's Antibody Program for Cancer Treatment, Eyes FDA Submission in 2025", "summary": "", "symbols": ["IDYA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/government/24/11/41874253/ideaya-licenses-biocytogens-antibody-program-for-cancer-treatment-eyes-fda-submission-in-2025", "tags": ["fda"]}
{"id": 41874256, "time": "2024-11-11 06:05:38", "headline": "BrainStorm Enters Memorandum Of Understanding With Pluri To Manufacture NurOwn For Use In Planned Phase 3b Trial In Amyotrophic Lateral Sclerosis", "summary": "", "symbols": ["BCLI", "PLUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874256/brainstorm-enters-memorandum-of-understanding-with-pluri-to-manufacture-nurown-for-use-in-planned-ph", "tags": ["fda"]}
{"id": 41874288, "time": "2024-11-11 06:07:13", "headline": "Bitcoin, Ethereum ETFs React As BTC Surges Past $82K After Trump's Win", "summary": "Bitcoin (CRYPTo: BTC) has reached a new milestone, soaring past $82,000, fueled by optimism over a potentially favorable regulatory environment following Donald Trump\u2019s election as U.S. president.", "symbols": ["BITB", "BTC", "EETH", "ETHA", "ETHUSD", "ETHW", "GBTC", "IBIT"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41874288/bitcoin-ethereum-etfs-react-as-btc-surges-past-82k-after-trumps-win", "tags": []}
{"id": 41874368, "time": "2024-11-11 06:09:13", "headline": "TD Cowen Reiterates Buy on Starbucks, Maintains $110 Price Target", "summary": "", "symbols": ["SBUX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874368/td-cowen-reiterates-buy-on-starbucks-maintains-110-price-target", "tags": ["analyst_other"]}
{"id": 41874524, "time": "2024-11-11 06:16:49", "headline": "Asia Mixed And Europe Up, Dollar Gains To 3-Month High - Global Markets Today While US Slept", "summary": "On Nov 8, US markets rallied on Trump&#39;s win, Fed rate cut, &amp; Republican sweep hopes. Consumer sentiment reached 7-month high. Asia markets mixed.", "symbols": ["ADIV", "AGOV", "ASHR", "BBEU", "BOIL", "CQQQ", "DBC", "EEM", "EEMA", "EWU", "EZU", "FLAX", "FXA", "FXB", "FXC", "FXE", "FXI", "GLD", "GSG", "GXC", "IEMG", "IEUR", "IEV", "KDIV", "SPEM", "SPY", "UNG", "USDU", "USO", "UUP", "VGK", "VWO"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/24/11/41874524/asia-mixed-and-europe-rallies-on-trump-optimism-oil-and-gold-weaken-global-markets-today-while-us-slept", "tags": []}
{"id": 41874525, "time": "2024-11-11 06:16:53", "headline": "Needham Reiterates Buy on SkyWater Technology, Maintains $12 Price Target", "summary": "", "symbols": ["SKYT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874525/needham-reiterates-buy-on-skywater-technology-maintains-12-price-target", "tags": ["analyst_other"]}
{"id": 41874534, "time": "2024-11-11 06:17:46", "headline": "Canaan Secures Major Mining Deal With HIVE, Shares Soar On Equipment Order", "summary": "Canaan to supply HIVE Digital Technologies with 6,500 Avalon A1566 miners, boosting stocks for both companies.", "symbols": ["CAN", "HIVE"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41874534/canaan-secures-major-mining-deal-with-hive-shares-soar-on-equipment-order", "tags": ["contract"]}
{"id": 41874537, "time": "2024-11-11 06:18:06", "headline": "As Nvidia Replaces Intel On S&P Dow Jones Indices, Here's A Comparison Of How Both Stocks Performed Over The Past Year", "summary": "As the euphoria pertaining to artificial intelligence has increased in recent years, the 128-year-old Dow Jones Industrial Average index replaced the shares of Intel Corp (NASDAQ: INTC) with Nvidia Corp (NASDAQ: NVDA) in its index.\u00a0", "symbols": ["AAPL", "INTC", "NVDA"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/general/market-summary/24/11/41874537/nvidia-replaces-intel-on-dow-fineprint-of-what-led-to-the-change-along-with-stock-performance", "tags": []}
{"id": 41874548, "time": "2024-11-11 06:18:37", "headline": "Top 4 Health Care Stocks That May Plunge This Quarter", "summary": " ", "symbols": ["AIRS", "NUVB", "PODD", "QDEL"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/short-ideas/24/11/41874548/top-4-health-care-stocks-that-may-plunge-this-quarter", "tags": []}
{"id": 41874549, "time": "2024-11-11 06:18:42", "headline": "HC Wainwright & Co. Reiterates Buy on Soleno Therapeutics, Maintains $70 Price Target", "summary": "", "symbols": ["SLNO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874549/hc-wainwright-co-reiterates-buy-on-soleno-therapeutics-maintains-70-price-target", "tags": ["analyst_other"]}
{"id": 41874553, "time": "2024-11-11 06:18:59", "headline": "Bridgestone Sees FY2024 GAAP EPS JPY 490.69; Sees Sales JPY 4410B.", "summary": "", "symbols": ["BRDCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874553/bridgestone-sees-fy2024-gaap-eps-jpy-490-69-sees-sales-jpy-4410b", "tags": ["earnings"]}
{"id": 41874603, "time": "2024-11-11 06:22:13", "headline": "Park Hotels Reinstates 2024 Outlook: EPS Guidance Set Between $0.68-$0.77 Following Labor Agreements", "summary": "", "symbols": ["PK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874603/park-hotels-reinstates-2024-outlook-eps-guidance-set-between-0-68-0-77-following-labor-agreements", "tags": ["earnings", "guidance"]}
{"id": 41874604, "time": "2024-11-11 06:23:08", "headline": "Needham Reiterates Buy on N-able, Maintains $16.5 Price Target", "summary": "", "symbols": ["NABL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874604/needham-reiterates-buy-on-n-able-maintains-16-5-price-target", "tags": ["analyst_other"]}
{"id": 41873479, "time": "2024-11-11 05:02:16", "headline": "After Anthony Scaramucci, FTX Sues Binance And Ex-CEO Changpeng 'CZ' Zhao To Reclaim $1.8B Amid Bankruptcy Tussle", "summary": "In the latest development in the FTX bankruptcy case, the collapsed entity has launched a lawsuit against cryptocurrency exchange Binance (CRYPTO: BNB), aiming to reclaim $1.8 billion.", "symbols": ["BNBUSD", "BUSDUSD", "FTTUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41873479/after-anthony-scaramucci-ftx-sues-binance-and-ex-ceo-changpeng-cz-zhao-to-reclaim-1-8b-amid-bankruptcy-tussle", "tags": ["legal", "management"]}
{"id": 41874605, "time": "2024-11-11 06:25:24", "headline": "Michael Saylor's MicroStrategy Racks Up Over $10B In Unrealized Profit As Bitcoin Blows Past $82K", "summary": "Bitcoin (CRYPTO: BTC) flew above $82,000 early Monday morning as the blistering rally sparked by Donald Trump&#39;s presidential victory continued to bring riches to investors, particularly those with very large holdings.", "symbols": ["BTCUSD", "MSTR"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41874605/michael-saylors-microstrategy-racks-up-over-10b-in-unrealized-profit-as-bitcoin-blows-past-82k", "tags": []}
{"id": 41874626, "time": "2024-11-11 06:27:56", "headline": "HC Wainwright & Co. Reiterates Buy on Mural Oncology, Maintains $18 Price Target", "summary": "", "symbols": ["MURA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874626/hc-wainwright-co-reiterates-buy-on-mural-oncology-maintains-18-price-target", "tags": ["analyst_other"]}
{"id": 41874627, "time": "2024-11-11 06:28:06", "headline": "BMO Capital Downgrades Celanese to Underperform, Lowers Price Target to $76", "summary": "", "symbols": ["CE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874627/bmo-capital-downgrades-celanese-to-underperform-lowers-price-target-to-76", "tags": ["analyst_down", "price_target_down"]}
{"id": 41874668, "time": "2024-11-11 06:30:23", "headline": "B of A Securities Upgrades Tanger to Buy, Raises Price Target to $40", "summary": "", "symbols": ["SKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874668/b-of-a-securities-upgrades-tanger-to-buy-raises-price-target-to-40", "tags": ["analyst_up", "price_target_up"]}
{"id": 41874682, "time": "2024-11-11 06:31:48", "headline": "SpringWorks Unveils Results from Phase 2b Trial for Rare Tumor Treatment", "summary": "", "symbols": ["SWTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874682/springworks-unveils-results-from-phase-2b-trial-for-rare-tumor-treatment", "tags": ["fda"]}
{"id": 41874685, "time": "2024-11-11 06:33:25", "headline": "TD Cowen Downgrades GCM Grosvenor to Hold, Announces $12.5 Price Target", "summary": "", "symbols": ["GCMG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874685/td-cowen-downgrades-gcm-grosvenor-to-hold-announces-12-5-price-target", "tags": ["analyst_down"]}
{"id": 41874686, "time": "2024-11-11 06:33:26", "headline": "Babcock & Wilcox Partners with Swedish Plant, Aiming to Cut 400,000 Tonnes of CO2", "summary": "", "symbols": ["BW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874686/babcock-wilcox-partners-with-swedish-plant-aiming-to-cut-400-000-tonnes-of-co2", "tags": ["contract"]}
{"id": 41874687, "time": "2024-11-11 06:34:00", "headline": "Pan Pacific International Sees FY2025 GAAP EPS JPY 144.9; Sees Sales JPY 2,220B.", "summary": "", "symbols": ["DQJCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874687/pan-pacific-international-sees-fy2025-gaap-eps-jpy-144-9-sees-sales-jpy-2-220b", "tags": ["earnings"]}
{"id": 41874689, "time": "2024-11-11 06:34:10", "headline": "Deutsche Bank Upgrades Cboe Global Markets to Buy, Raises Price Target to $222", "summary": "", "symbols": ["CBOE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874689/deutsche-bank-upgrades-cboe-global-markets-to-buy-raises-price-target-to-222", "tags": ["analyst_up", "price_target_up"]}
{"id": 41874691, "time": "2024-11-11 06:35:32", "headline": "Chinese EV Maker BYD Edges Closer To Ford's Sales Volume After Beating Tesla In Revenue Race", "summary": "Chinese EV maker BYD Co Ltd is closing in fast on Michigan-based Ford Motor Co&#39;s global sales despite the former not manufacturing combustion engine vehicles. ", "symbols": ["BYDDF", "BYDDY", "F"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/24/11/41874691/chinese-ev-maker-byd-is-now-closing-in-on-fords-global-sales-volume-after-beating-tesla-in-revenue", "tags": ["earnings"]}
{"id": 41874692, "time": "2024-11-11 06:35:49", "headline": "Aramark Q4 2024 Adj EPS $0.54 Beats $0.53 Estimate, Sales $4.42B Miss $4.46B Estimate", "summary": "", "symbols": ["ARMK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41874692/aramark-q4-2024-adj-eps-0-54-beats-0-53-estimate-sales-4-42b-miss-4-46b-estimate", "tags": ["earnings"]}
{"id": 41874713, "time": "2024-11-11 06:36:18", "headline": "Hyperscale Data Moves Ahead with Stock Split Plan, Shareholders Approve Up to 1-for-35", "summary": "", "symbols": ["GPUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874713/hyperscale-data-moves-ahead-with-stock-split-plan-shareholders-approve-up-to-1-for-35", "tags": []}
{"id": 41874714, "time": "2024-11-11 06:36:37", "headline": "Aramark Board Approves New $500M Share Repurchase Program In Early November", "summary": "", "symbols": ["ARMK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874714/aramark-board-approves-new-500m-share-repurchase-program-in-early-november", "tags": ["buyback"]}
{"id": 41874716, "time": "2024-11-11 06:37:13", "headline": "Morgan Stanley Maintains Overweight on NVIDIA, Raises Price Target to $160", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874716/morgan-stanley-maintains-overweight-on-nvidia-raises-price-target-to-160", "tags": ["analyst_other", "price_target_up"]}
{"id": 41874718, "time": "2024-11-11 06:37:39", "headline": "TD Cowen Downgrades Osisko Gold Royalties to Hold, Announces C$31 Price Target", "summary": "", "symbols": ["OR", "TSX:OR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874718/td-cowen-downgrades-osisko-gold-royalties-to-hold-announces-c-31-price-target", "tags": ["analyst_down"]}
{"id": 41874820, "time": "2024-11-11 06:38:15", "headline": "CGI Teams Up with Wounded Warrior Project for New Veteran Support Platform", "summary": "", "symbols": ["GIB", "TSX:GIB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874820/cgi-teams-up-with-wounded-warrior-project-for-new-veteran-support-platform", "tags": []}
{"id": 41874821, "time": "2024-11-11 06:38:29", "headline": "Aramark's Board Approves 11% Increase To Quarterly Dividend From $0.095 To $0.105 Per Share", "summary": "", "symbols": ["ARMK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874821/aramarks-board-approves-11-increase-to-quarterly-dividend-from-0-095-to-0-105-per-share", "tags": ["dividend"]}
{"id": 41874248, "time": "2024-11-11 06:02:04", "headline": "Reuters Reported Amazon Is Developing Smart Eyeglasses To Help Delivery Drivers To Guide Them To, Around And Within Building", "summary": "", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874248/reuters-reported-amazon-is-developing-smart-eyeglasses-to-help-delivery-drivers-to-guide-them-to-aro", "tags": []}
{"id": 41874825, "time": "2024-11-11 06:40:36", "headline": "Mizuho Downgrades Immunocore Hldgs to Neutral, Lowers Price Target to $38", "summary": "", "symbols": ["IMCR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874825/mizuho-downgrades-immunocore-hldgs-to-neutral-lowers-price-target-to-38", "tags": ["analyst_down", "price_target_down"]}
{"id": 41874826, "time": "2024-11-11 06:40:37", "headline": "Aramark Expects FY25 Organic Revenue Of +7.5% \u2014 +9.5%, Adjusted EPS Of +23% \u2014 +28%", "summary": "", "symbols": ["ARMK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874826/aramark-expects-fy25-organic-revenue-of-7-5-9-5-adjusted-eps-of-23-28", "tags": ["earnings"]}
{"id": 41874828, "time": "2024-11-11 06:41:15", "headline": "GoldMining Unveils Promising Drill Results at S\u00e3o Jorge Project, Eyes Expansion in Brazil", "summary": "", "symbols": ["GLDG", "TSX:GOLD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/government/24/11/41874828/goldmining-unveils-promising-drill-results-at-s-o-jorge-project-eyes-expansion-in-brazil", "tags": []}
{"id": 41874832, "time": "2024-11-11 06:44:44", "headline": "Oppenheimer Downgrades WhiteHorse Finance to Perform, Lowers Price Target to $12", "summary": "", "symbols": ["WHF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874832/oppenheimer-downgrades-whitehorse-finance-to-perform-lowers-price-target-to-12", "tags": ["analyst_down", "price_target_down"]}
{"id": 41874839, "time": "2024-11-11 06:45:27", "headline": "HC Wainwright & Co. Reiterates Neutral on Co-Diagnostics, Maintains $1.5 Price Target", "summary": "", "symbols": ["CODX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874839/hc-wainwright-co-reiterates-neutral-on-co-diagnostics-maintains-1-5-price-target", "tags": ["analyst_other"]}
{"id": 41874980, "time": "2024-11-11 06:46:44", "headline": "Inspire Medical Accelerates $75M Stock Repurchase as Part of $150M Buyback Plan", "summary": "", "symbols": ["INSP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874980/inspire-medical-accelerates-75m-stock-repurchase-as-part-of-150m-buyback-plan", "tags": ["buyback"]}
{"id": 41874986, "time": "2024-11-11 06:47:39", "headline": "Piper Sandler Downgrades Xeris Biopharma Holdings to Neutral, Maintains Price Target to $3", "summary": "", "symbols": ["XERS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874986/piper-sandler-downgrades-xeris-biopharma-holdings-to-neutral-maintains-price-target-to-3", "tags": ["analyst_down", "analyst_other"]}
{"id": 41874989, "time": "2024-11-11 06:48:52", "headline": "Invitation Homes Pays Off $630M Loan Early, Eases Debt Burden Until 2027", "summary": "", "symbols": ["INVH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874989/invitation-homes-pays-off-630m-loan-early-eases-debt-burden-until-2027", "tags": []}
{"id": 41874995, "time": "2024-11-11 06:50:27", "headline": "HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $12 Price Target", "summary": "", "symbols": ["LFMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874995/hc-wainwright-co-reiterates-buy-on-lifemd-maintains-12-price-target", "tags": ["analyst_other"]}
{"id": 41874997, "time": "2024-11-11 06:51:16", "headline": "Piper Sandler Maintains Overweight on NVIDIA, Raises Price Target to $175", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874997/piper-sandler-maintains-overweight-on-nvidia-raises-price-target-to-175", "tags": ["analyst_other", "price_target_up"]}
{"id": 41874998, "time": "2024-11-11 06:52:01", "headline": "Seaport Global Downgrades NVR to Neutral", "summary": "", "symbols": ["NVR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41874998/seaport-global-downgrades-nvr-to-neutral", "tags": ["analyst_down"]}
{"id": 41875006, "time": "2024-11-11 06:54:31", "headline": "Raymond James Downgrades Tidewater to Outperform, Lowers Price Target to $102", "summary": "", "symbols": ["TDW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875006/raymond-james-downgrades-tidewater-to-outperform-lowers-price-target-to-102", "tags": ["analyst_down", "price_target_down"]}
{"id": 41875007, "time": "2024-11-11 06:54:45", "headline": "HC Wainwright & Co. Reiterates Buy on Aquestive Therapeutics, Maintains $10 Price Target", "summary": "", "symbols": ["AQST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875007/hc-wainwright-co-reiterates-buy-on-aquestive-therapeutics-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 41875036, "time": "2024-11-11 06:56:31", "headline": "Canaccord Genuity Maintains Hold on Payfare, Lowers Price Target to C$2", "summary": "", "symbols": ["TSX:PAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875036/canaccord-genuity-maintains-hold-on-payfare-lowers-price-target-to-c-2", "tags": ["analyst_other", "price_target_down"]}
{"id": 41875037, "time": "2024-11-11 06:56:59", "headline": "Priceline Kicks Off Black Friday Travel Sale, Includes Flash Deals and Partner Offers", "summary": "", "symbols": ["BKNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875037/priceline-kicks-off-black-friday-travel-sale-includes-flash-deals-and-partner-offers", "tags": []}
{"id": 41875038, "time": "2024-11-11 06:57:22", "headline": "B. Riley Securities Upgrades Universal Electronics to Buy, Raises Price Target to $14", "summary": "", "symbols": ["UEIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875038/b-riley-securities-upgrades-universal-electronics-to-buy-raises-price-target-to-14", "tags": ["analyst_up", "price_target_up"]}
{"id": 41875040, "time": "2024-11-11 06:57:44", "headline": "Tradeweb Expands Horizons With TSE Partnership, Boosting Access To Japanese ETFs", "summary": "Tradeweb partners with Tokyo Stock Exchange to improve access to Japanese ETF liquidity, expanding its ETF platform and global trading volume.", "symbols": ["BCDF", "NBDS", "TW"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/contracts/24/11/41875040/tradeweb-expands-horizons-with-tse-partnership-boosting-access-to-japanese-etfs", "tags": ["contract"]}
{"id": 41875041, "time": "2024-11-11 06:57:52", "headline": "HC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target", "summary": "", "symbols": ["ENTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875041/hc-wainwright-co-reiterates-buy-on-entera-bio-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 41875054, "time": "2024-11-11 06:59:17", "headline": "Telsey Advisory Group Maintains Outperform on Holley, Lowers Price Target to $4.5", "summary": "", "symbols": ["HLLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875054/telsey-advisory-group-maintains-outperform-on-holley-lowers-price-target-to-4-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41875055, "time": "2024-11-11 06:59:25", "headline": "Roth MKM Initiates Coverage On TriSalus Life Sciences with Buy Rating, Announces Price Target of $11", "summary": "", "symbols": ["TLSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875055/roth-mkm-initiates-coverage-on-trisalus-life-sciences-with-buy-rating-announces-price-target-of-11", "tags": ["analyst_init"]}
{"id": 41875058, "time": "2024-11-11 06:59:38", "headline": "HC Wainwright & Co. Reiterates Buy on Coya Therapeutics, Maintains $18 Price Target", "summary": "", "symbols": ["COYA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875058/hc-wainwright-co-reiterates-buy-on-coya-therapeutics-maintains-18-price-target", "tags": ["analyst_other"]}
{"id": 41875112, "time": "2024-11-11 07:00:23", "headline": "The Latest Analyst Ratings For Smartsheet", "summary": " ", "symbols": ["SMAR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41875112/the-latest-analyst-ratings-for-smartsheet", "tags": []}
{"id": 41875114, "time": "2024-11-11 07:00:31", "headline": "NewAmsterdam Pharma Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)", "summary": " ", "symbols": ["NAMS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41875114/newamsterdam-pharma-stock-a-deep-dive-into-analyst-perspectives-5-ratings", "tags": []}
{"id": 41875115, "time": "2024-11-11 07:00:38", "headline": "Beyond The Numbers: 23 Analysts Discuss DraftKings Stock", "summary": " ", "symbols": ["DKNG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41875115/beyond-the-numbers-23-analysts-discuss-draftkings-stock", "tags": []}
{"id": 41875116, "time": "2024-11-11 07:00:44", "headline": "Telsey Advisory Group Maintains Market Perform on Floor & Decor Hldgs, Maintains $95 Price Target", "summary": "", "symbols": ["FND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875116/telsey-advisory-group-maintains-market-perform-on-floor-decor-hldgs-maintains-95-price-target", "tags": ["analyst_other"]}
{"id": 41875117, "time": "2024-11-11 07:00:49", "headline": "Beyond The Numbers: 4 Analysts Discuss Holley Stock", "summary": " ", "symbols": ["HLLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41875117/beyond-the-numbers-4-analysts-discuss-holley-stock", "tags": []}
{"id": 41875118, "time": "2024-11-11 07:00:57", "headline": "Navigating 8 Analyst Ratings For Immunocore Hldgs", "summary": " ", "symbols": ["IMCR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41875118/navigating-8-analyst-ratings-for-immunocore-hldgs", "tags": []}
{"id": 41875121, "time": "2024-11-11 07:01:00", "headline": "Monday.Com Q3 2024 Adj. EPS $0.85 Beats $0.63 Estimate, Sales $251.000M Beat $246.095M Estimate", "summary": "", "symbols": ["MNDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41875121/monday-com-q3-2024-adj-eps-0-85-beats-0-63-estimate-sales-251-000m-beat-246-095m-estimate", "tags": ["earnings"]}
{"id": 41875123, "time": "2024-11-11 07:01:04", "headline": "Stifel Downgrades Tempus AI to Hold, Raises Price Target to $65", "summary": "", "symbols": ["TEM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875123/stifel-downgrades-tempus-ai-to-hold-raises-price-target-to-65", "tags": ["analyst_down", "price_target_up"]}
{"id": 41875124, "time": "2024-11-11 07:01:06", "headline": "HC Wainwright & Co. Reiterates Buy on Oculis Holding, Maintains $30 Price Target", "summary": "", "symbols": ["OCS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875124/hc-wainwright-co-reiterates-buy-on-oculis-holding-maintains-30-price-target", "tags": ["analyst_other"]}
{"id": 41875125, "time": "2024-11-11 07:01:06", "headline": "In-Depth Examination Of 8 Analyst Recommendations For Tanger", "summary": " ", "symbols": ["SKT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41875125/in-depth-examination-of-8-analyst-recommendations-for-tanger", "tags": []}
{"id": 41875146, "time": "2024-11-11 07:02:24", "headline": "Bristol Myers Squibb To Showcase Cardiovascular Breakthroughs At AHA, Including New CAMZYOS Data", "summary": "", "symbols": ["BMY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875146/bristol-myers-squibb-to-showcase-cardiovascular-breakthroughs-at-aha-including-new-camzyos-data", "tags": []}
{"id": 41875154, "time": "2024-11-11 07:03:03", "headline": "Chimerix Announced Upcoming Presentations At The 2024 Society For Neuro-oncology Annual Meeting, Including Updated Phase 2 Response Assessment Of Dordaviprone In Recurrent H3 K27M Glioma", "summary": "", "symbols": ["CMRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41875154/chimerix-announced-upcoming-presentations-at-the-2024-society-for-neuro-oncology-annual-meeting-i", "tags": ["fda"]}
{"id": 41875164, "time": "2024-11-11 07:03:39", "headline": "Pitney Bowes Expects Q4 Revenue Of $505M - $515M, Est $489.772M", "summary": "", "symbols": ["PBI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875164/pitney-bowes-expects-q4-revenue-of-505m-515m-est-489-772m", "tags": ["earnings"]}
{"id": 41875165, "time": "2024-11-11 07:03:40", "headline": "SpringWorks Therapeutics To Present Mirdametinib Data At The 2024 Society For Neuro-Oncology Annual Meeting", "summary": "", "symbols": ["SWTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875165/springworks-therapeutics-to-present-mirdametinib-data-at-the-2024-society-for-neuro-oncology-annual", "tags": []}
{"id": 41875163, "time": "2024-11-11 07:03:37", "headline": "NuCana Shares Results For Cancer Therapy, Sees Partial Responses In Phase 1b/2 Study", "summary": "", "symbols": ["NCNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875163/nucana-shares-promising-results-for-cancer-therapy-sees-partial-responses-in-phase-1b2-study", "tags": []}
{"id": 41875180, "time": "2024-11-11 07:04:37", "headline": "Can-Fite Biopharma Has Started Dosing Of The First Patient In The Phase 2a Trial In Patients With Advanced Pancreatic Adenocarcinoma", "summary": "", "symbols": ["CANF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41875180/can-fite-biopharma-has-started-dosing-of-the-first-patient-in-the-phase-2a-trial-in-patients-with", "tags": ["fda"]}
{"id": 41875187, "time": "2024-11-11 07:05:45", "headline": "Pitney Bowes Expects SendTech's Revenue To Flatten Out By The Start Of FY26", "summary": "", "symbols": ["PBI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875187/pitney-bowes-expects-sendtechs-revenue-to-flatten-out-by-the-start-of-fy26", "tags": ["earnings"]}
{"id": 41875194, "time": "2024-11-11 07:06:26", "headline": "monday.com Expects Q4 Revenue Of $260M-$262M Vs $246.1M Est", "summary": "", "symbols": ["MNDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875194/monday-com-expects-q4-revenue-of-260m-262m-vs-246-1m-est", "tags": ["earnings"]}
{"id": 41875316, "time": "2024-11-11 07:09:08", "headline": "Climb Bio Appoints Douglas E. Williams As Chair Of Its Board Of Directors", "summary": "", "symbols": ["CLYM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875316/climb-bio-appoints-douglas-e-williams-as-chair-of-its-board-of-directors", "tags": ["management"]}
{"id": 41875317, "time": "2024-11-11 07:09:34", "headline": "monday.com Ltd Expects FY24 Revenue Of $964M-$966M (Prior $956M-$961M) Vs $960.23M Est", "summary": "", "symbols": ["MNDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875317/monday-com-ltd-expects-fy24-revenue-of-964m-966m-prior-956m-961m-vs-960-23m-est", "tags": ["earnings"]}
{"id": 41875318, "time": "2024-11-11 07:10:19", "headline": "First Watch Restaurant Acquires 16 Franchise Locations In North And South Carolina For $49M", "summary": "", "symbols": ["FWRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875318/first-watch-restaurant-acquires-16-franchise-locations-in-north-and-south-carolina-for-49m", "tags": ["merger"]}
{"id": 41875331, "time": "2024-11-11 07:11:38", "headline": "The FDA Has Accepted Unicycive Therapeutics' New Drug Application For Oxylanthanum Carbonate For Hyperphosphatemia In Chronic Kidney Disease Patients On Dialysis And Has Set A Prescription Drug User Fee Act Target Action Date Of June 28, 2025", "summary": "", "symbols": ["UNCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41875331/the-fda-has-accepted-unicycive-therapeutics-new-drug-application-for-oxylanthanum-carbonate-for-h", "tags": ["fda"]}
{"id": 41875338, "time": "2024-11-11 07:12:32", "headline": "Ispire Technology Q1 2025 GAAP EPS $(0.10) Misses $(0.06) Estimate, Sales $39.338M Miss $51.660M Estimate", "summary": "", "symbols": ["ISPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41875338/ispire-technology-q1-2025-gaap-eps-0-10-misses-0-06-estimate-sales-39-338m-miss-51-660m-estimate", "tags": ["earnings"]}
{"id": 41875341, "time": "2024-11-11 07:14:16", "headline": "Moleculin Biotech Q3 2024 GAAP EPS $(2.85) Misses $(2.80) Estimate, Cash And Cash Equivalents Of $9.4M, Expected To Be Sufficient To Fund Planned Operations Into Q1 2025", "summary": "", "symbols": ["MBRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41875341/moleculin-biotech-q3-2024-gaap-eps-2-85-misses-2-80-estimate-cash-and-cash-equivalents-of-9-4m-expe", "tags": ["earnings"]}
{"id": 41875342, "time": "2024-11-11 07:14:49", "headline": "HC Wainwright & Co. Maintains Buy on EyePoint Pharmaceuticals, Lowers Price Target to $22", "summary": "", "symbols": ["EYPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875342/hc-wainwright-co-maintains-buy-on-eyepoint-pharmaceuticals-lowers-price-target-to-22", "tags": ["analyst_other", "price_target_down"]}
{"id": 41875347, "time": "2024-11-11 07:15:17", "headline": "India's Business Standard Reported New Study Claims Mpox Clade la Has Evolved To Spread From Human To Human, Citing October 24 Uploaded Paper On Virologica", "summary": "", "symbols": ["EBS", "GOVX", "MRNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875347/indias-business-standard-reported-new-study-claims-mpox-clade-la-has-evolved-to-spread-from-human-to", "tags": []}
{"id": 41875465, "time": "2024-11-11 07:16:26", "headline": "RYVYL Reaches MOU Agreement To Settle Senior Note And Series B Preferred Stock, Announces $16.5M Repayment Plan By January 2025", "summary": "", "symbols": ["RVYL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875465/ryvyl-reaches-mou-agreement-to-settle-senior-note-and-series-b-preferred-stock-announces-16-5m-repay", "tags": ["contract"]}
{"id": 41875587, "time": "2024-11-11 07:16:59", "headline": "TriSalus Teams Up With Veteran-Owned Geo-Med To Boost Cancer Treatment Access At VA Centers", "summary": "", "symbols": ["TLSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875587/trisalus-teams-up-with-veteran-owned-geo-med-to-boost-cancer-treatment-access-at-va-centers", "tags": []}
{"id": 41875588, "time": "2024-11-11 07:17:15", "headline": "This Celanese Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday", "summary": " ", "symbols": ["AGL", "CE", "NVR", "SMAR", "TDW"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41875588/this-celanese-analyst-turns-bearish-here-are-top-5-downgrades-for-monday", "tags": ["analyst_down"]}
{"id": 41875599, "time": "2024-11-11 07:17:39", "headline": "Morgan Stanley Maintains Overweight on Insulet, Raises Price Target to $317", "summary": "", "symbols": ["PODD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875599/morgan-stanley-maintains-overweight-on-insulet-raises-price-target-to-317", "tags": ["analyst_other", "price_target_up"]}
{"id": 41875600, "time": "2024-11-11 07:18:28", "headline": "HC Wainwright & Co. Downgrades Ardelyx to Neutral, Announces $5.5 Price Target", "summary": "", "symbols": ["ARDX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875600/hc-wainwright-co-downgrades-ardelyx-to-neutral-announces-5-5-price-target", "tags": ["analyst_down"]}
{"id": 41875601, "time": "2024-11-11 07:18:37", "headline": "Morgan Stanley Maintains Equal-Weight on Solventum, Raises Price Target to $73", "summary": "", "symbols": ["SOLV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875601/morgan-stanley-maintains-equal-weight-on-solventum-raises-price-target-to-73", "tags": ["analyst_other", "price_target_up"]}
{"id": 41875609, "time": "2024-11-11 07:20:08", "headline": "Morgan Stanley Maintains Equal-Weight on Globus Medical, Raises Price Target to $83", "summary": "", "symbols": ["GMED"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875609/morgan-stanley-maintains-equal-weight-on-globus-medical-raises-price-target-to-83", "tags": ["analyst_other", "price_target_up"]}
{"id": 41875610, "time": "2024-11-11 07:20:33", "headline": "Jefferies Upgrades Mercury Sys to Hold, Raises Price Target to $42", "summary": "", "symbols": ["MRCY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875610/jefferies-upgrades-mercury-sys-to-hold-raises-price-target-to-42", "tags": ["analyst_up", "price_target_up"]}
{"id": 41875614, "time": "2024-11-11 07:21:10", "headline": "Morgan Stanley Maintains Equal-Weight on Sight Sciences, Lowers Price Target to $5", "summary": "", "symbols": ["SGHT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875614/morgan-stanley-maintains-equal-weight-on-sight-sciences-lowers-price-target-to-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41875622, "time": "2024-11-11 07:22:16", "headline": "Morgan Stanley Maintains Overweight on Dell Technologies, Raises Price Target to $154", "summary": "", "symbols": ["DELL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875622/morgan-stanley-maintains-overweight-on-dell-technologies-raises-price-target-to-154", "tags": ["analyst_other", "price_target_up"]}
{"id": 41875623, "time": "2024-11-11 07:22:24", "headline": "JP Morgan Downgrades Cabot to Underweight, Maintains Price Target to $105", "summary": "", "symbols": ["CBT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875623/jp-morgan-downgrades-cabot-to-underweight-maintains-price-target-to-105", "tags": ["analyst_down", "analyst_other"]}
{"id": 41875624, "time": "2024-11-11 07:22:32", "headline": "Tesla Bull Hikes Elon Musk's EV Giant's Price Target To $400 As Stock Rallies 47% In One Month", "summary": "Wedbush analyst Dan Ives on Monday raised his price target on Tesla Inc from $300 to $400, in the hope that Donald Trump winning the Presidential election will be a &#34;gamechanger&#34; for the EV giant spearheaded by billionaire Elon Musk. ", "symbols": ["TSLA"], "source": "benzinga", "author": "Anan Ashraf", "url": "https://www.benzinga.com/analyst-ratings/price-target/24/11/41875624/tesla-bull-hikes-elon-musks-ev-giants-price-target-to-400-as-stock-rallies-47-in-one-month", "tags": []}
{"id": 41875637, "time": "2024-11-11 07:23:40", "headline": "JP Morgan Upgrades Orion to Overweight, Raises Price Target to $21", "summary": "", "symbols": ["OEC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875637/jp-morgan-upgrades-orion-to-overweight-raises-price-target-to-21", "tags": ["analyst_up", "price_target_up"]}
{"id": 41875638, "time": "2024-11-11 07:23:42", "headline": "Morgan Stanley Maintains Equal-Weight on Corpay, Raises Price Target to $350", "summary": "", "symbols": ["CPAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875638/morgan-stanley-maintains-equal-weight-on-corpay-raises-price-target-to-350", "tags": ["analyst_other", "price_target_up"]}
{"id": 41875643, "time": "2024-11-11 07:25:15", "headline": "Tesla Stock Gains Over 7% In Monday Pre Market: What's Going On?", "summary": "The ongoing rally in Tesla&#39;s stock price is noteworthy, especially in the context of the recent U.S. Presidential election.", "symbols": ["TSLA"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/tech/24/11/41875643/tesla-stock-gains-over-7-in-monday-pre-market-whats-going-on", "tags": ["why_moving"]}
{"id": 41875650, "time": "2024-11-11 07:25:36", "headline": "Morgan Stanley Maintains Equal-Weight on P10, Raises Price Target to $13", "summary": "", "symbols": ["PX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875650/morgan-stanley-maintains-equal-weight-on-p10-raises-price-target-to-13", "tags": ["analyst_other", "price_target_up"]}
{"id": 41875651, "time": "2024-11-11 07:25:39", "headline": "HC Wainwright & Co. Reiterates Buy on 89bio, Maintains $29 Price Target", "summary": "", "symbols": ["ETNB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875651/hc-wainwright-co-reiterates-buy-on-89bio-maintains-29-price-target", "tags": ["analyst_other"]}
{"id": 41875654, "time": "2024-11-11 07:26:43", "headline": "Morgan Stanley Maintains Equal-Weight on Victory Capital Holdings, Raises Price Target to $64", "summary": "", "symbols": ["VCTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875654/morgan-stanley-maintains-equal-weight-on-victory-capital-holdings-raises-price-target-to-64", "tags": ["analyst_other", "price_target_up"]}
{"id": 41875754, "time": "2024-11-11 07:27:14", "headline": "HC Wainwright & Co. Reiterates Buy on Regulus Therapeutics, Maintains $10 Price Target", "summary": "", "symbols": ["RGLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875754/hc-wainwright-co-reiterates-buy-on-regulus-therapeutics-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 41875755, "time": "2024-11-11 07:28:13", "headline": "This Upstart Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday", "summary": " ", "symbols": ["MRCY", "SKT", "UEIC", "UPST", "WBD"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41875755/this-upstart-analyst-is-no-longer-bearish-here-are-top-5-upgrades-for-monday", "tags": ["analyst_up"]}
{"id": 41875756, "time": "2024-11-11 07:28:15", "headline": "Morgan Stanley Maintains Equal-Weight on Madison Square Garden, Lowers Price Target to $44", "summary": "", "symbols": ["MSGE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875756/morgan-stanley-maintains-equal-weight-on-madison-square-garden-lowers-price-target-to-44", "tags": ["analyst_other", "price_target_down"]}
{"id": 41875764, "time": "2024-11-11 07:28:41", "headline": "HC Wainwright & Co. Reiterates Buy on Annovis Bio, Maintains $30 Price Target", "summary": "", "symbols": ["ANVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875764/hc-wainwright-co-reiterates-buy-on-annovis-bio-maintains-30-price-target", "tags": ["analyst_other"]}
{"id": 41875892, "time": "2024-11-11 07:30:48", "headline": "JP Morgan Upgrades Cisco Systems to Overweight, Raises Price Target to $66", "summary": "", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875892/jp-morgan-upgrades-cisco-systems-to-overweight-raises-price-target-to-66", "tags": ["analyst_up", "price_target_up"]}
{"id": 41875894, "time": "2024-11-11 07:31:30", "headline": "Super Micro Computer Shares Are Down By Over 4% In Pre-Market: What's Going On?", "summary": "Super Micro is facing potential delisting threats. ", "symbols": ["NVDA", "SMCI"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/markets/equities/24/11/41875894/super-micro-computer-shares-are-down-by-over-4-in-pre-market-whats-going-on", "tags": ["why_moving"]}
{"id": 41875932, "time": "2024-11-11 07:32:27", "headline": "JP Morgan Upgrades Valley Ntl to Overweight, Raises Price Target to $11", "summary": "", "symbols": ["VLY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875932/jp-morgan-upgrades-valley-ntl-to-overweight-raises-price-target-to-11", "tags": ["analyst_up", "price_target_up"]}
{"id": 41875936, "time": "2024-11-11 07:33:33", "headline": "Cigna Confirms It Is Not Pursuing A Combination With Humana", "summary": "", "symbols": ["CI", "HUM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41875936/cigna-confirms-it-is-not-pursuing-a-combination-with-humana", "tags": []}
{"id": 41875945, "time": "2024-11-11 07:34:47", "headline": "JP Morgan Downgrades Nerdy to Underweight", "summary": "", "symbols": ["NRDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875945/jp-morgan-downgrades-nerdy-to-underweight", "tags": ["analyst_down"]}
{"id": 41875965, "time": "2024-11-11 07:35:52", "headline": "Morgan Stanley Maintains Equal-Weight on Robinhood Markets, Raises Price Target to $24", "summary": "", "symbols": ["HOOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41875965/morgan-stanley-maintains-equal-weight-on-robinhood-markets-raises-price-target-to-24", "tags": ["analyst_other", "price_target_up"]}
{"id": 41876108, "time": "2024-11-11 07:37:16", "headline": "Morgan Stanley Maintains Equal-Weight on Hamilton Lane, Raises Price Target to $190", "summary": "", "symbols": ["HLNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876108/morgan-stanley-maintains-equal-weight-on-hamilton-lane-raises-price-target-to-190", "tags": ["analyst_other", "price_target_up"]}
{"id": 41876109, "time": "2024-11-11 07:37:24", "headline": "argenx And Zai Lab Announce China's National Medical Products Administration Approved The Supplemental sBLA For VYVGART Hytrulo In Chronic Inflammatory Demyelinating Polyneuropathy", "summary": "", "symbols": ["ARGX", "ZLAB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41876109/argenx-and-zai-lab-announce-chinas-national-medical-products-administration-approved-the-suppleme", "tags": []}
{"id": 41876111, "time": "2024-11-11 07:37:58", "headline": "JP Morgan Assumes Alarm.com Holdings at Underweight, Lowers Price Target of $50", "summary": "", "symbols": ["ALRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876111/jp-morgan-assumes-alarm-com-holdings-at-underweight-lowers-price-target-of-50", "tags": ["price_target_down"]}
{"id": 41876212, "time": "2024-11-11 07:38:24", "headline": "Morgan Stanley Maintains Equal-Weight on Lamar Advertising, Raises Price Target to $135", "summary": "", "symbols": ["LAMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876212/morgan-stanley-maintains-equal-weight-on-lamar-advertising-raises-price-target-to-135", "tags": ["analyst_other", "price_target_up"]}
{"id": 41876213, "time": "2024-11-11 07:38:44", "headline": "Cytokinetics Initiates Phase 1 Clinical Study Of CK-4015089", "summary": "", "symbols": ["CYTK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41876213/cytokinetics-initiates-phase-1-clinical-study-of-ck-4015089", "tags": ["fda"]}
{"id": 41876215, "time": "2024-11-11 07:39:59", "headline": "Morgan Stanley Maintains Equal-Weight on Flywire, Raises Price Target to $21", "summary": "", "symbols": ["FLYW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876215/morgan-stanley-maintains-equal-weight-on-flywire-raises-price-target-to-21", "tags": ["analyst_other", "price_target_up"]}
{"id": 41876217, "time": "2024-11-11 07:40:44", "headline": "Altimmune Appoints Greg Weaver As Chief Financial Officer", "summary": "", "symbols": ["ALT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876217/altimmune-appoints-greg-weaver-as-chief-financial-officer", "tags": ["management"]}
{"id": 41876219, "time": "2024-11-11 07:41:02", "headline": "Morgan Stanley Maintains Overweight on CRH, Raises Price Target to $104", "summary": "", "symbols": ["CRH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876219/morgan-stanley-maintains-overweight-on-crh-raises-price-target-to-104", "tags": ["analyst_other", "price_target_up"]}
{"id": 41876221, "time": "2024-11-11 07:41:26", "headline": "Citigroup Downgrades NOV to Neutral, Lowers Price Target to $18", "summary": "", "symbols": ["NOV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876221/citigroup-downgrades-nov-to-neutral-lowers-price-target-to-18", "tags": ["analyst_down", "price_target_down"]}
{"id": 41876225, "time": "2024-11-11 07:41:39", "headline": "ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic Reaction Treatment, Analyst Sees Further Stock Upside Despite 200% Surge In 2024", "summary": "ALK and ARS Pharmaceuticals sign a deal giving ALK global rights to Neffy nasal spray outside key regions, targeting peak sales of around $400 million in anaphylaxis treatment.", "symbols": ["SPRY"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41876225/ars-pharmaceuticals-inks-licensing-pact-for-neffy-allergic-reaction-treatment-analyst-sees-further-stock-upside-despite-200-surge-in-2024", "tags": ["contract"]}
{"id": 41876234, "time": "2024-11-11 07:42:06", "headline": "Assertio Writes Response To Short Seller, Says 'Claims about Rolvedon and Assertio's Accounting Practices are False and Baseless' And Says It Is Considering Regal/Regulatory Action", "summary": "", "symbols": ["ASRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/short-sellers/24/11/41876234/assertio-writes-response-to-short-seller-says-claims-about-rolvedon-and-assertios-accounting-practi", "tags": []}
{"id": 41876246, "time": "2024-11-11 07:42:14", "headline": "Morgan Stanley Maintains Overweight on MercadoLibre, Lowers Price Target to $2450", "summary": "", "symbols": ["MELI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876246/morgan-stanley-maintains-overweight-on-mercadolibre-lowers-price-target-to-2450", "tags": ["analyst_other", "price_target_down"]}
{"id": 41876247, "time": "2024-11-11 07:42:44", "headline": "HC Wainwright & Co. Reiterates Buy on Compass Therapeutics, Maintains $10 Price Target", "summary": "", "symbols": ["CMPX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876247/hc-wainwright-co-reiterates-buy-on-compass-therapeutics-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 41876250, "time": "2024-11-11 07:43:58", "headline": "Scotiabank Upgrades Netstreit to Sector Outperform, Raises Price Target to $18", "summary": "", "symbols": ["NTST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876250/scotiabank-upgrades-netstreit-to-sector-outperform-raises-price-target-to-18", "tags": ["analyst_up", "price_target_up"]}
{"id": 41876260, "time": "2024-11-11 07:44:43", "headline": "HC Wainwright & Co. Reiterates Buy on Ikena Oncology, Maintains $4 Price Target", "summary": "", "symbols": ["IKNA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876260/hc-wainwright-co-reiterates-buy-on-ikena-oncology-maintains-4-price-target", "tags": ["analyst_other"]}
{"id": 41876266, "time": "2024-11-11 07:45:34", "headline": "Bitcoin Blasts Past $82,000: 'Buy Everything You Can,' Says Bernstein", "summary": "Bernstein on Monday reiterated a robust bullish stance on the crypto market, encouraging investors to &#34;buy everything you can&#34; as Bitcoin surged above the $82,000 mark on Monday morning.", "symbols": ["BTCUSD", "ETHUSD", "MSTR"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41876266/bitcoin-blasts-past-82000-buy-everything-you-can-says-bernstein", "tags": []}
{"id": 41876380, "time": "2024-11-11 07:46:22", "headline": "Market-Moving News for November 11th", "summary": "", "symbols": ["CAN", "CI", "COIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41876380/market-moving-news-for-november-11th", "tags": []}
{"id": 41876381, "time": "2024-11-11 07:46:26", "headline": "HC Wainwright & Co. Reiterates Buy on Cidara Therapeutics, Maintains $24 Price Target", "summary": "", "symbols": ["CDTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876381/hc-wainwright-co-reiterates-buy-on-cidara-therapeutics-maintains-24-price-target", "tags": ["analyst_other"]}
{"id": 41876382, "time": "2024-11-11 07:46:31", "headline": "Scotiabank Upgrades EPAM Sys to Sector Outperform, Raises Price Target to $275", "summary": "", "symbols": ["EPAM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876382/scotiabank-upgrades-epam-sys-to-sector-outperform-raises-price-target-to-275", "tags": ["analyst_up", "price_target_up"]}
{"id": 41876402, "time": "2024-11-11 07:48:40", "headline": "Piper Sandler Maintains Overweight on TWFG, Raises Price Target to $37", "summary": "", "symbols": ["TWFG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876402/piper-sandler-maintains-overweight-on-twfg-raises-price-target-to-37", "tags": ["analyst_other", "price_target_up"]}
{"id": 41876404, "time": "2024-11-11 07:49:20", "headline": "UBS Upgrades MeridianLink to Neutral, Raises Price Target to $25.5", "summary": "", "symbols": ["MLNK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876404/ubs-upgrades-meridianlink-to-neutral-raises-price-target-to-25-5", "tags": ["analyst_up", "price_target_up"]}
{"id": 41876407, "time": "2024-11-11 07:49:40", "headline": "Piper Sandler Maintains Overweight on Adaptive Biotechnologies, Raises Price Target to $7", "summary": "", "symbols": ["ADPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876407/piper-sandler-maintains-overweight-on-adaptive-biotechnologies-raises-price-target-to-7", "tags": ["analyst_other", "price_target_up"]}
{"id": 41876434, "time": "2024-11-11 07:50:54", "headline": "Alliance Global Partners Initiates Coverage On Geovax Labs with Buy Rating, Announces Price Target of $15", "summary": "", "symbols": ["GOVX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876434/alliance-global-partners-initiates-coverage-on-geovax-labs-with-buy-rating-announces-price-target-of", "tags": ["analyst_init"]}
{"id": 41876451, "time": "2024-11-11 07:51:34", "headline": "Piper Sandler Maintains Overweight on Cytek Biosciences, Raises Price Target to $8.5", "summary": "", "symbols": ["CTKB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876451/piper-sandler-maintains-overweight-on-cytek-biosciences-raises-price-target-to-8-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 41876456, "time": "2024-11-11 07:53:10", "headline": "UBS Downgrades Celanese to Neutral, Lowers Price Target to $97", "summary": "", "symbols": ["CE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876456/ubs-downgrades-celanese-to-neutral-lowers-price-target-to-97", "tags": ["analyst_down", "price_target_down"]}
{"id": 41876457, "time": "2024-11-11 07:53:15", "headline": "Benchmark Maintains Buy on Spotify Technology, Raises Price Target to $440", "summary": "", "symbols": ["SPOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876457/benchmark-maintains-buy-on-spotify-technology-raises-price-target-to-440", "tags": ["analyst_other", "price_target_up"]}
{"id": 41876458, "time": "2024-11-11 07:53:20", "headline": "Piper Sandler Maintains Overweight on Exact Sciences, Lowers Price Target to $75", "summary": "", "symbols": ["EXAS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876458/piper-sandler-maintains-overweight-on-exact-sciences-lowers-price-target-to-75", "tags": ["analyst_other", "price_target_down"]}
{"id": 41876480, "time": "2024-11-11 07:54:36", "headline": "Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $22", "summary": "", "symbols": ["FLGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876480/piper-sandler-maintains-neutral-on-fulgent-genetics-lowers-price-target-to-22", "tags": ["analyst_other", "price_target_down"]}
{"id": 41876482, "time": "2024-11-11 07:55:39", "headline": "Piper Sandler Maintains Overweight on Illumina, Lowers Price Target to $185", "summary": "", "symbols": ["ILMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876482/piper-sandler-maintains-overweight-on-illumina-lowers-price-target-to-185", "tags": ["analyst_other", "price_target_down"]}
{"id": 41876483, "time": "2024-11-11 07:55:48", "headline": "UBS Downgrades Teck Resources to Neutral, Maintains Price Target to C$76", "summary": "", "symbols": ["TSX:TECK", "TSX:TECK.B"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876483/ubs-downgrades-teck-resources-to-neutral-maintains-price-target-to-c-76", "tags": ["analyst_down", "analyst_other"]}
{"id": 41876486, "time": "2024-11-11 07:56:07", "headline": "Dogecoin Explodes For 86% Weekly Gain: What Is Going On?", "summary": "Dogecoin&#39;s (CRYPTO: DOGE) monster rally has traders speculating about elevated price targets.", "symbols": ["DOGEUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41876486/dogecoin-explodes-for-86-weekly-gain-what-is-going-on", "tags": []}
{"id": 41876494, "time": "2024-11-11 07:56:40", "headline": "Piper Sandler Maintains Neutral on Myriad Genetics, Lowers Price Target to $24", "summary": "", "symbols": ["MYGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876494/piper-sandler-maintains-neutral-on-myriad-genetics-lowers-price-target-to-24", "tags": ["analyst_other", "price_target_down"]}
{"id": 41876507, "time": "2024-11-11 07:57:22", "headline": "ASML's IT Outage Affected Chipmaking Operations Worldwide", "summary": "ASML (NASDAQ: ASML) faced a global IT outage, disrupting operations. Issue began morning, resolved by late afternoon. ASML investigating cause.", "symbols": ["AAPL", "ASML", "NVDA", "TSM"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/government/regulations/24/11/41876507/asmls-it-outage-affected-chipmaking-operations-worldwide", "tags": []}
{"id": 41876512, "time": "2024-11-11 07:57:31", "headline": "Piper Sandler Maintains Neutral on Pacific Biosciences, Raises Price Target to $2.5", "summary": "", "symbols": ["PACB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876512/piper-sandler-maintains-neutral-on-pacific-biosciences-raises-price-target-to-2-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 41876524, "time": "2024-11-11 07:58:53", "headline": "BTIG Maintains Buy on Consensus Cloud Solns, Raises Price Target to $32", "summary": "", "symbols": ["CCSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876524/btig-maintains-buy-on-consensus-cloud-solns-raises-price-target-to-32", "tags": ["analyst_other", "price_target_up"]}
{"id": 41876526, "time": "2024-11-11 07:59:07", "headline": "Piper Sandler Maintains Neutral on Dutch Bros, Raises Price Target to $51", "summary": "", "symbols": ["BROS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876526/piper-sandler-maintains-neutral-on-dutch-bros-raises-price-target-to-51", "tags": ["analyst_other", "price_target_up"]}
{"id": 41876527, "time": "2024-11-11 07:59:16", "headline": "Top 4 Real Estate Stocks That May Rocket Higher In November", "summary": " ", "symbols": ["COLD", "DHC", "IIPR", "LINE"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/11/41876527/top-4-real-estate-stocks-that-may-rocket-higher-in-november", "tags": []}
{"id": 41876635, "time": "2024-11-11 08:00:16", "headline": "P/E Ratio Insights for Cheesecake Factory", "summary": " ", "symbols": ["CAKE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41876635/pe-ratio-insights-for-cheesecake-factory", "tags": []}
{"id": 41876646, "time": "2024-11-11 08:00:19", "headline": "Piper Sandler Maintains Overweight on US Foods Hldg, Raises Price Target to $75", "summary": "", "symbols": ["USFD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876646/piper-sandler-maintains-overweight-on-us-foods-hldg-raises-price-target-to-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 41876648, "time": "2024-11-11 08:00:19", "headline": "Demystifying Sprout Social: Insights From 5 Analyst Reviews", "summary": " ", "symbols": ["SPT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41876648/demystifying-sprout-social-insights-from-5-analyst-reviews", "tags": []}
{"id": 41876665, "time": "2024-11-11 08:00:30", "headline": "What Analysts Are Saying About PAR Technology Stock", "summary": " ", "symbols": ["PAR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41876665/what-analysts-are-saying-about-par-technology-stock", "tags": []}
{"id": 41876670, "time": "2024-11-11 08:00:40", "headline": "Forecasting The Future: 11 Analyst Projections For Corpay", "summary": " ", "symbols": ["CPAY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41876670/forecasting-the-future-11-analyst-projections-for-corpay", "tags": []}
{"id": 41876678, "time": "2024-11-11 08:01:02", "headline": "What Analysts Are Saying About Floor & Decor Hldgs Stock", "summary": " ", "symbols": ["FND"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41876678/what-analysts-are-saying-about-floor-decor-hldgs-stock", "tags": []}
{"id": 41876681, "time": "2024-11-11 08:01:04", "headline": "BTIG Maintains Buy on Flutter Entertainment, Raises Price Target to $305", "summary": "", "symbols": ["FLUT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876681/btig-maintains-buy-on-flutter-entertainment-raises-price-target-to-305", "tags": ["analyst_other", "price_target_up"]}
{"id": 41876690, "time": "2024-11-11 08:01:24", "headline": "9 Analysts Assess Valley Ntl: What You Need To Know", "summary": " ", "symbols": ["VLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41876690/9-analysts-assess-valley-ntl-what-you-need-to-know", "tags": []}
{"id": 41876698, "time": "2024-11-11 08:01:32", "headline": "A Glimpse Into The Expert Outlook On Cisco Systems Through 11 Analysts", "summary": " ", "symbols": ["CSCO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41876698/a-glimpse-into-the-expert-outlook-on-cisco-systems-through-11-analysts", "tags": ["guidance"]}
{"id": 41876714, "time": "2024-11-11 08:01:59", "headline": "Lincoln Educational Servs Q3 2024 GAAP EPS $0.13 Beats $0.09 Estimate, Sales $114.41M Beat $110.78M Estimate", "summary": "", "symbols": ["LINC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41876714/lincoln-educational-servs-q3-2024-gaap-eps-0-13-beats-0-09-estimate-sales-114-41m-beat-110-78m-esti", "tags": ["earnings"]}
{"id": 41876716, "time": "2024-11-11 08:02:05", "headline": "RAPT Therapeutics Terminates Zelnecirnon Program Following FDA Clinical Hold Due To Single SAE Of Severe Liver Injury", "summary": "", "symbols": ["RAPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41876716/rapt-therapeutics-terminates-zelnecirnon-program-following-fda-clinical-hold-due-to-single-sae-of", "tags": ["fda"]}
{"id": 41876730, "time": "2024-11-11 08:02:24", "headline": "Aethlon Medical Enrolls First Patient In Australian Hemopurifier Cancer Trial; Study Targets Patients With Solid Tumors Unresponsive To Anti-PD-1 Therapy", "summary": "", "symbols": ["AEMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41876730/aethlon-medical-enrolls-first-patient-in-australian-hemopurifier-cancer-trial-study-targets-patie", "tags": ["fda"]}
{"id": 41876744, "time": "2024-11-11 08:02:45", "headline": "Olympic Steel Acquires Metal Works; The All-Cash Purchase Is Expected To Be Immediately Accretive; Terms Were Not Disclosed", "summary": "", "symbols": ["ZEUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41876744/olympic-steel-acquires-metal-works-the-all-cash-purchase-is-expected-to-be-immediately-accretive-ter", "tags": ["merger"]}
{"id": 41876745, "time": "2024-11-11 08:02:49", "headline": "Nuwellis Q3 2024 GAAP EPS $1.74 May Not Be Comparable To $(1.28) Estimate, Sales $2.37M Beat $2.36M Estimate", "summary": "", "symbols": ["NUWE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41876745/nuwellis-q3-2024-gaap-eps-1-74-may-not-be-comparable-to-1-28-estimate-sales-2-37m-beat-2-36m-estima", "tags": ["earnings"]}
{"id": 41876751, "time": "2024-11-11 08:03:01", "headline": "Dynavax Announces $100M Accelerated Share Repurchase Program Under Agreement With Goldman Sachs", "summary": "", "symbols": ["DVAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876751/dynavax-announces-100m-accelerated-share-repurchase-program-under-agreement-with-goldman-sachs", "tags": ["contract", "buyback"]}
{"id": 41876752, "time": "2024-11-11 08:03:02", "headline": "Nvidia To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Monday", "summary": " ", "symbols": ["CSCO", "DELL", "MRCY", "MSGE", "NVDA", "PAR", "SLDP", "TEM", "TOST", "WHF"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41876752/nvidia-to-rally-more-than-18-here-are-10-top-analyst-forecasts-for-monday", "tags": []}
{"id": 41876756, "time": "2024-11-11 08:03:21", "headline": "SunCar Technology Partners With Wuhan JIDU To Launch Nationwide Intelligent Insurance Platform For Auto Buyers In China", "summary": "", "symbols": ["SDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876756/suncar-technology-partners-with-wuhan-jidu-to-launch-nationwide-intelligent-insurance-platform-for-a", "tags": ["contract"]}
{"id": 41876761, "time": "2024-11-11 08:03:37", "headline": "Global Ship Lease Q3 2024 Adj. EPS $2.45 Beats $2.41 Estimate, Sales $174.064M Miss $174.309M Estimate", "summary": "", "symbols": ["GSL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41876761/global-ship-lease-q3-2024-adj-eps-2-45-beats-2-41-estimate-sales-174-064m-miss-174-309m-estimate", "tags": ["earnings"]}
{"id": 41876766, "time": "2024-11-11 08:03:51", "headline": "MicroStrategy Announces BTC And ATM Activity; Raised $2.03B; Purchased 27,200 BTC; Now Holds 279,420 BTC With BTC Yield Of 26.4% YTD", "summary": "", "symbols": ["MSTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876766/microstrategy-announces-btc-and-atm-activity-raised-2-03b-purchased-27-200-btc-now-holds-279-420-btc", "tags": []}
{"id": 41876767, "time": "2024-11-11 08:03:52", "headline": "UBS Downgrades Vale to Neutral, Lowers Price Target to $11.5", "summary": "", "symbols": ["VALE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876767/ubs-downgrades-vale-to-neutral-lowers-price-target-to-11-5", "tags": ["analyst_down", "price_target_down"]}
{"id": 41876770, "time": "2024-11-11 08:04:15", "headline": "Resolute Mining CEO Detained In Mali, Shares Crater", "summary": "Resolute Mining CEO and executives detained in Mali while addressing concerns over in-country practices. Escalating risks for foreign mining operations.", "symbols": ["GOLD", "RMGGY"], "source": "benzinga", "author": "Stjepan Kalinic", "url": "https://www.benzinga.com/news/management/24/11/41876770/resolute-mining-ceo-detained-in-mali-shares-crater", "tags": ["management"]}
{"id": 41876792, "time": "2024-11-11 08:04:51", "headline": "Jumia Ghana Launches New 6,000 Sqm Warehouse In Tema To Boost Delivery Speed, Product Range, And E-Commerce Growth; Expansion Reinforces Strategic Focus On Operational Efficiency", "summary": "", "symbols": ["JMIA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876792/jumia-ghana-launches-new-6-000-sqm-warehouse-in-tema-to-boost-delivery-speed-product-range-and-e-com", "tags": []}
{"id": 41876797, "time": "2024-11-11 08:05:01", "headline": "Lincoln Educational Services Raises FY24 Revenue Outlook From $423M - $430M To $430M $435M, Est $427.55M", "summary": "", "symbols": ["LINC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876797/lincoln-educational-services-raises-fy24-revenue-outlook-from-423m-430m-to-430m-435m-est-427-55m", "tags": ["earnings", "guidance"]}
{"id": 41876807, "time": "2024-11-11 08:05:09", "headline": "Janover Announces The Launch Of Its AI Voice Tool For CRM Operations", "summary": "", "symbols": ["JNVR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876807/janover-announces-the-launch-of-its-ai-voice-tool-for-crm-operations", "tags": []}
{"id": 41876810, "time": "2024-11-11 08:05:12", "headline": "JMP Securities Maintains Market Outperform on CarGurus, Raises Price Target to $41", "summary": "", "symbols": ["CARG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876810/jmp-securities-maintains-market-outperform-on-cargurus-raises-price-target-to-41", "tags": ["analyst_other", "price_target_up"]}
{"id": 41876811, "time": "2024-11-11 08:05:18", "headline": "ISS Recommends Shareholders Vote On Cracker Barrel's WHITE Proxy Card And \"WITHHOLD\" On Milena Alberti-Perez And Sardar Biglari; ISS Cites Alberti-Perez's Lack Of Relevant Experience And Biglari's Poor Governance Track Record; Has Recommended Against Biglari Every Time He Has Nominated Himself At Cracker Barrel", "summary": "", "symbols": ["CBRL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876811/iss-recommends-shareholders-vote-on-cracker-barrels-white-proxy-card-and-withhold-on-milena-alberti", "tags": []}
{"id": 41876815, "time": "2024-11-11 08:05:24", "headline": "Baird Maintains Outperform on EyePoint Pharmaceuticals, Lowers Price Target to $33", "summary": "", "symbols": ["EYPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876815/baird-maintains-outperform-on-eyepoint-pharmaceuticals-lowers-price-target-to-33", "tags": ["analyst_other", "price_target_down"]}
{"id": 41876831, "time": "2024-11-11 08:06:16", "headline": "Baird Maintains Outperform on Fortrea Holdings, Raises Price Target to $30", "summary": "", "symbols": ["FTRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876831/baird-maintains-outperform-on-fortrea-holdings-raises-price-target-to-30", "tags": ["analyst_other", "price_target_up"]}
{"id": 41876835, "time": "2024-11-11 08:06:39", "headline": "Annovis Bio Q3 EPS $(0.97) Misses $(0.38) Estimate", "summary": "", "symbols": ["ANVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41876835/annovis-bio-q3-eps-0-97-misses-0-38-estimate", "tags": ["earnings"]}
{"id": 41876836, "time": "2024-11-11 08:06:40", "headline": "Ainos Receives Institutional Review Board Approval From Shuang Ho Hospital For Its Trial Of VELDONA In Sj\u00f6gren's Syndrome", "summary": "", "symbols": ["AIMD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41876836/ainos-receives-institutional-review-board-approval-from-shuang-ho-hospital-for-its-trial-of-veldo", "tags": ["fda"]}
{"id": 41876843, "time": "2024-11-11 08:07:21", "headline": "JMP Securities Maintains Market Outperform on DraftKings, Raises Price Target to $52", "summary": "", "symbols": ["DKNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876843/jmp-securities-maintains-market-outperform-on-draftkings-raises-price-target-to-52", "tags": ["analyst_other", "price_target_up"]}
{"id": 41876851, "time": "2024-11-11 08:07:30", "headline": "Baird Maintains Neutral on Mettler-Toledo Intl, Lowers Price Target to $1310", "summary": "", "symbols": ["MTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876851/baird-maintains-neutral-on-mettler-toledo-intl-lowers-price-target-to-1310", "tags": ["analyst_other", "price_target_down"]}
{"id": 41876913, "time": "2024-11-11 08:07:49", "headline": "Ceribell Receives Authority To Operate From The U.S. Department Of Veterans Affairs; Ceribell System Stands To Reduce Costly ICU Admissions And Intra-Facility Patient Transfers; Military Veterans Face Elevated Risks Of Developing Seizure Disorders", "summary": "", "symbols": ["CBLL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41876913/ceribell-receives-authority-to-operate-from-the-u-s-department-of-veterans-affairs-ceribell-system-s", "tags": []}
{"id": 41876915, "time": "2024-11-11 08:07:53", "headline": "Aptevo Therapeutics And Alligator Bioscience's Bispecific Antibody ALG.APV-527 Meets Key Endpoints In Phase 1 Solid Tumor Trial; Shows Favorable Safety And Immune Activation With Stable Disease In Colon And Breast Cancer Patients", "summary": "", "symbols": ["APVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41876915/aptevo-therapeutics-and-alligator-biosciences-bispecific-antibody-alg-apv-527-meets-key-endpoints", "tags": ["fda"]}
{"id": 41876916, "time": "2024-11-11 08:08:05", "headline": "Food Company Aramark Posts Mixed Q4, Increases Dividend By 11% & More", "summary": "Aramark reported Q4 results, revenue up 5% YoY, raised dividend, and expects strong growth in FY25. ", "symbols": ["ARMK", "EATZ", "SWP"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/buybacks/24/11/41876916/food-company-aramark-posts-mixed-q4-increases-dividend-by-11-more", "tags": ["earnings", "dividend"]}
{"id": 41877020, "time": "2024-11-11 08:08:29", "headline": "CBL & Associates Q3 EPS $0.52 Up From $0.41 YoY, Sales $125.09M Down From $129.35M YoY", "summary": "", "symbols": ["CBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41877020/cbl-associates-q3-eps-0-52-up-from-0-41-yoy-sales-125-09m-down-from-129-35m-yoy", "tags": ["earnings"]}
{"id": 41877026, "time": "2024-11-11 08:08:34", "headline": "Baird Maintains Outperform on CNH Industrial, Lowers Price Target to $13", "summary": "", "symbols": ["CNH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877026/baird-maintains-outperform-on-cnh-industrial-lowers-price-target-to-13", "tags": ["analyst_other", "price_target_down"]}
{"id": 41877037, "time": "2024-11-11 08:09:32", "headline": "Nano Labs Announces That The Company Has Set Up A Coinbase Account And Starts Accepting Payments In Bitcoin In Exchange For Its Products", "summary": "", "symbols": ["NA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877037/nano-labs-announces-that-the-company-has-set-up-a-coinbase-account-and-starts-accepting-payments-in", "tags": []}
{"id": 41877038, "time": "2024-11-11 08:09:35", "headline": "Baird Maintains Outperform on RB Global, Raises Price Target to $100", "summary": "", "symbols": ["RBA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877038/baird-maintains-outperform-on-rb-global-raises-price-target-to-100", "tags": ["analyst_other", "price_target_up"]}
{"id": 41877049, "time": "2024-11-11 08:10:06", "headline": "Leading And Lagging Sectors For November 11, 2024", "summary": " ", "symbols": ["XLB", "XLC", "XLE", "XLF", "XLI", "XLK", "XLP", "XLU", "XLV", "XLY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/sector-etfs/24/11/41877049/leading-and-lagging-sectors-for-november-11-2024", "tags": []}
{"id": 41877068, "time": "2024-11-11 08:10:56", "headline": "Baird Maintains Outperform on Advanced Drainage Systems, Lowers Price Target to $161", "summary": "", "symbols": ["WMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877068/baird-maintains-outperform-on-advanced-drainage-systems-lowers-price-target-to-161", "tags": ["analyst_other", "price_target_down"]}
{"id": 41877078, "time": "2024-11-11 08:11:24", "headline": "Indaptus Therapeutics' Pioneering Research On Novel Immunotherapy Approach Published In Peer-Reviewed Frontiers In Immunology", "summary": "", "symbols": ["INDP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41877078/indaptus-therapeutics-pioneering-research-on-novel-immunotherapy-approach-published-in-peer-revie", "tags": []}
{"id": 41877081, "time": "2024-11-11 08:11:58", "headline": "Baird Maintains Outperform on Akamai Techs, Lowers Price Target to $115", "summary": "", "symbols": ["AKAM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877081/baird-maintains-outperform-on-akamai-techs-lowers-price-target-to-115", "tags": ["analyst_other", "price_target_down"]}
{"id": 41877099, "time": "2024-11-11 08:12:26", "headline": "JMP Securities Maintains Market Outperform on Kratos Defense & Security, Raises Price Target to $30", "summary": "", "symbols": ["KTOS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877099/jmp-securities-maintains-market-outperform-on-kratos-defense-security-raises-price-target-to-30", "tags": ["analyst_other", "price_target_up"]}
{"id": 41877125, "time": "2024-11-11 08:13:13", "headline": "Baird Maintains Neutral on Five9, Raises Price Target to $43", "summary": "", "symbols": ["FIVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877125/baird-maintains-neutral-on-five9-raises-price-target-to-43", "tags": ["analyst_other", "price_target_up"]}
{"id": 41877128, "time": "2024-11-11 08:14:09", "headline": "Imaging Centers Operator RadNet Q3 Earnings: Strong Q3 Performance On Positive Trends, Raises Annual Outlook", "summary": "RadNet posted Q3 2024 revenue of $461.1 million, beating estimates. Digital Health revenue rose 34.3%, driving growth in AI mammography.", "symbols": ["RDNT"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/health-care/24/11/41877128/imaging-centers-operator-radnet-q3-earnings-strong-q3-performance-on-positive-trends-raises-annual-outlook", "tags": ["earnings", "guidance"]}
{"id": 41877129, "time": "2024-11-11 08:14:17", "headline": "Baird Maintains Neutral on RingCentral, Raises Price Target to $38", "summary": "", "symbols": ["RNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877129/baird-maintains-neutral-on-ringcentral-raises-price-target-to-38", "tags": ["analyst_other", "price_target_up"]}
{"id": 41877135, "time": "2024-11-11 08:14:27", "headline": "Keybanc Maintains Overweight on Pinterest, Lowers Price Target to $39", "summary": "", "symbols": ["PINS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877135/keybanc-maintains-overweight-on-pinterest-lowers-price-target-to-39", "tags": ["analyst_other", "price_target_down"]}
{"id": 41877138, "time": "2024-11-11 08:14:31", "headline": "Cognyte Software Announces A Significant Expansion Agreement, Valued At Over $10M, With A Longstanding Customer In The Asia-Pacific Region", "summary": "", "symbols": ["CGNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877138/cognyte-software-announces-a-significant-expansion-agreement-valued-at-over-10m-with-a-longstanding", "tags": ["contract"]}
{"id": 41877140, "time": "2024-11-11 08:14:42", "headline": "Wells Fargo Downgrades Atmus Filtration Techs to Equal-Weight, Raises Price Target to $45", "summary": "", "symbols": ["ATMU"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877140/wells-fargo-downgrades-atmus-filtration-techs-to-equal-weight-raises-price-target-to-45", "tags": ["analyst_down", "price_target_up"]}
{"id": 41877157, "time": "2024-11-11 08:15:08", "headline": "Baird Maintains Outperform on TaskUs, Raises Price Target to $22", "summary": "", "symbols": ["TASK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877157/baird-maintains-outperform-on-taskus-raises-price-target-to-22", "tags": ["analyst_other", "price_target_up"]}
{"id": 41877293, "time": "2024-11-11 08:16:41", "headline": "Sapiens International Posts Downbeat Results, Joins Sky Harbour And Other Big Stocks Moving Lower In Monday's Pre-Market Session", "summary": " ", "symbols": ["BFLY", "GFI", "LWAY", "SKYH", "SMR", "SPNS", "TEM", "XERS"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41877293/sapiens-international-posts-downbeat-results-joins-sky-harbour-and-other-big-stocks-moving-lower-in-mondays-pre-market-session", "tags": ["why_moving"]}
{"id": 41877325, "time": "2024-11-11 08:17:30", "headline": "Icon Energy Corp. Reports 9-Month Revenue Of $3.6 Million; EPS $0.06 Vs $3.76 YoY", "summary": "", "symbols": ["ICON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41877325/icon-energy-corp-reports-9-month-revenue-of-3-6-million-eps-0-06-vs-3-76-yoy", "tags": ["earnings"]}
{"id": 41877326, "time": "2024-11-11 08:17:33", "headline": "STRATA Skin Sciences Announces US District Court For The Eastern District Of Pennsylvania Entered A Court Order In Favor Of The Company In Its Complaint Agains LaserOptek, Monarch Laser Services And The Pinnacle Health Group", "summary": "", "symbols": ["SSKN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877326/strata-skin-sciences-announces-us-district-court-for-the-eastern-district-of-pennsylvania-entered-a", "tags": ["legal"]}
{"id": 41877429, "time": "2024-11-11 08:17:47", "headline": "Nexalin Technology CEO Highlights Breakthroughs In DIFS For Alzheimer's And MDD; New Patent Granted, Clinical Trial Launched For Veterans With mTBI, And Global Regulatory Approvals Expanded With First Latin American Clearance", "summary": "", "symbols": ["NXL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877429/nexalin-technology-ceo-highlights-breakthroughs-in-difs-for-alzheimers-and-mdd-new-patent-granted-cl", "tags": ["fda", "management"]}
{"id": 41877431, "time": "2024-11-11 08:18:21", "headline": "Spruce Biosciences Q3 EPS $(0.21) Beats $(0.24) Estimate", "summary": "", "symbols": ["SPRB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41877431/spruce-biosciences-q3-eps-0-21-beats-0-24-estimate", "tags": ["earnings"]}
{"id": 41877439, "time": "2024-11-11 08:18:36", "headline": "Spruce Biosciences Q3 EPS $(0.21) Beats $(0.24) Estimate, Sales $602.00K Miss $1.49M Estimate", "summary": "", "symbols": ["SPRB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41877439/spruce-biosciences-q3-eps-0-21-beats-0-24-estimate-sales-602-00k-miss-1-49m-estimate", "tags": ["earnings"]}
{"id": 41877440, "time": "2024-11-11 08:18:58", "headline": "Pharma Two B And Hepion Pharmaceuticals Announce SEC Approval Of Registration Statement For Proposed Merger; Closing Expected Q4 2024 Pending Shareholder And Regulatory Approvals, Nasdaq Listing", "summary": "", "symbols": ["HEPA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41877440/pharma-two-b-and-hepion-pharmaceuticals-announce-sec-approval-of-registration-statement-for-proposed", "tags": ["merger"]}
{"id": 41877441, "time": "2024-11-11 08:19:18", "headline": "Keybanc Maintains Overweight on Snowflake, Lowers Price Target to $150", "summary": "", "symbols": ["SNOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877441/keybanc-maintains-overweight-on-snowflake-lowers-price-target-to-150", "tags": ["analyst_other", "price_target_down"]}
{"id": 41877442, "time": "2024-11-11 08:19:27", "headline": "Oppenheimer Maintains Outperform on Dianthus Therapeutics, Raises Price Target to $52", "summary": "", "symbols": ["DNTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877442/oppenheimer-maintains-outperform-on-dianthus-therapeutics-raises-price-target-to-52", "tags": ["analyst_other", "price_target_up"]}
{"id": 41877445, "time": "2024-11-11 08:20:07", "headline": "The Oncology Institute Announces Certification To Administer Pluvicto Therapy In California", "summary": "", "symbols": ["TOI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877445/the-oncology-institute-announces-certification-to-administer-pluvicto-therapy-in-california", "tags": []}
{"id": 41877446, "time": "2024-11-11 08:20:11", "headline": "BeyondSpring Reports Phase 2 Results For Triple IO Combo Of Pembrolizumab, Plinabulin, And Docetaxel In Metastatic NSCLC At SITC 2024; 21.1% ORR And 8.6-Month Median PFS Observed", "summary": "", "symbols": ["BYSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877446/beyondspring-reports-phase-2-results-for-triple-io-combo-of-pembrolizumab-plinabulin-and-docetaxel-i", "tags": ["fda"]}
{"id": 41877447, "time": "2024-11-11 08:20:17", "headline": "Oppenheimer Maintains Outperform on Playa Hotels & Resorts, Raises Price Target to $12", "summary": "", "symbols": ["PLYA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877447/oppenheimer-maintains-outperform-on-playa-hotels-resorts-raises-price-target-to-12", "tags": ["analyst_other", "price_target_up"]}
{"id": 41877449, "time": "2024-11-11 08:20:54", "headline": "CERo Therapeutics Presents Preclinical Data At SITC 2024 Showing CER-1236 Effectively Kills Ovarian Cancer Cells Without Toxicity In Animal Models", "summary": "", "symbols": ["CERO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41877449/cero-therapeutics-presents-preclinical-data-at-sitc-2024-showing-cer-1236-effectively-kills-ovari", "tags": []}
{"id": 41877452, "time": "2024-11-11 08:21:19", "headline": "As Of September 30, 2024 Autonomix Medical Had Cash Of $5.2M", "summary": "", "symbols": ["AMIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41877452/as-of-september-30-2024-autonomix-medical-had-cash-of-5-2m", "tags": []}
{"id": 41877453, "time": "2024-11-11 08:21:20", "headline": "Oppenheimer Maintains Outperform on Intellia Therapeutics, Lowers Price Target to $60", "summary": "", "symbols": ["NTLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877453/oppenheimer-maintains-outperform-on-intellia-therapeutics-lowers-price-target-to-60", "tags": ["analyst_other", "price_target_down"]}
{"id": 41877454, "time": "2024-11-11 08:21:41", "headline": "Monday.com Stock Tanks Despite Q3 Beat, Raised Outlook", "summary": "Monday.com (MNDY) beat revenue and EPS estimates in Q3 with 33% growth and $0.85, respectively. The net dollar retention rate was 111%, with strong customer growth and retention. The stock price dropped despite positive outlook and analyst upgrade.", "symbols": ["MNDY"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/news/earnings/24/11/41877454/monday-com-stock-tanks-despite-q3-beat-raised-outlook", "tags": ["analyst_up", "earnings", "guidance"]}
{"id": 41877456, "time": "2024-11-11 08:21:52", "headline": "CG Oncology Announces Nature Medicine Publication Of Phase 1b Study Results Evaluating Cretostimogene Grenadenorepvec In Combination With Nivolumab In Muscle-Invasive Bladder Cancer", "summary": "", "symbols": ["CGON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41877456/cg-oncology-announces-nature-medicine-publication-of-phase-1b-study-results-evaluating-cretostimo", "tags": []}
{"id": 41877465, "time": "2024-11-11 08:22:05", "headline": "Wells Fargo Reinstates Equal-Weight on RXO, Announces $31 Price Target", "summary": "", "symbols": ["RXO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877465/wells-fargo-reinstates-equal-weight-on-rxo-announces-31-price-target", "tags": []}
{"id": 41877466, "time": "2024-11-11 08:22:19", "headline": "Oppenheimer Maintains Outperform on Advanced Drainage Systems, Lowers Price Target to $184", "summary": "", "symbols": ["WMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877466/oppenheimer-maintains-outperform-on-advanced-drainage-systems-lowers-price-target-to-184", "tags": ["analyst_other", "price_target_down"]}
{"id": 41877477, "time": "2024-11-11 08:22:55", "headline": "Amarin Corporation Announces That Investigators Will Present An Additional Subgroup Analysis From The REDUCE-IT Outcomes Trial In Patients With And Without Coronary Artery Disease History And Mechanistic Data On Eicosapentaenoic Acid At The American Heart Association's Scientific Sessions", "summary": "", "symbols": ["AMRN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41877477/amarin-corporation-announces-that-investigators-will-present-an-additional-subgroup-analysis-from", "tags": ["fda"]}
{"id": 41877488, "time": "2024-11-11 08:23:11", "headline": "Oppenheimer Maintains Outperform on Carlyle Group, Raises Price Target to $85", "summary": "", "symbols": ["CG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877488/oppenheimer-maintains-outperform-on-carlyle-group-raises-price-target-to-85", "tags": ["analyst_other", "price_target_up"]}
{"id": 41877491, "time": "2024-11-11 08:23:40", "headline": "Wedbush Maintains Neutral on One Group Hospitality, Lowers Price Target to $3.5", "summary": "", "symbols": ["STKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877491/wedbush-maintains-neutral-on-one-group-hospitality-lowers-price-target-to-3-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41877493, "time": "2024-11-11 08:24:07", "headline": "MultiMetaVerse Holdings Limited Provides Update On Joint Venture; On November 8th, 2024, MMV And Zhenghe Entered Into An Agreement Whereby Zhenghe Agreed To Waive The Interest Payment", "summary": "", "symbols": ["MMV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877493/multimetaverse-holdings-limited-provides-update-on-joint-venture-on-november-8th-2024-mmv-and-zhengh", "tags": ["contract"]}
{"id": 41877497, "time": "2024-11-11 08:24:39", "headline": "How To Earn $500 A Month From Home Depot Stock Ahead Of Q3 Earnings", "summary": "Home Depot offers an annual dividend yield of 2.22%, a quarterly dividend amount of $2.25 per share. Here&#39;s how to earn $500 month.", "symbols": ["HD"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41877497/how-to-earn-500-a-month-from-home-depot-stock-ahead-of-q3-earnings", "tags": ["earnings", "dividend"]}
{"id": 41877430, "time": "2024-11-11 08:18:18", "headline": "STRATA Skin Sciences shares are trading higher after the US District Court for the Eastern District of Pennsylvania issued a favorable court order for the company in its complaint against LaserOptek, Monarch Laser Services, and The Pinnacle Health Group.", "summary": "", "symbols": ["SSKN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41877430/strata-skin-sciences-shares-are-trading-higher-after-the-us-district-court-for-the-eastern-district", "tags": ["why_moving", "legal"]}
{"id": 41877515, "time": "2024-11-11 08:25:47", "headline": "DA Davidson Maintains Buy on Trade Desk, Raises Price Target to $134", "summary": "", "symbols": ["TTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877515/da-davidson-maintains-buy-on-trade-desk-raises-price-target-to-134", "tags": ["analyst_other", "price_target_up"]}
{"id": 41877517, "time": "2024-11-11 08:26:20", "headline": "GE HealthCare And DeepHealth Team Up To Advance AI-Powered Breast Cancer Screening: Details", "summary": "GE HealthCare and DeepHealth collaborate to develop AI-powered solutions for imaging, starting with breast cancer screening. ", "symbols": ["CSD", "GEHC", "LGHT", "RDNT"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/11/41877517/ge-healthcare-and-deephealth-team-up-to-advance-ai-powered-breast-cancer-screening", "tags": []}
{"id": 41877535, "time": "2024-11-11 08:27:19", "headline": "DA Davidson Maintains Neutral on Q2 Holdings, Raises Price Target to $86", "summary": "", "symbols": ["QTWO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877535/da-davidson-maintains-neutral-on-q2-holdings-raises-price-target-to-86", "tags": ["analyst_other", "price_target_up"]}
{"id": 41877539, "time": "2024-11-11 08:27:49", "headline": "Needham Reiterates Buy on NXP Semiconductors, Maintains $250 Price Target", "summary": "", "symbols": ["NXPI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877539/needham-reiterates-buy-on-nxp-semiconductors-maintains-250-price-target", "tags": ["analyst_other"]}
{"id": 41877573, "time": "2024-11-11 08:28:32", "headline": "Cigna Not Pursuing Humana Merger, Stock Soars", "summary": "Cigna Group reaffirms 2024 EPS outlook, reports strong Q3 results, and clarifies it is not pursuing a merger with Humana amid ongoing speculation.", "symbols": ["CI", "HUM"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/health-care/24/11/41877573/cigna-not-pursuing-humana-merger-stock-soars", "tags": ["earnings", "guidance", "merger"]}
{"id": 41877633, "time": "2024-11-11 08:30:15", "headline": "HC Wainwright & Co. Reiterates Buy on Calumet, Maintains $25 Price Target", "summary": "", "symbols": ["CLMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877633/hc-wainwright-co-reiterates-buy-on-calumet-maintains-25-price-target", "tags": ["analyst_other"]}
{"id": 41877638, "time": "2024-11-11 08:31:00", "headline": "Jim Cramer: This Tech Stock Can 'Go To 160,' Recommends Buying Domino's Pizza", "summary": "Domino&#39;s Pizza reported third-quarter sales growth of 5.1% Y/Y to $1.08 billion, missing the analyst consensus estimate of $1.1 billion.", "symbols": ["ARM", "CME", "DPZ", "EPD"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/11/41877638/jim-cramer-tech-stock-go-to-160-recommends-buying-dominos-pizza", "tags": []}
{"id": 41877656, "time": "2024-11-11 08:31:55", "headline": "HC Wainwright & Co. Reiterates Buy on Newpark Resources, Maintains $12 Price Target", "summary": "", "symbols": ["NR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877656/hc-wainwright-co-reiterates-buy-on-newpark-resources-maintains-12-price-target", "tags": ["analyst_other"]}
{"id": 41877634, "time": "2024-11-11 08:30:48", "headline": "U.S. FDA  Has Removed The Clinical Hold On Novavax's IND Application For Its COVID-19-influenza Combination And Stand-Alone Influenza Vaccine Candidates", "summary": "", "symbols": ["NVAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41877634/u-s-fda-removes-clinical-hold-on-novavaxs-covid-19-influenza-combination-and-stand-alone-influenz", "tags": ["fda"]}
{"id": 41877665, "time": "2024-11-11 08:32:18", "headline": "Banzai Regains Nasdaq Compliance With Minimum Market Value Of Publicly Held Shares Requirement Following 10-Day Trading Period Above $1M", "summary": "", "symbols": ["BNZI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877665/banzai-regains-nasdaq-compliance-with-minimum-market-value-of-publicly-held-shares-requirement-follo", "tags": []}
{"id": 41877671, "time": "2024-11-11 08:33:00", "headline": "Trump Media (DJT) Stock Surges On Monday Pre-Market As Trump Denies Sale Rumors", "summary": "Trump, who owns 115 million shares, values his investment at approximately $3.7 billion.", "symbols": ["DJT"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/markets/24/11/41877671/trump-media-djt-stock-surges-on-monday-pre-market-as-trump-denies-sale-rumors", "tags": []}
{"id": 41877675, "time": "2024-11-11 08:33:17", "headline": "ReShape Lifesciences Secures $241K NIH Grant With USC's CARSS To Advance Next-Gen Electrodes For Diabetes Bloc-Stim Neuromodulation Technology", "summary": "", "symbols": ["RSLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877675/reshape-lifesciences-secures-241k-nih-grant-with-uscs-carss-to-advance-next-gen-electrodes-for-diabe", "tags": []}
{"id": 41877682, "time": "2024-11-11 08:33:29", "headline": "After Trump's Win, It's Time To Take Profits On Gold", "summary": " ", "symbols": ["EBS", "IAG", "INOD", "LNTH", "POWL", "SMCI", "TSLA", "TZOO"], "source": "benzinga", "author": "David Pinsen", "url": "https://www.benzinga.com/markets/commodities/24/11/41877682/after-trumps-win-its-time-to-take-profits-on-gold", "tags": []}
{"id": 41877684, "time": "2024-11-11 08:33:51", "headline": "Tempus Announces Publication Of Its Study, \"Actionable Structural Variant Detection Via RNA-NGS And DNA-NGS In Patients With Advanced Non-small Cell Lung Cancer,\" In Jama Network Open", "summary": "", "symbols": ["TEM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877684/tempus-announces-publication-of-its-study-actionable-structural-variant-detection-via-rna-ngs-and-dn", "tags": []}
{"id": 41877685, "time": "2024-11-11 08:34:06", "headline": "AbbVie Reports Phase 2 EMPOWER Trials For Emraclidine In Schizophrenia Miss Primary Endpoint; Treatment Well-Tolerated, Further Data Analysis Underway", "summary": "", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41877685/abbvie-reports-phase-2-empower-trials-for-emraclidine-in-schizophrenia-miss-primary-endpoint-trea", "tags": ["fda"]}
{"id": 41877689, "time": "2024-11-11 08:34:25", "headline": "MARA Adds 372 Megawatts Of Capacity In Ohio; Acquires Two Data Centers OFfering A Combined 222 Megawatts Of Interconnect-Approved Capacity And Development Of Third Center Expected To Add 150 Megawatts Of Compute Capacity", "summary": "", "symbols": ["MARA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877689/mara-adds-372-megawatts-of-capacity-in-ohio-acquires-two-data-centers-offering-a-combined-222-megawa", "tags": ["offering", "merger"]}
{"id": 41877697, "time": "2024-11-11 08:34:47", "headline": "EHang, Enpower Team Up On Next-Gen eVTOL Tech: Details", "summary": "EHang Holdings forms strategic partnership for advanced eVTOL electric motor drive systems with Zhuhai Enpower Electric Co., Ltd. This will enhance performance and reliability of EHang&#39;s aircraft in meeting industry demands.", "symbols": ["EH", "HAIL", "KOMP"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/large-cap/24/11/41877697/ehang-enpower-team-up-on-next-gen-evtol-tech-details", "tags": ["contract"]}
{"id": 41877705, "time": "2024-11-11 08:34:50", "headline": "Clean Harbors' Safety-Kleen Is Revising Pricing Related To Collecting And Managing Used Engine And Industrial Oils. Effective Immediately, The Company Will Be Targeting A Broad Range Of Rate Changes Across Its Used Oil Customer Base", "summary": "", "symbols": ["CLH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877705/clean-harbors-safety-kleen-is-revising-pricing-related-to-collecting-and-managing-used-engine-and-in", "tags": []}
{"id": 41877716, "time": "2024-11-11 08:35:05", "headline": "HC Wainwright & Co. Reiterates Buy on Cibus, Maintains $25 Price Target", "summary": "", "symbols": ["CBUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877716/hc-wainwright-co-reiterates-buy-on-cibus-maintains-25-price-target", "tags": ["analyst_other"]}
{"id": 41877742, "time": "2024-11-11 08:36:11", "headline": "Piper Sandler Maintains Overweight on Amneal Pharmaceuticals, Raises Price Target to $11", "summary": "", "symbols": ["AMRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877742/piper-sandler-maintains-overweight-on-amneal-pharmaceuticals-raises-price-target-to-11", "tags": ["analyst_other", "price_target_up"]}
{"id": 41877743, "time": "2024-11-11 08:37:01", "headline": "HC Wainwright & Co. Maintains Buy on AudioEye, Raises Price Target to $37", "summary": "", "symbols": ["AEYE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877743/hc-wainwright-co-maintains-buy-on-audioeye-raises-price-target-to-37", "tags": ["analyst_other", "price_target_up"]}
{"id": 41877753, "time": "2024-11-11 08:37:21", "headline": "Piper Sandler Maintains Neutral on NewtekOne, Raises Price Target to $15", "summary": "", "symbols": ["NEWT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877753/piper-sandler-maintains-neutral-on-newtekone-raises-price-target-to-15", "tags": ["analyst_other", "price_target_up"]}
{"id": 41877780, "time": "2024-11-11 08:38:18", "headline": "CME Group, Glacier Bancorp And More On CNBC's 'Final Trades'", "summary": "CME Group extended CEO Terry Duffy&#39;s contract through 2026. The company appointed Lynne Fitzpatrick as CFO.", "symbols": ["CME", "GBCI", "IBIT", "IYF"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/11/41877780/cme-group-glacier-bancorp-and-more-on-cnbcs-final-trades", "tags": ["contract", "management"]}
{"id": 41877801, "time": "2024-11-11 08:38:31", "headline": "Piper Sandler Maintains Neutral on Bloomin Brands, Lowers Price Target to $16", "summary": "", "symbols": ["BLMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877801/piper-sandler-maintains-neutral-on-bloomin-brands-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 41877892, "time": "2024-11-11 08:39:23", "headline": "DA Davidson Maintains Neutral on Nikola, Lowers Price Target to $4", "summary": "", "symbols": ["NKLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877892/da-davidson-maintains-neutral-on-nikola-lowers-price-target-to-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 41877894, "time": "2024-11-11 08:40:01", "headline": "Piper Sandler Maintains Overweight on First Watch Restaurant Gr, Raises Price Target to $23", "summary": "", "symbols": ["FWRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877894/piper-sandler-maintains-overweight-on-first-watch-restaurant-gr-raises-price-target-to-23", "tags": ["analyst_other", "price_target_up"]}
{"id": 41877899, "time": "2024-11-11 08:40:28", "headline": "Trump Re-Election Jolts Metals Market As Gold Sees A 'Stumble, Not A Sea Change'", "summary": "Metal markets facing turbulence under Trump, but gold stays strong as a debasement trade and aluminum may also hold up. Traders should wait, investors wary.", "symbols": ["CPER", "DBB", "GLD", "IAU"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41877899/trump-re-election-jolts-metals-market-as-gold-sees-a-stumble-not-a-sea-change", "tags": []}
{"id": 41877912, "time": "2024-11-11 08:41:12", "headline": "DA Davidson Maintains Buy on CRH, Raises Price Target to $120", "summary": "", "symbols": ["CRH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877912/da-davidson-maintains-buy-on-crh-raises-price-target-to-120", "tags": ["analyst_other", "price_target_up"]}
{"id": 41877924, "time": "2024-11-11 08:41:47", "headline": "Bitcoin's Rally to $82K Post Trump's Election Win Not Enough To Flip Over Long-Term Critic Peter Schiff: No Fundamentals, Just 'Mania'", "summary": "Peter Schiff, a long-time critic of Bitcoin (CRYPTO: BTC), expressed skepticism about the recent surge in Bitcoin\u2019s value.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Pooja Rajkumari", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41877924/bitcoins-rally-to-82k-post-trumps-election-win-not-enough-to-flip-over-long-term-critic-peter-schiff-no-fundamentals-just-mania", "tags": []}
{"id": 41877936, "time": "2024-11-11 08:42:16", "headline": "AUD/USD Stabilises As Traders Await Economic Signals", "summary": "By RoboForex Analytical Department", "symbols": [], "source": "benzinga", "author": "Dmitriy Gurkovskiy", "url": "https://www.benzinga.com/24/11/41877936/audusd-stabilises-as-traders-await-economic-signals", "tags": []}
{"id": 41877950, "time": "2024-11-11 08:43:18", "headline": "Needham Reiterates Buy on SEMrush Hldgs, Maintains $18 Price Target", "summary": "", "symbols": ["SEMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877950/needham-reiterates-buy-on-semrush-hldgs-maintains-18-price-target", "tags": ["analyst_other"]}
{"id": 41877974, "time": "2024-11-11 08:45:12", "headline": "Jefferies Maintains Buy on Salesforce, Raises Price Target to $400", "summary": "", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877974/jefferies-maintains-buy-on-salesforce-raises-price-target-to-400", "tags": ["analyst_other", "price_target_up"]}
{"id": 41877975, "time": "2024-11-11 08:45:17", "headline": "Keybanc Maintains Overweight on Advanced Drainage Systems, Lowers Price Target to $180", "summary": "", "symbols": ["WMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41877975/keybanc-maintains-overweight-on-advanced-drainage-systems-lowers-price-target-to-180", "tags": ["analyst_other", "price_target_down"]}
{"id": 41877984, "time": "2024-11-11 08:45:51", "headline": "Looking Into Tradeweb Markets's Recent Short Interest", "summary": " ", "symbols": ["TW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41877984/looking-into-tradeweb-marketss-recent-short-interest", "tags": []}
{"id": 41877986, "time": "2024-11-11 08:45:56", "headline": "Peering Into F5's Recent Short Interest", "summary": " ", "symbols": ["FFIV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41877986/peering-into-f5s-recent-short-interest", "tags": []}
{"id": 41877987, "time": "2024-11-11 08:46:01", "headline": "Looking Into SentinelOne's Recent Short Interest", "summary": " ", "symbols": ["S"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41877987/looking-into-sentinelones-recent-short-interest", "tags": []}
{"id": 41878060, "time": "2024-11-11 08:46:28", "headline": "Lakeside Holding Acquires Hupan Pharmaceutical For $0.6M", "summary": "", "symbols": ["LSH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41878060/lakeside-holding-acquires-hupan-pharmaceutical-for-0-6m", "tags": ["merger"]}
{"id": 41877995, "time": "2024-11-11 08:46:11", "headline": "Budweiser's China Glass Drains As Consumers Have Less To Toast", "summary": "Key Takeaways:\n\n\n\tBudweiser APAC\u2019s profit fell 15% in the first nine months of the year as its revenue in China fell 16.1% in the third quarter\n\tThe mainstream beer maker\u2019s efforts to develop higher-end products may be meeting with headwinds from increasingly cautious Chinese consumer\n\n\nBy Lau Chi Hang", "symbols": ["BDWBF"], "source": "benzinga", "author": "The Bamboo Works", "url": "https://www.benzinga.com/24/11/41877995/budweisers-china-glass-drains-as-consumers-have-less-to-toast", "tags": ["earnings"]}
{"id": 41878003, "time": "2024-11-11 08:46:21", "headline": "Citius Pharmaceuticals And Citius Oncology Report Phase I Results For Pembrolizumab And LYMPHIR Combo In Recurrent Solid Tumors; 27% ORR, 33% CBR, And 57-Week Median PFS", "summary": "", "symbols": ["CTOR", "CTXR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41878003/citius-pharmaceuticals-and-citius-oncology-report-promising-phase-i-results-for-pembrolizumab-and", "tags": ["fda"]}
{"id": 41878143, "time": "2024-11-11 08:47:35", "headline": "Northland Capital Markets Maintains Outperform on Excelerate Energy, Raises Price Target to $29", "summary": "", "symbols": ["EE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878143/northland-capital-markets-maintains-outperform-on-excelerate-energy-raises-price-target-to-29", "tags": ["analyst_other", "price_target_up"]}
{"id": 41878145, "time": "2024-11-11 08:47:38", "headline": "Breton Eyes Big Haul From Investors With Hong Kong IPO Plan", "summary": "Key Takeaways:\n\n\n\tBreton Technology has filed for a Hong Kong IPO, reporting strong growth for its business making and selling electric-powered loaders and dump trucks\n\tThe company looks well positioned to benefit from China\u2019s strong support for green technology makers\n\n\nBy Doug Young", "symbols": ["NKLA", "TSLA"], "source": "benzinga", "author": "The Bamboo Works", "url": "https://www.benzinga.com/markets/penny-stocks/24/11/41878145/breton-eyes-big-haul-from-investors-with-hong-kong-ipo-plan", "tags": []}
{"id": 41878254, "time": "2024-11-11 08:48:33", "headline": "Trump's DJT Surges 26% In Past Month, Boosting Investors' Wealth By Over $1B As Ex-President Returns To White House For A Second Term", "summary": "Shares of Trump Media &amp; Technology Group Corp (NASDAQ: DJT) experienced a sharp uptick in the past month driven by Donald Trump&#39;s return to the White House for a second term. The stock has rallied over 26.23% in the last month.", "symbols": ["DJT", "SPY"], "source": "benzinga", "author": "Rishabh Mishra", "url": "https://www.benzinga.com/markets/equities/24/11/41878254/trumps-djt-surges-26-in-past-month-boosting-investors-wealth-by-over-1b-as-ex-president-returns-to-white-house-for-a-second-term", "tags": []}
{"id": 41871183, "time": "2024-11-11 03:23:39", "headline": "India's Annual iPhone Output Could Be Worth Up To $30B If Trump Tariffs Come Into Play: Report", "summary": "Annual production of\u00a0iPhones\u00a0in India could be set to witness a significant surge, doubling to a whopping $30 billion\u00a0if\u00a0policies proposed by the Trump administration come into effect and\u00a0result in a shift in global supply chains.", "symbols": [], "source": "benzinga", "author": "Ananthu C U", "url": "https://www.benzinga.com/markets/asia/24/11/41871183/indias-annual-iphone-output-could-be-worth-up-to-30b-if-trump-tariffs-come-into-play-report", "tags": []}
{"id": 41878267, "time": "2024-11-11 08:49:07", "headline": "Northland Capital Markets Maintains Outperform on Axon Enterprise, Raises Price Target to $550", "summary": "", "symbols": ["AXON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878267/northland-capital-markets-maintains-outperform-on-axon-enterprise-raises-price-target-to-550", "tags": ["analyst_other", "price_target_up"]}
{"id": 41878272, "time": "2024-11-11 08:49:38", "headline": "Jefferies Maintains Buy on Vital Farms, Lowers Price Target to $41", "summary": "", "symbols": ["VITL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878272/jefferies-maintains-buy-on-vital-farms-lowers-price-target-to-41", "tags": ["analyst_other", "price_target_down"]}
{"id": 41878273, "time": "2024-11-11 08:49:49", "headline": "Noble Capital Markets Downgrades GEO Group to Market Perform", "summary": "", "symbols": ["GEO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878273/noble-capital-markets-downgrades-geo-group-to-market-perform", "tags": ["analyst_down"]}
{"id": 41878274, "time": "2024-11-11 08:49:51", "headline": "FX Insights: US Dollar Strength and Potential EURUSD Reversal Zones", "summary": "USD strength and EURUSD reversal levels. ", "symbols": [], "source": "benzinga", "author": "Forex Analytix", "url": "https://www.benzinga.com/markets/24/11/41878274/fx-insights-us-dollar-strength-and-potential-eurusd-reversal-zones", "tags": []}
{"id": 41878284, "time": "2024-11-11 08:50:35", "headline": "Northland Capital Markets Maintains Outperform on IntL Money Express, Raises Price Target to $27", "summary": "", "symbols": ["IMXI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878284/northland-capital-markets-maintains-outperform-on-intl-money-express-raises-price-target-to-27", "tags": ["analyst_other", "price_target_up"]}
{"id": 41878288, "time": "2024-11-11 08:51:21", "headline": "JP Morgan Maintains Overweight on Dana, Lowers Price Target to $14", "summary": "", "symbols": ["DAN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878288/jp-morgan-maintains-overweight-on-dana-lowers-price-target-to-14", "tags": ["analyst_other", "price_target_down"]}
{"id": 41878294, "time": "2024-11-11 08:53:08", "headline": "Northland Capital Markets Maintains Market Perform on MACOM Technology Solns, Raises Price Target to $105", "summary": "", "symbols": ["MTSI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878294/northland-capital-markets-maintains-market-perform-on-macom-technology-solns-raises-price-target-to", "tags": ["analyst_other", "price_target_up"]}
{"id": 41878298, "time": "2024-11-11 08:53:37", "headline": "RBC Capital Maintains Outperform on Westlake, Lowers Price Target to $167", "summary": "", "symbols": ["WLK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878298/rbc-capital-maintains-outperform-on-westlake-lowers-price-target-to-167", "tags": ["analyst_other", "price_target_down"]}
{"id": 41878311, "time": "2024-11-11 08:55:08", "headline": "Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["VLCN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41878311/trading-halt-halt-status-updated-at-8-55-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 41878312, "time": "2024-11-11 08:55:11", "headline": "Northland Capital Markets Maintains Outperform on Cantaloupe, Raises Price Target to $12", "summary": "", "symbols": ["CTLP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878312/northland-capital-markets-maintains-outperform-on-cantaloupe-raises-price-target-to-12", "tags": ["analyst_other", "price_target_up"]}
{"id": 41878313, "time": "2024-11-11 08:55:29", "headline": "RBC Capital Maintains Sector Perform on Vivid Seats, Lowers Price Target to $6", "summary": "", "symbols": ["SEAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878313/rbc-capital-maintains-sector-perform-on-vivid-seats-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 41878317, "time": "2024-11-11 08:56:05", "headline": "Policymakers Don't Want To Tank The Stock Market", "summary": "The stock market climbed to all-time highs,\u00a0with the S&amp;P 500 setting an intraday high of 6,012.45 and a closing high of 5,995.54 on Friday. The index gained 4.7% last week, the best weekly performance\u00a0since last November.", "symbols": [], "source": "benzinga", "author": "Sam Ro", "url": "https://www.benzinga.com/economics/24/11/41878317/policymakers-dont-want-to-tank-the-stock-market", "tags": []}
{"id": 41878329, "time": "2024-11-11 08:57:45", "headline": "RBC Capital Maintains Outperform on Targa Resources, Raises Price Target to $199", "summary": "", "symbols": ["TRGP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878329/rbc-capital-maintains-outperform-on-targa-resources-raises-price-target-to-199", "tags": ["analyst_other", "price_target_up"]}
{"id": 41878332, "time": "2024-11-11 08:58:06", "headline": "Craig-Hallum Maintains Buy on PAR Technology, Raises Price Target to $85", "summary": "", "symbols": ["PAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878332/craig-hallum-maintains-buy-on-par-technology-raises-price-target-to-85", "tags": ["analyst_other", "price_target_up"]}
{"id": 41878334, "time": "2024-11-11 08:58:16", "headline": "FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial", "summary": "FDA lifts clinical hold on Novavax&#39;s COVID-19-influenza combo vaccine, clearing path for Phase 3 trials. Novavax to resume trial activities soon.", "symbols": ["NVAX"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41878334/fda-gives-green-signal-to-novavaxs-covid-19-influenza-combo-vaccine-late-stage-trial", "tags": ["fda"]}
{"id": 41878361, "time": "2024-11-11 08:58:26", "headline": "What's Going On With MicroStrategy Stock Monday?", "summary": "MicroStrategy Inc (NASDAQ:MSTR) shares are trading higher Monday after Bitcoin (CRYPTO: BTC) prices hit new all-time highs over the weekend.", "symbols": ["BTCUSD", "MSTR"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41878361/whats-going-on-with-microstrategy-stock-monday-2", "tags": ["why_moving"]}
{"id": 41878376, "time": "2024-11-11 08:58:58", "headline": "Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 4% Dividend Yields", "summary": " ", "symbols": ["CC", "DOW", "MERC"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/price-target/24/11/41878376/wall-streets-most-accurate-analysts-weigh-in-on-3-materials-stocks-with-over-4-dividend-yields-2", "tags": ["dividend"]}
{"id": 41878381, "time": "2024-11-11 08:59:21", "headline": "Craig-Hallum Maintains Buy on Docebo, Raises Price Target to $62", "summary": "", "symbols": ["DCBO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878381/craig-hallum-maintains-buy-on-docebo-raises-price-target-to-62", "tags": ["analyst_other", "price_target_up"]}
{"id": 41878394, "time": "2024-11-11 08:59:45", "headline": "This Analyst With 86% Accuracy Rate Sees More Than 58% Upside In Pinterest - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts", "summary": " ", "symbols": ["AAON", "DIOD", "HRB", "HUBS", "PINS"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/price-target/24/11/41878394/this-analyst-with-86-accuracy-rate-sees-more-than-58-upside-in-pinterest-here-are-5-stock-picks-for-last-week-from-wall-streets-most-accurate-analysts", "tags": []}
{"id": 41878471, "time": "2024-11-11 09:00:14", "headline": "Advanced Drainage Systems Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)", "summary": " ", "symbols": ["WMS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41878471/advanced-drainage-systems-stock-a-deep-dive-into-analyst-perspectives-4-ratings", "tags": []}
{"id": 41878490, "time": "2024-11-11 09:00:18", "headline": "Barclays Maintains Underweight on Agilon Health, Lowers Price Target to $2", "summary": "", "symbols": ["AGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878490/barclays-maintains-underweight-on-agilon-health-lowers-price-target-to-2", "tags": ["analyst_other", "price_target_down"]}
{"id": 41878494, "time": "2024-11-11 09:00:22", "headline": "What Analysts Are Saying About Cibus Stock", "summary": " ", "symbols": ["CBUS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41878494/what-analysts-are-saying-about-cibus-stock", "tags": []}
{"id": 41878498, "time": "2024-11-11 09:00:29", "headline": "Critical Insights From CarGurus Analyst Ratings: What You Need To Know", "summary": " ", "symbols": ["CARG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41878498/critical-insights-from-cargurus-analyst-ratings-what-you-need-to-know", "tags": []}
{"id": 41878500, "time": "2024-11-11 09:00:36", "headline": "Assessing Bloomin Brands: Insights From 4 Financial Analysts", "summary": " ", "symbols": ["BLMN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41878500/assessing-bloomin-brands-insights-from-4-financial-analysts", "tags": []}
{"id": 41878504, "time": "2024-11-11 09:00:44", "headline": "Analyst Ratings For Atmus Filtration Techs", "summary": " ", "symbols": ["ATMU"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41878504/analyst-ratings-for-atmus-filtration-techs", "tags": []}
{"id": 41878513, "time": "2024-11-11 09:00:52", "headline": "Expert Outlook: Excelerate Energy Through The Eyes Of 5 Analysts", "summary": " ", "symbols": ["EE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41878513/expert-outlook-excelerate-energy-through-the-eyes-of-5-analysts", "tags": ["guidance"]}
{"id": 41878516, "time": "2024-11-11 09:00:55", "headline": "A Preview Of Groupon's Earnings", "summary": " ", "symbols": ["GRPN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41878516/a-preview-of-groupons-earnings", "tags": ["earnings"]}
{"id": 41878517, "time": "2024-11-11 09:00:55", "headline": "Barclays Maintains Overweight on Bloomin Brands, Lowers Price Target to $19", "summary": "", "symbols": ["BLMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878517/barclays-maintains-overweight-on-bloomin-brands-lowers-price-target-to-19", "tags": ["analyst_other", "price_target_down"]}
{"id": 41878526, "time": "2024-11-11 09:01:03", "headline": "A Look Ahead: Azenta's Earnings Forecast", "summary": " ", "symbols": ["AZTA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41878526/a-look-ahead-azentas-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 41878533, "time": "2024-11-11 09:01:12", "headline": "Insights into Ginkgo Bioworks Holdings's Upcoming Earnings", "summary": " ", "symbols": ["DNA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41878533/insights-into-ginkgo-bioworks-holdingss-upcoming-earnings", "tags": ["earnings"]}
{"id": 41878535, "time": "2024-11-11 09:01:15", "headline": "Babcock & Wilcox Wins Contract For Carbon Capture Study At Swedish Facility", "summary": " ", "symbols": ["BW"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/news/contracts/24/11/41878535/babcock-wilcox-wins-contract-for-carbon-capture-study-at-swedish-facility", "tags": ["contract"]}
{"id": 41878536, "time": "2024-11-11 09:01:19", "headline": "Earnings Preview: Xenon Pharmaceuticals", "summary": " ", "symbols": ["XENE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41878536/earnings-preview-xenon-pharmaceuticals", "tags": ["earnings"]}
{"id": 41878539, "time": "2024-11-11 09:01:25", "headline": "Coffee Holding Co., Purchases All Assets Of Empire Coffee Company For $800,000", "summary": "", "symbols": ["JVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41878539/coffee-holding-co-purchases-all-assets-of-empire-coffee-company-for-800-000", "tags": []}
{"id": 41878542, "time": "2024-11-11 09:01:28", "headline": "An Overview of Corvus Pharma's Earnings", "summary": " ", "symbols": ["CRVS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41878542/an-overview-of-corvus-pharmas-earnings", "tags": ["earnings"]}
{"id": 41878545, "time": "2024-11-11 09:01:37", "headline": "Earnings Preview For Prothena Corp", "summary": " ", "symbols": ["PRTA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41878545/earnings-preview-for-prothena-corp", "tags": ["earnings"]}
{"id": 41878550, "time": "2024-11-11 09:01:47", "headline": "A Preview Of RumbleON's Earnings", "summary": " ", "symbols": ["RMBL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41878550/a-preview-of-rumbleons-earnings", "tags": ["earnings"]}
{"id": 41878551, "time": "2024-11-11 09:01:52", "headline": "Verizon Business Awarded Over $98M Contract Extension From U.S. Department Of Defense", "summary": "", "symbols": ["VZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878551/verizon-business-awarded-over-98m-contract-extension-from-u-s-department-of-defense", "tags": ["contract"]}
{"id": 41878552, "time": "2024-11-11 09:01:53", "headline": "Examining the Future: CAE's Earnings Outlook", "summary": " ", "symbols": ["CAE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41878552/examining-the-future-caes-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41878553, "time": "2024-11-11 09:01:58", "headline": "Instacart Announces That Multiple Local And Independent Grocers, Including Bowman's Market, Maurer's Market IGA, Neiman's Family Market, Queen's Price Chopper And Soelbergs Market Are Adopting Caper Carts, Instacart's AI-Powered Smart Carts, Across Their Stores", "summary": "", "symbols": ["CART"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878553/instacart-announces-that-multiple-local-and-independent-grocers-including-bowmans-market-maurers-mar", "tags": []}
{"id": 41878560, "time": "2024-11-11 09:02:06", "headline": "Preview: Outfront Media's Earnings", "summary": " ", "symbols": ["OUT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41878560/preview-outfront-medias-earnings", "tags": ["earnings"]}
{"id": 41878564, "time": "2024-11-11 09:02:10", "headline": "Craig-Hallum Maintains Buy on Power Solutions Intl, Raises Price Target to $37", "summary": "", "symbols": ["PSIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878564/craig-hallum-maintains-buy-on-power-solutions-intl-raises-price-target-to-37", "tags": ["analyst_other", "price_target_up"]}
{"id": 41878565, "time": "2024-11-11 09:02:14", "headline": "A Peek at Marathon Digital Holdings's Future Earnings", "summary": " ", "symbols": ["MARA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41878565/a-peek-at-marathon-digital-holdingss-future-earnings", "tags": ["earnings"]}
{"id": 41878566, "time": "2024-11-11 09:02:23", "headline": "2seventy bio Earnings Preview", "summary": " ", "symbols": ["TSVT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41878566/2seventy-bio-earnings-preview", "tags": ["earnings"]}
{"id": 41878569, "time": "2024-11-11 09:02:31", "headline": "What's Next: WAVE Life Sciences's Earnings Preview", "summary": " ", "symbols": ["WVE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41878569/whats-next-wave-life-sciencess-earnings-preview", "tags": ["earnings"]}
{"id": 41878582, "time": "2024-11-11 09:03:20", "headline": "Better.com Expands Mortgage Offerings For Veterans through VA Interest Rate Reduction Refinance Loan Through Program Backed By The U.S. Department Of Veteran Affairs", "summary": "", "symbols": ["BETR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878582/better-com-expands-mortgage-offerings-for-veterans-through-va-interest-rate-reduction-refinance-loan", "tags": []}
{"id": 41878586, "time": "2024-11-11 09:03:26", "headline": "Ciena WaveLogic 6 Extreme Used To Deploy euNetworks First-Ever 1.6 Tb/s Coherent Solution", "summary": "", "symbols": ["CIEN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878586/ciena-wavelogic-6-extreme-used-to-deploy-eunetworks-first-ever-1-6-tbs-coherent-solution", "tags": []}
{"id": 41878587, "time": "2024-11-11 09:03:32", "headline": "Barclays Maintains Equal-Weight on Edgewell Personal Care, Lowers Price Target to $36", "summary": "", "symbols": ["EPC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878587/barclays-maintains-equal-weight-on-edgewell-personal-care-lowers-price-target-to-36", "tags": ["analyst_other", "price_target_down"]}
{"id": 41878593, "time": "2024-11-11 09:03:55", "headline": "Evercore ISI Group Upgrades American Homes 4 Rent to Outperform, Raises Price Target to $42", "summary": "", "symbols": ["AMH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878593/evercore-isi-group-upgrades-american-homes-4-rent-to-outperform-raises-price-target-to-42", "tags": ["analyst_up", "price_target_up"]}
{"id": 41878605, "time": "2024-11-11 09:04:28", "headline": "Gogoro And Copec Announces They Are Launching The First Two-Wheel Battery Swapping Platform And Smartscooters In Chile", "summary": "", "symbols": ["GGR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878605/gogoro-and-copec-announces-they-are-launching-the-first-two-wheel-battery-swapping-platform-and-smar", "tags": []}
{"id": 41878624, "time": "2024-11-11 09:05:25", "headline": "Roth CH Acquisition V Co. Announces Effectiveness Of Registration Statement For Proposed Business Combination With New Era Helium Corp.", "summary": "", "symbols": ["ROCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41878624/roth-ch-acquisition-v-co-announces-effectiveness-of-registration-statement-for-proposed-business-com", "tags": []}
{"id": 41878654, "time": "2024-11-11 09:06:08", "headline": "Stephens & Co. Maintains Overweight on Porch Group, Raises Price Target to $5", "summary": "", "symbols": ["PRCH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878654/stephens-co-maintains-overweight-on-porch-group-raises-price-target-to-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 41878659, "time": "2024-11-11 09:06:18", "headline": "Freight Technologies' Waavely Platform Gains Early Traction With Four Active Customers Since July Launch; Focused On Expanding Client Volume And Enhancing Service Capabilities", "summary": "", "symbols": ["FRGT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878659/freight-technologies-waavely-platform-gains-early-traction-with-four-active-customers-since-july-lau", "tags": []}
{"id": 41878690, "time": "2024-11-11 09:07:28", "headline": "'Blackstone's Spanx And Supergoop Bets Are Stuck In Low Gear' - The Information", "summary": "", "symbols": ["BX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878690/blackstones-spanx-and-supergoop-bets-are-stuck-in-low-gear-the-information", "tags": []}
{"id": 41878708, "time": "2024-11-11 09:08:22", "headline": "Barclays Maintains Overweight on Evolent Health, Lowers Price Target to $19", "summary": "", "symbols": ["EVH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878708/barclays-maintains-overweight-on-evolent-health-lowers-price-target-to-19", "tags": ["analyst_other", "price_target_down"]}
{"id": 41878930, "time": "2024-11-11 09:10:26", "headline": "B. Riley Securities Maintains Buy on CarGurus, Raises Price Target to $40", "summary": "", "symbols": ["CARG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878930/b-riley-securities-maintains-buy-on-cargurus-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 41878932, "time": "2024-11-11 09:10:34", "headline": "Barclays Maintains Overweight on First Watch Restaurant Gr, Raises Price Target to $24", "summary": "", "symbols": ["FWRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878932/barclays-maintains-overweight-on-first-watch-restaurant-gr-raises-price-target-to-24", "tags": ["analyst_other", "price_target_up"]}
{"id": 41878941, "time": "2024-11-11 09:10:48", "headline": "AI Meets Real Estate: Janover Launches Advanced Voice Tool For Customer Relationship Management", "summary": "Janover Inc. (JNVR) shares soar after announcing AI voice tool for CRM operations, designed to enhance customer management in real estate.", "symbols": ["JNVR"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/large-cap/24/11/41878941/ai-meets-real-estate-janover-launches-advanced-voice-tool-for-customer-relationship-management", "tags": []}
{"id": 41878960, "time": "2024-11-11 09:11:42", "headline": "B. Riley Securities Maintains Buy on CompoSecure, Raises Price Target to $23", "summary": "", "symbols": ["CMPO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878960/b-riley-securities-maintains-buy-on-composecure-raises-price-target-to-23", "tags": ["analyst_other", "price_target_up"]}
{"id": 41878963, "time": "2024-11-11 09:11:58", "headline": "Barclays Maintains Equal-Weight on Fortrea Holdings, Raises Price Target to $25", "summary": "", "symbols": ["FTRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878963/barclays-maintains-equal-weight-on-fortrea-holdings-raises-price-target-to-25", "tags": ["analyst_other", "price_target_up"]}
{"id": 41878981, "time": "2024-11-11 09:12:28", "headline": "MicroStrategy Acquires Another 27,200 Bitcoin Worth $2 Billion", "summary": "MicroStrategy Inc. (NASDAQ:MSTR) on Monday announced it has purchased 27,200 Bitcoin (CRYPTO: BTC) for approximately $2.03 billion in cash over a ten-day period between Oct. 31 and Nov. 10, this year. ", "symbols": ["BTCUSD", "MSTR"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41878981/microstrategy-acquires-another-27200-bitcoin-worth-2-billion", "tags": ["merger"]}
{"id": 41878984, "time": "2024-11-11 09:12:48", "headline": "B. Riley Securities Maintains Neutral on Gladstone Inv, Raises Price Target to $13.5", "summary": "", "symbols": ["GAIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878984/b-riley-securities-maintains-neutral-on-gladstone-inv-raises-price-target-to-13-5", "tags": ["analyst_other", "price_target_up"]}
{"id": 41878998, "time": "2024-11-11 09:14:56", "headline": "Super League Announces Its Partnership With Paramount Pictures To Release A Custom Gladiator II-Inspired Fortnite Map, Gladiator Gauntlet, Ahead Of The Film's Release On November 22", "summary": "", "symbols": ["DXYZ", "PARA", "SLE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41878998/super-league-announces-its-partnership-with-paramount-pictures-to-release-a-custom-gladiator-ii-insp", "tags": ["contract"]}
{"id": 41879005, "time": "2024-11-11 09:15:10", "headline": "Barclays Maintains Overweight on GoodRx Holdings, Lowers Price Target to $6", "summary": "", "symbols": ["GDRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879005/barclays-maintains-overweight-on-goodrx-holdings-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 41879006, "time": "2024-11-11 09:15:25", "headline": "A Look Into National Energy Services Inc's Price Over Earnings", "summary": " ", "symbols": ["NESR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41879006/a-look-into-national-energy-services-incs-price-over-earnings", "tags": ["earnings"]}
{"id": 41879037, "time": "2024-11-11 09:16:01", "headline": "Morgan Stanley Capital Partners To Sell Sila Services To Goldman Sachs Alternatives; Financial Terms Not Disclosed; Sila Management To Retain Minority Stake And Continue Leadership", "summary": "", "symbols": ["GS", "MS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879037/morgan-stanley-capital-partners-to-sell-sila-services-to-goldman-sachs-alternatives-financial-terms", "tags": []}
{"id": 41879137, "time": "2024-11-11 09:16:44", "headline": "Shengfeng Development Enters China's Low-Altitude Logistics Sector; Co Believes This Move Will Allow It To Leverage Its Logistics Expertise In An Emerging Field That Integrates Drone Technology For Streamlined, Efficient Logistics Solutions Across Diverse Sectors, Particularly In High-Demand And Remote Regions", "summary": "", "symbols": ["SFWL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879137/shengfeng-development-enters-chinas-low-altitude-logistics-sector-co-believes-this-move-will-allow-i", "tags": []}
{"id": 41879138, "time": "2024-11-11 09:16:47", "headline": "B. Riley Securities Maintains Neutral on Main Street Capital, Raises Price Target to $51", "summary": "", "symbols": ["MAIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879138/b-riley-securities-maintains-neutral-on-main-street-capital-raises-price-target-to-51", "tags": ["analyst_other", "price_target_up"]}
{"id": 41879140, "time": "2024-11-11 09:17:04", "headline": "Nisun International Acquires Minority Stake In KFC Franchisee, Nanjing Pin Bai Sheng; Terms Not Disclosed", "summary": "", "symbols": ["NISN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41879140/nisun-international-acquires-minority-stake-in-kfc-franchisee-nanjing-pin-bai-sheng-terms-not-disclo", "tags": ["merger"]}
{"id": 41879152, "time": "2024-11-11 09:17:56", "headline": "Barclays Maintains Equal-Weight on Hain Celestial Group, Lowers Price Target to $8", "summary": "", "symbols": ["HAIN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879152/barclays-maintains-equal-weight-on-hain-celestial-group-lowers-price-target-to-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 41879153, "time": "2024-11-11 09:18:00", "headline": "Stephens & Co. Maintains Equal-Weight on Customers Bancorp, Raises Price Target to $55", "summary": "", "symbols": ["CUBI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879153/stephens-co-maintains-equal-weight-on-customers-bancorp-raises-price-target-to-55", "tags": ["analyst_other", "price_target_up"]}
{"id": 41879201, "time": "2024-11-11 09:19:16", "headline": "B. Riley Securities Maintains Buy on RCM Technologies, Raises Price Target to $37", "summary": "", "symbols": ["RCMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879201/b-riley-securities-maintains-buy-on-rcm-technologies-raises-price-target-to-37", "tags": ["analyst_other", "price_target_up"]}
{"id": 41879202, "time": "2024-11-11 09:19:21", "headline": "Barclays Maintains Equal-Weight on Hanesbrands, Raises Price Target to $7", "summary": "", "symbols": ["HBI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879202/barclays-maintains-equal-weight-on-hanesbrands-raises-price-target-to-7", "tags": ["analyst_other", "price_target_up"]}
{"id": 41879212, "time": "2024-11-11 09:20:59", "headline": "Euroseas Extends Charter Contract For Two 2,500 teu Feeder Containerships; EM Corfu Fixed For Minimum Period Of 18 Months And Maximum Period Of 20 Months At $28,000/Day; Evridiki G Fixed For Minimum Period Of 14 Months And 16 Months Maxinum Period At $29,500/Day", "summary": "", "symbols": ["ESEA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879212/euroseas-extends-charter-contract-for-two-2-500-teu-feeder-containerships-em-corfu-fixed-for-minimum", "tags": ["contract"]}
{"id": 41879225, "time": "2024-11-11 09:21:40", "headline": "Stephens & Co. Maintains Overweight on P10, Raises Price Target to $13", "summary": "", "symbols": ["PX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879225/stephens-co-maintains-overweight-on-p10-raises-price-target-to-13", "tags": ["analyst_other", "price_target_up"]}
{"id": 41879236, "time": "2024-11-11 09:23:25", "headline": "Barclays Maintains Equal-Weight on LegalZoom.com, Raises Price Target to $8", "summary": "", "symbols": ["LZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879236/barclays-maintains-equal-weight-on-legalzoom-com-raises-price-target-to-8", "tags": ["analyst_other", "price_target_up"]}
{"id": 41879239, "time": "2024-11-11 09:24:34", "headline": "B. Riley Securities Maintains Buy on Tango Therapeutics, Lowers Price Target to $8", "summary": "", "symbols": ["TNGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879239/b-riley-securities-maintains-buy-on-tango-therapeutics-lowers-price-target-to-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 41879242, "time": "2024-11-11 09:24:50", "headline": "Barclays Maintains Underweight on LifeStance Health Gr, Raises Price Target to $7", "summary": "", "symbols": ["LFST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879242/barclays-maintains-underweight-on-lifestance-health-gr-raises-price-target-to-7", "tags": ["analyst_other", "price_target_up"]}
{"id": 41879254, "time": "2024-11-11 09:25:42", "headline": "Barclays Maintains Equal-Weight on Methanex, Raises Price Target to $46", "summary": "", "symbols": ["MEOH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879254/barclays-maintains-equal-weight-on-methanex-raises-price-target-to-46", "tags": ["analyst_other", "price_target_up"]}
{"id": 41879255, "time": "2024-11-11 09:25:48", "headline": "Jumia Expands Its Logistics Network With New Warehouse To Strengthen E-Commerce In Ghana", "summary": "Jumia expands with new warehouse in Ghana to optimize operations and enhance customer experience. ", "symbols": ["JMIA"], "source": "benzinga", "author": "Akanksha Bakshi", "url": "https://www.benzinga.com/markets/equities/24/11/41879255/jumia-expands-its-logistics-network-with-new-warehouse-to-strengthen-e-commerce-in-ghana", "tags": []}
{"id": 41879265, "time": "2024-11-11 09:26:13", "headline": "B. Riley Securities Maintains Neutral on TrueCar, Raises Price Target to $4", "summary": "", "symbols": ["TRUE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879265/b-riley-securities-maintains-neutral-on-truecar-raises-price-target-to-4", "tags": ["analyst_other", "price_target_up"]}
{"id": 41879288, "time": "2024-11-11 09:27:22", "headline": "Top 10 Trending Stocks On WallStreetBets As Of November 11, 2024 (Via Swaggy Stocks)", "summary": "", "symbols": ["COIN", "CORN", "HOOD", "LUNR", "MARA", "MSTR", "NVDA", "PLTR", "RKLB", "TSLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41879288/top-10-trending-stocks-on-wallstreetbets-as-of-november-11-2024-via-swaggy-stocks", "tags": []}
{"id": 41879289, "time": "2024-11-11 09:27:27", "headline": "Wedbush Upgrades Pinterest to Outperform, Announces $38 Price Target", "summary": "", "symbols": ["PINS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879289/wedbush-upgrades-pinterest-to-outperform-announces-38-price-target", "tags": ["analyst_up"]}
{"id": 41879386, "time": "2024-11-11 09:30:56", "headline": "Founder Group Secures Multiple Contracts Worth ~$5.5M; Co Will Assume Various Responsibilities Across The Projects, Including Full EPCC Services, The Supply And Installation Of DC And AC Electrical Systems, Instrumentation & Control Systems, And Civil Works", "summary": "", "symbols": ["FGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879386/founder-group-secures-multiple-contracts-worth-5-5m-co-will-assume-various-responsibilities-across-t", "tags": []}
{"id": 41879388, "time": "2024-11-11 09:31:15", "headline": "Wedbush Maintains Outperform on Tesla, Raises Price Target to $400", "summary": "", "symbols": ["TSLA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879388/wedbush-maintains-outperform-on-tesla-raises-price-target-to-400", "tags": ["analyst_other", "price_target_up"]}
{"id": 41879393, "time": "2024-11-11 09:31:59", "headline": "Bitcoin Mining Stock MARA Holdings Is Surging Monday: What's Going On?", "summary": "MARA Holdings Inc (NASDAQ:MARA) shares are trading higher Monday as Bitcoin (CRYPTO: BTC) hovers around all-time highs. The mining company announced additional capacity in Ohio.", "symbols": ["BTCUSD", "MARA"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41879393/bitcoin-mining-stock-mara-holdings-is-surging-monday-whats-going-on", "tags": ["why_moving"]}
{"id": 41879400, "time": "2024-11-11 09:32:07", "headline": "ViiV Healthcare's DOLCE Study Shows 2-Drug Regimen Dovato Is Highly Effective In Treatment-Na\u00efve People With Advanced HIV, Matching 3-Drug Therapy Efficacy At 48 Weeks", "summary": "", "symbols": ["GSK", "PFE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41879400/viiv-healthcares-dolce-study-shows-2-drug-regimen-dovato-is-highly-effective-in-treatment-na-ve-p", "tags": []}
{"id": 41879415, "time": "2024-11-11 09:32:22", "headline": "Xiao-I Corporation Enhances HR Operations For Hong Kong Public Sector Client With AI-Powered Solution, Generating Initial Revenue Of 8 Million Hong Kong Dollars", "summary": "", "symbols": ["AIXI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879415/xiao-i-corporation-enhances-hr-operations-for-hong-kong-public-sector-client-with-ai-powered-solutio", "tags": ["earnings"]}
{"id": 41879431, "time": "2024-11-11 09:33:59", "headline": "Barclays Maintains Equal-Weight on ODDITY Tech, Raises Price Target to $42", "summary": "", "symbols": ["ODD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879431/barclays-maintains-equal-weight-on-oddity-tech-raises-price-target-to-42", "tags": ["analyst_other", "price_target_up"]}
{"id": 41879447, "time": "2024-11-11 09:36:01", "headline": "HC Wainwright & Co. Reiterates Buy on Adlai Nortye, Maintains $9 Price Target", "summary": "", "symbols": ["ANL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879447/hc-wainwright-co-reiterates-buy-on-adlai-nortye-maintains-9-price-target", "tags": ["analyst_other"]}
{"id": 41879458, "time": "2024-11-11 09:37:37", "headline": "NYSE American To Commence Delisting Proceedings Against Regional Health Properties, Inc.", "summary": "", "symbols": ["RHE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879458/nyse-american-to-commence-delisting-proceedings-against-regional-health-properties-inc", "tags": []}
{"id": 41879459, "time": "2024-11-11 09:37:53", "headline": "Needham Maintains Buy on Blue Bird, Lowers Price Target to $66", "summary": "", "symbols": ["BLBD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879459/needham-maintains-buy-on-blue-bird-lowers-price-target-to-66", "tags": ["analyst_other", "price_target_down"]}
{"id": 41879583, "time": "2024-11-11 09:39:28", "headline": "HC Wainwright & Co. Reiterates Neutral on CytomX Therapeutics", "summary": "", "symbols": ["CTMX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879583/hc-wainwright-co-reiterates-neutral-on-cytomx-therapeutics", "tags": ["analyst_other"]}
{"id": 41879584, "time": "2024-11-11 09:39:54", "headline": "Barclays Maintains Equal-Weight on Olaplex Hldgs, Lowers Price Target to $1.5", "summary": "", "symbols": ["OLPX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879584/barclays-maintains-equal-weight-on-olaplex-hldgs-lowers-price-target-to-1-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41879586, "time": "2024-11-11 09:40:03", "headline": "Watching Estee Lauder; Traders Circulate Unconfirmed Rumor Of Analyst Comments Suggesting Nelson Peltz's Trian Will Be Revealing A Big Stake In Estee Lauder This Week. Peltz Is Scheduled To Speak On Wednesday Afternoon At CNBC's 'Delivering Alpha' Get-Together", "summary": "", "symbols": ["EL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879586/watching-estee-lauder-traders-circulate-unconfirmed-rumor-of-analyst-comments-suggesting-nelson-pelt", "tags": []}
{"id": 41879587, "time": "2024-11-11 09:40:08", "headline": "From $16,000 To $18 Million In Unrealized Gains\u2014Millionaire BONK, DOGE Trader Shares Update: 'If You Can't Hold, You Won't Be Rich'", "summary": "Unipcs, the millionaire trader known as \u2018BONK guy,\u2019 recently shared his journey and insights into meme coin trading, particularly his long-term position in Bonk (CRYPTO: ", "symbols": ["BONKUSD", "DOGEUSD", "SHIBUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41879587/from-16000-to-18-million-in-unrealized-gainsmillionaire-bonk-doge-trader-shares-update-if-you-cant-hold-you-wont-be-rich", "tags": []}
{"id": 41879601, "time": "2024-11-11 09:42:21", "headline": "Avanos Medical Announced That The CMS Has Issued Its Final Medicare Hospital OPPS And Medicare ASC Payment System Rule For 2025; Effective Jan. 1, 2025, Implements The Non-Opioids Prevent Addiction In The Nation Act That Mandates Separate Medicare Payment For Qualifying Non-Opioid Drugs And Devices", "summary": "", "symbols": ["AVNS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879601/avanos-medical-announced-that-the-cms-has-issued-its-final-medicare-hospital-opps-and-medicare-asc-p", "tags": []}
{"id": 41879605, "time": "2024-11-11 09:42:47", "headline": "Sapiens Shares Tumble On Q3 Miss: Adjusts Outlook Amid Revenue Shortfalls", "summary": "Sapiens Int&#39;l shares down after reporting 3Q 2024 results. Revenue rose 4.8% but missed consensus, adjusted EPS below consensus.", "symbols": ["SPNS"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/11/41879605/sapiens-shares-tumble-as-q3-revenue-misses-mark-lowering-2024-outlook", "tags": ["earnings", "guidance"]}
{"id": 41879615, "time": "2024-11-11 09:44:06", "headline": "Trump Media & Technology Group Shares Halted To The Upside; Stock Now Up 6.80%", "summary": "", "symbols": ["DJT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41879615/trump-media-technology-group-shares-halted-to-the-upside-stock-now-up-6-80", "tags": ["halt"]}
{"id": 41879618, "time": "2024-11-11 09:44:36", "headline": "HC Wainwright & Co. Reiterates Neutral on Zura Bio, Maintains $5 Price Target", "summary": "", "symbols": ["ZURA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879618/hc-wainwright-co-reiterates-neutral-on-zura-bio-maintains-5-price-target", "tags": ["analyst_other"]}
{"id": 41879623, "time": "2024-11-11 09:45:56", "headline": "NVIDIA Unusual Options Activity", "summary": " ", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41879623/nvidia-unusual-options-activity", "tags": []}
{"id": 41879625, "time": "2024-11-11 09:46:01", "headline": "Behind the Scenes of AppLovin's Latest Options Trends", "summary": " ", "symbols": ["APP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41879625/behind-the-scenes-of-applovins-latest-options-trends", "tags": []}
{"id": 41879628, "time": "2024-11-11 09:46:07", "headline": "Behind the Scenes of MicroStrategy's Latest Options Trends", "summary": " ", "symbols": ["MSTR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41879628/behind-the-scenes-of-microstrategys-latest-options-trends", "tags": []}
{"id": 41879690, "time": "2024-11-11 09:46:49", "headline": "HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $30", "summary": "", "symbols": ["TYRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879690/hc-wainwright-co-maintains-buy-on-tyra-biosciences-lowers-price-target-to-30", "tags": ["analyst_other", "price_target_down"]}
{"id": 41879708, "time": "2024-11-11 09:47:37", "headline": "Destiny Tech100 Shares Halted On Circuit Breaker To The Downside, Stock Now Up 19.1%", "summary": "", "symbols": ["DXYZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41879708/destiny-tech100-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-19-1", "tags": ["halt"]}
{"id": 41879707, "time": "2024-11-11 09:47:43", "headline": "Reddit Stock Soars 167% Year-To-Date, Unshaken By Exec Sell-Offs", "summary": "Reddit stock has gained 167% this year and execs are selling millions of dollars worth of shares, raising concerns about a potential peak.", "symbols": ["RDDT"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/general/social-media/24/11/41879707/reddit-execs-offload-shares-should-investors-follow", "tags": []}
{"id": 41847581, "time": "2024-11-11 09:47:48", "headline": "El Salvador's Bitcoin Bet Is Paying Off\u2014Here's How Much The Country Is Up (UPDATED)", "summary": "Editor\u2019s note: This story has been updated with recent figures about El Salvador\u2019s returns on its Bitcoin investment.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41847581/el-salvadors-bitcoin-bet-is-paying-off-heres-how-much-the-country-is-up", "tags": []}
{"id": 41879720, "time": "2024-11-11 09:48:26", "headline": "Trump Media & Technology Group Shares Resume Trade", "summary": "", "symbols": ["DJT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41879720/trump-media-technology-group-shares-resume-trade", "tags": []}
{"id": 41879709, "time": "2024-11-11 09:47:45", "headline": "Market Clubhouse Morning Memo - November 11th, 2024 (Trade Strategy For SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META And TSLA)", "summary": "Good Morning Traders! In today&#39;s Market Clubhouse Morning Memo, we will discuss SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA.", "symbols": ["AAPL", "GOOGL", "META", "MSFT", "NVDA", "QQQ", "SPY", "TSLA"], "source": "benzinga", "author": "RIPS", "url": "https://www.benzinga.com/trading-ideas/24/11/41879709/market-clubhouse-morning-memo-november-11th-2024-trade-strategy-for-spy-qqq-aapl-msft-nvda-googl-me", "tags": []}
{"id": 41879728, "time": "2024-11-11 09:49:03", "headline": "Nexalin Technology Shares Resume Trade Following Circuit Breaker Halt", "summary": "", "symbols": ["NXL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41879728/nexalin-technology-shares-resume-trade-following-circuit-breaker-halt", "tags": ["halt"]}
{"id": 41879773, "time": "2024-11-11 09:49:48", "headline": "Benzinga Market Summary: Bitcoin Rises Above $82,000, Indexes Continue To Rise On US Election And Fed Rate Cut, Oil Prices Fall", "summary": "", "symbols": ["BTCUSD", "SPY", "USO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41879773/benzinga-market-summary-bitcoin-rises-above-82-000-indexes-continue-to-rise-on-us", "tags": []}
{"id": 41879774, "time": "2024-11-11 09:49:56", "headline": "Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results", "summary": " ", "symbols": ["CERO", "EFSH", "FOXO", "HOVR", "MNDY", "NXL", "RAPT"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41879774/dow-jumps-over-400-points-monday-com-shares-fall-after-q3-results", "tags": ["earnings"]}
{"id": 41879783, "time": "2024-11-11 09:50:28", "headline": "Destiny Tech100 Shares Resume Trade", "summary": "", "symbols": ["DXYZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41879783/destiny-tech100-shares-resume-trade", "tags": []}
{"id": 41879839, "time": "2024-11-11 09:55:24", "headline": "Barclays Maintains Equal-Weight on TruBridge, Raises Price Target to $14", "summary": "", "symbols": ["TBRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879839/barclays-maintains-equal-weight-on-trubridge-raises-price-target-to-14", "tags": ["analyst_other", "price_target_up"]}
{"id": 41879840, "time": "2024-11-11 09:55:34", "headline": "Sonoma Pharmaceuticals Announces The FDA 510k Review Panel Has Rated Its Microdacyn Hydrogel Substantially Equivalent For General & Plastic Surgery On November 8, 2024", "summary": "", "symbols": ["SNOA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41879840/sonoma-pharmaceuticals-announces-the-fda-510k-review-panel-has-rated-its-microdacyn-hydrogel-subs", "tags": ["fda"]}
{"id": 41879845, "time": "2024-11-11 09:56:16", "headline": "Founder Group Shares Halted On Circuit Breaker To The Downside, Stock Now Down -9.24%", "summary": "", "symbols": ["FGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41879845/founder-group-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down-9-24", "tags": ["halt"]}
{"id": 41879823, "time": "2024-11-11 09:52:37", "headline": "Nexalin Technology Shares Halted On Circuit Breaker To The Upside, Stock Now Down -28.4%", "summary": "", "symbols": ["NXL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41879823/nexalin-technology-shares-halted-on-circuit-breaker-to-the-upside-stock-now-down-28-4", "tags": ["halt"]}
{"id": 41879848, "time": "2024-11-11 09:57:37", "headline": "HC Wainwright & Co. Reiterates Buy on InflaRx, Maintains $8 Price Target", "summary": "", "symbols": ["IFRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41879848/hc-wainwright-co-reiterates-buy-on-inflarx-maintains-8-price-target", "tags": ["analyst_other"]}
{"id": 41879849, "time": "2024-11-11 09:57:50", "headline": "Live Nation Entertainment Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call", "summary": " ", "symbols": ["LYV"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/price-target/24/11/41879849/live-nation-entertainment-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call", "tags": ["earnings"]}
{"id": 41879866, "time": "2024-11-11 09:59:07", "headline": "CBD Of Denver Reports Revenue Growth, Delays Germany Spin-Off", "summary": " ", "symbols": ["CBDD"], "source": "benzinga", "author": "Nina Zdinjak", "url": "https://www.benzinga.com/markets/cannabis/24/11/41879866/cbd-of-denver-reports-revenue-growth-delays-germany-spin-off", "tags": ["earnings"]}
{"id": 41879867, "time": "2024-11-11 09:59:19", "headline": "Founder Group Shares Resume Trade", "summary": "", "symbols": ["FGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41879867/founder-group-shares-resume-trade", "tags": []}
{"id": 41879938, "time": "2024-11-11 10:00:14", "headline": "Market Analysis: NVIDIA And Competitors In Semiconductors &amp; Semiconductor Equipment Industry", "summary": " ", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41879938/market-analysis-nvidia-and-competitors-in-semiconductors-amp-semiconductor-equipment-industry", "tags": []}
{"id": 41879942, "time": "2024-11-11 10:00:16", "headline": "9 Analysts Have This To Say About Intellia Therapeutics", "summary": " ", "symbols": ["NTLA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41879942/9-analysts-have-this-to-say-about-intellia-therapeutics", "tags": []}
{"id": 41879953, "time": "2024-11-11 10:00:23", "headline": "Insights Into Microsoft's Performance Versus Peers In Software Sector", "summary": " ", "symbols": ["MSFT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41879953/insights-into-microsofts-performance-versus-peers-in-software-sector", "tags": []}
{"id": 41879954, "time": "2024-11-11 10:00:27", "headline": "5 Analysts Assess MACOM Technology Solns: What You Need To Know", "summary": " ", "symbols": ["MTSI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41879954/5-analysts-assess-macom-technology-solns-what-you-need-to-know", "tags": []}
{"id": 41879956, "time": "2024-11-11 10:00:32", "headline": "Investigating Apple's Standing In Technology Hardware, Storage &amp; Peripherals Industry Compared To Competitors", "summary": " ", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41879956/investigating-apples-standing-in-technology-hardware-storage-amp-peripherals-industry-compared-to-c", "tags": []}
{"id": 41879958, "time": "2024-11-11 10:00:35", "headline": "Decoding 4 Analyst Evaluations For GEO Group", "summary": " ", "symbols": ["GEO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41879958/decoding-4-analyst-evaluations-for-geo-group", "tags": []}
{"id": 41879961, "time": "2024-11-11 10:00:39", "headline": "Unpacking the Latest Options Trading Trends in UnitedHealth Group", "summary": " ", "symbols": ["UNH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41879961/unpacking-the-latest-options-trading-trends-in-unitedhealth-group", "tags": []}
{"id": 41879962, "time": "2024-11-11 10:00:41", "headline": "Comparative Study: Meta Platforms And Industry Competitors In Interactive Media &amp; Services Industry", "summary": " ", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41879962/comparative-study-meta-platforms-and-industry-competitors-in-interactive-media-amp-services-industr", "tags": []}
{"id": 41879964, "time": "2024-11-11 10:00:45", "headline": "This Is What Whales Are Betting On Meta Platforms", "summary": " ", "symbols": ["META"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41879964/this-is-what-whales-are-betting-on-meta-platforms", "tags": []}
{"id": 41879965, "time": "2024-11-11 10:00:45", "headline": "Forecasting The Future: 7 Analyst Projections For Fortrea Holdings", "summary": " ", "symbols": ["FTRE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41879965/forecasting-the-future-7-analyst-projections-for-fortrea-holdings", "tags": []}
{"id": 41879966, "time": "2024-11-11 10:00:50", "headline": "Competitor Analysis: Evaluating Amazon.com And Competitors In Broadline Retail Industry", "summary": " ", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41879966/competitor-analysis-evaluating-amazon-com-and-competitors-in-broadline-retail-industry", "tags": []}
{"id": 41879970, "time": "2024-11-11 10:00:55", "headline": "Where Victory Capital Holdings Stands With Analysts", "summary": " ", "symbols": ["VCTR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41879970/where-victory-capital-holdings-stands-with-analysts", "tags": []}
{"id": 41879975, "time": "2024-11-11 10:01:02", "headline": "Earnings Outlook For FibroGen", "summary": " ", "symbols": ["FGEN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41879975/earnings-outlook-for-fibrogen", "tags": ["earnings", "guidance"]}
{"id": 41879977, "time": "2024-11-11 10:01:02", "headline": "Unveiling 5 Analyst Insights On Netstreit", "summary": " ", "symbols": ["NTST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41879977/unveiling-5-analyst-insights-on-netstreit", "tags": []}
{"id": 41879987, "time": "2024-11-11 10:01:13", "headline": "Earnings Outlook For Mirum Pharmaceuticals", "summary": " ", "symbols": ["MIRM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41879987/earnings-outlook-for-mirum-pharmaceuticals", "tags": ["earnings", "guidance"]}
{"id": 41879993, "time": "2024-11-11 10:01:21", "headline": "Insights Ahead: Southland Holdings's Quarterly Earnings", "summary": " ", "symbols": ["SLND"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41879993/insights-ahead-southland-holdingss-quarterly-earnings", "tags": ["earnings"]}
{"id": 41879995, "time": "2024-11-11 10:01:29", "headline": "A Glimpse of American Public Education's Earnings Potential", "summary": " ", "symbols": ["APEI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41879995/a-glimpse-of-american-public-educations-earnings-potential", "tags": ["earnings"]}
{"id": 41880000, "time": "2024-11-11 10:01:37", "headline": "Preview: Voyager Therapeutics's Earnings", "summary": " ", "symbols": ["VYGR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41880000/preview-voyager-therapeuticss-earnings", "tags": ["earnings"]}
{"id": 41880001, "time": "2024-11-11 10:01:39", "headline": "HC Wainwright & Co. Reiterates Buy on Delcath Systems, Maintains $22 Price Target", "summary": "", "symbols": ["DCTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41880001/hc-wainwright-co-reiterates-buy-on-delcath-systems-maintains-22-price-target", "tags": ["analyst_other"]}
{"id": 41880011, "time": "2024-11-11 10:01:45", "headline": "Preview: Lexicon Pharmaceuticals's Earnings", "summary": " ", "symbols": ["LXRX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41880011/preview-lexicon-pharmaceuticalss-earnings", "tags": ["earnings"]}
{"id": 41880014, "time": "2024-11-11 10:01:53", "headline": "Insights into Belite Bio's Upcoming Earnings", "summary": " ", "symbols": ["BLTE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41880014/insights-into-belite-bios-upcoming-earnings", "tags": ["earnings"]}
{"id": 41880017, "time": "2024-11-11 10:02:02", "headline": "A Look at Radiant Logistics's Upcoming Earnings Report", "summary": " ", "symbols": ["RLGT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41880017/a-look-at-radiant-logisticss-upcoming-earnings-report", "tags": ["earnings"]}
{"id": 41877752, "time": "2024-11-11 08:37:20", "headline": "ReShape Lifesciences shares are trading higher after the NIH, with the University of Southern California's Center for Autonomic Nerve Recording and Stimulation Systems, awarded the company an approximately $241,000 supplementary grant for the development of the next-generation electrodes for ReShape's Diabetes Bloc-Stim Neuromodulation device.", "summary": "", "symbols": ["RSLS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41877752/reshape-lifesciences-shares-are-trading-higher-after-the-nih-with-the-university-of-southern-califor", "tags": ["why_moving", "contract"]}
{"id": 41880023, "time": "2024-11-11 10:02:17", "headline": "What's Next: Quanterix's Earnings Preview", "summary": " ", "symbols": ["QTRX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41880023/whats-next-quanterixs-earnings-preview", "tags": ["earnings"]}
{"id": 41880025, "time": "2024-11-11 10:02:25", "headline": "A Peek at Topgolf Callaway Brands's Future Earnings", "summary": " ", "symbols": ["MODG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41880025/a-peek-at-topgolf-callaway-brandss-future-earnings", "tags": ["earnings"]}
{"id": 41880031, "time": "2024-11-11 10:02:36", "headline": "Earnings Preview For EchoStar", "summary": " ", "symbols": ["SATS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41880031/earnings-preview-for-echostar", "tags": ["earnings"]}
{"id": 41880041, "time": "2024-11-11 10:02:46", "headline": "Exploring Sphere Entertainment's Earnings Expectations", "summary": " ", "symbols": ["SPHR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41880041/exploring-sphere-entertainments-earnings-expectations", "tags": ["earnings"]}
{"id": 41877050, "time": "2024-11-11 08:10:12", "headline": "Janover shares are trading higher after the company announced the launch of its AI voice tool for CRM operations.", "summary": "", "symbols": ["JNVR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41877050/janover-shares-are-trading-higher-after-the-company-announced-the-launch-of-its-ai-voice-tool-for-cr", "tags": ["why_moving"]}
{"id": 41880075, "time": "2024-11-11 10:04:34", "headline": "Barclays Maintains Underweight on WK Kellogg, Raises Price Target to $19", "summary": "", "symbols": ["KLG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41880075/barclays-maintains-underweight-on-wk-kellogg-raises-price-target-to-19", "tags": ["analyst_other", "price_target_up"]}
{"id": 41877708, "time": "2024-11-11 08:34:58", "headline": "Ispire Technology shares are trading lower after the company reported worse-than-expected Q1 financial results.", "summary": "", "symbols": ["ISPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41877708/ispire-technology-shares-are-trading-lower-after-the-company-reported-worse-than-expected-q1-financi", "tags": ["why_moving"]}
{"id": 41880094, "time": "2024-11-11 10:05:33", "headline": "Barclays Maintains Equal-Weight on Ziff Davis, Raises Price Target to $61", "summary": "", "symbols": ["ZD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41880094/barclays-maintains-equal-weight-on-ziff-davis-raises-price-target-to-61", "tags": ["analyst_other", "price_target_up"]}
{"id": 41880095, "time": "2024-11-11 10:05:42", "headline": "HC Wainwright & Co. Reiterates Buy on Protagonist Therapeutics, Maintains $50 Price Target", "summary": "", "symbols": ["PTGX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41880095/hc-wainwright-co-reiterates-buy-on-protagonist-therapeutics-maintains-50-price-target", "tags": ["analyst_other"]}
{"id": 41880110, "time": "2024-11-11 10:06:23", "headline": "Solar, Renewables Stocks Crash After Trump Win: Should You Buy Now At Cheap Valuations?", "summary": "Trump&#39;s election win and GOP control of Congress doesn&#39;t bode well for solar and other clean energy stocks.", "symbols": ["AMZN", "FSLR", "GOOGL", "NOVA", "PBD", "SEDG", "TAN"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41880110/solar-renewables-stocks-crash-after-trump-win-should-you-buy-now-at-cheap-valuations", "tags": []}
{"id": 41880147, "time": "2024-11-11 10:08:13", "headline": "Barclays Maintains Overweight on Advanced Drainage Systems, Lowers Price Target to $172", "summary": "", "symbols": ["WMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41880147/barclays-maintains-overweight-on-advanced-drainage-systems-lowers-price-target-to-172", "tags": ["analyst_other", "price_target_down"]}
{"id": 41880353, "time": "2024-11-11 10:10:05", "headline": "Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: News and Resumption Times", "summary": "", "symbols": ["CLSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41880353/trading-halt-halt-status-updated-at-10-10-00-am-et-quotation-resumption-news-and-resumption-times", "tags": []}
{"id": 41880384, "time": "2024-11-11 10:10:35", "headline": "HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target", "summary": "", "symbols": ["GOSS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41880384/hc-wainwright-co-reiterates-buy-on-gossamer-bio-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 41880438, "time": "2024-11-11 10:11:58", "headline": "BMO Capital Maintains Market Perform on DXC Technology, Raises Price Target to $25", "summary": "", "symbols": ["DXC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41880438/bmo-capital-maintains-market-perform-on-dxc-technology-raises-price-target-to-25", "tags": ["analyst_other", "price_target_up"]}
{"id": 41880482, "time": "2024-11-11 10:13:27", "headline": "BMO Capital Maintains Outperform on IntL Money Express, Raises Price Target to $30", "summary": "", "symbols": ["IMXI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41880482/bmo-capital-maintains-outperform-on-intl-money-express-raises-price-target-to-30", "tags": ["analyst_other", "price_target_up"]}
{"id": 41880494, "time": "2024-11-11 10:14:22", "headline": "HC Wainwright & Co. Reiterates Buy on Dianthus Therapeutics, Maintains $40 Price Target", "summary": "", "symbols": ["DNTH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41880494/hc-wainwright-co-reiterates-buy-on-dianthus-therapeutics-maintains-40-price-target", "tags": ["analyst_other"]}
{"id": 41880495, "time": "2024-11-11 10:14:25", "headline": "MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday", "summary": " ", "symbols": ["AFRM", "BMY", "BTBT", "BTDR", "CAN", "CANG", "CI", "COIN", "ELF", "HIMS", "HOOD", "HUT", "IREN", "LMND", "MARA", "NNOX", "RDNT", "RIOT", "RXRX"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41880495/mara-holdings-radnet-bit-digital-coinbase-and-other-big-stocks-moving-higher-on-monday", "tags": ["why_moving"]}
{"id": 41880516, "time": "2024-11-11 10:15:21", "headline": "BMO Capital Maintains Outperform on RB Global, Raises Price Target to $107", "summary": "", "symbols": ["RBA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41880516/bmo-capital-maintains-outperform-on-rb-global-raises-price-target-to-107", "tags": ["analyst_other", "price_target_up"]}
{"id": 41880518, "time": "2024-11-11 10:15:32", "headline": "This Is What Whales Are Betting On ARM Holdings", "summary": " ", "symbols": ["ARM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41880518/this-is-what-whales-are-betting-on-arm-holdings", "tags": []}
{"id": 41880519, "time": "2024-11-11 10:15:37", "headline": "Spotlight on SoFi Techs: Analyzing the Surge in Options Activity", "summary": " ", "symbols": ["SOFI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41880519/spotlight-on-sofi-techs-analyzing-the-surge-in-options-activity", "tags": []}
{"id": 41880645, "time": "2024-11-11 10:17:44", "headline": "Barclays Maintains Equal-Weight on BCE, Lowers Price Target to $30", "summary": "", "symbols": ["BCE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41880645/barclays-maintains-equal-weight-on-bce-lowers-price-target-to-30", "tags": ["analyst_other", "price_target_down"]}
{"id": 41880653, "time": "2024-11-11 10:19:04", "headline": "Barclays Maintains Overweight on Doximity, Raises Price Target to $75", "summary": "", "symbols": ["DOCS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41880653/barclays-maintains-overweight-on-doximity-raises-price-target-to-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 41880663, "time": "2024-11-11 10:19:46", "headline": "BMO Capital Maintains Outperform on Victory Capital Holdings, Raises Price Target to $71", "summary": "", "symbols": ["VCTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41880663/bmo-capital-maintains-outperform-on-victory-capital-holdings-raises-price-target-to-71", "tags": ["analyst_other", "price_target_up"]}
{"id": 41880673, "time": "2024-11-11 10:19:51", "headline": "CleanSpark Shares Resume Trade", "summary": "", "symbols": ["CLSK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41880673/cleanspark-shares-resume-trade", "tags": []}
{"id": 41880752, "time": "2024-11-11 10:19:59", "headline": "HC Wainwright & Co. Reiterates Buy on Ocugen, Maintains $7 Price Target", "summary": "", "symbols": ["OCGN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41880752/hc-wainwright-co-reiterates-buy-on-ocugen-maintains-7-price-target", "tags": ["analyst_other"]}
{"id": 41881488, "time": "2024-11-11 10:21:32", "headline": "Barclays Maintains Overweight on DraftKings, Raises Price Target to $50", "summary": "", "symbols": ["DKNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41881488/barclays-maintains-overweight-on-draftkings-raises-price-target-to-50", "tags": ["analyst_other", "price_target_up"]}
{"id": 41881498, "time": "2024-11-11 10:22:12", "headline": "HC Wainwright & Co. Reiterates Buy on ANI Pharmaceuticals, Maintains $94 Price Target", "summary": "", "symbols": ["ANIP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41881498/hc-wainwright-co-reiterates-buy-on-ani-pharmaceuticals-maintains-94-price-target", "tags": ["analyst_other"]}
{"id": 41881508, "time": "2024-11-11 10:23:02", "headline": "Barclays Maintains Overweight on Palo Alto Networks, Raises Price Target to $425", "summary": "", "symbols": ["PANW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41881508/barclays-maintains-overweight-on-palo-alto-networks-raises-price-target-to-425", "tags": ["analyst_other", "price_target_up"]}
{"id": 41881510, "time": "2024-11-11 10:23:26", "headline": "Aligos Therapeutics Shares Resume Trade Following Circuit Breaker Halt, Stock Now Up 60%", "summary": "", "symbols": ["ALGS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41881510/aligos-therapeutics-shares-resume-trade-following-circuit-breaker-halt-stock-now-up-60", "tags": ["halt"]}
{"id": 41881511, "time": "2024-11-11 10:24:23", "headline": "1847 Holdings Shares Halted On Circuit Breaker To The Upside, Stock Now Down -38.8%", "summary": "", "symbols": ["EFSH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41881511/1847-holdings-shares-halted-on-circuit-breaker-to-the-upside-stock-now-down-38-8", "tags": ["halt"]}
{"id": 41881528, "time": "2024-11-11 10:26:03", "headline": "Barclays Maintains Underweight on Ubiquiti, Raises Price Target to $236", "summary": "", "symbols": ["UI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41881528/barclays-maintains-underweight-on-ubiquiti-raises-price-target-to-236", "tags": ["analyst_other", "price_target_up"]}
{"id": 41881529, "time": "2024-11-11 10:26:11", "headline": "BMO Capital Maintains Outperform on AMN Healthcare Services, Lowers Price Target to $46", "summary": "", "symbols": ["AMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41881529/bmo-capital-maintains-outperform-on-amn-healthcare-services-lowers-price-target-to-46", "tags": ["analyst_other", "price_target_down"]}
{"id": 41881546, "time": "2024-11-11 10:27:31", "headline": "AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges", "summary": "AbbVie stock drops after Phase 2 trials of emraclidine fail to meet primary endpoint. The company continues data analysis for next steps.", "symbols": ["ABBV", "BMY"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41881546/abbvie-9billion-schizophrenia-studies-bristol-myers-stock-surges", "tags": ["fda"]}
{"id": 41881547, "time": "2024-11-11 10:27:45", "headline": "Barclays Maintains Equal-Weight on Insulet, Raises Price Target to $234", "summary": "", "symbols": ["PODD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41881547/barclays-maintains-equal-weight-on-insulet-raises-price-target-to-234", "tags": ["analyst_other", "price_target_up"]}
{"id": 41881556, "time": "2024-11-11 10:27:54", "headline": "Cisco Gains Ahead Of Q1 Earnings As JPMorgan Projects Networking Market Recovery In 2025", "summary": "Cisco&#39;s shares rise ahead of Q1 earnings release. JPMorgan analyst upgrades rating and price target, citing recovery in Networking market and refocus on Security.", "symbols": ["CSCO", "EXTR", "JNPR"], "source": "benzinga", "author": "Priya Nigam", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41881556/cisco-gains-ahead-of-q1-earnings-as-jpmorgan-projects-networking-market-recovery-in-2025", "tags": ["analyst_up", "earnings"]}
{"id": 41881567, "time": "2024-11-11 10:28:39", "headline": "1847 Holdings Shares Resume Trade", "summary": "", "symbols": ["EFSH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41881567/1847-holdings-shares-resume-trade", "tags": []}
{"id": 41881568, "time": "2024-11-11 10:28:42", "headline": "HC Wainwright & Co. Maintains Buy on Xeris Biopharma Holdings, Raises Price Target to $6.6", "summary": "", "symbols": ["XERS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41881568/hc-wainwright-co-maintains-buy-on-xeris-biopharma-holdings-raises-price-target-to-6-6", "tags": ["analyst_other", "price_target_up"]}
{"id": 41881591, "time": "2024-11-11 10:30:26", "headline": "Decoding ServiceNow's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["NOW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41881591/decoding-servicenows-options-activity-whats-the-big-picture", "tags": []}
{"id": 41881594, "time": "2024-11-11 10:30:31", "headline": "Monday.Com Unusual Options Activity", "summary": " ", "symbols": ["MNDY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41881594/monday-com-unusual-options-activity", "tags": []}
{"id": 41881597, "time": "2024-11-11 10:30:38", "headline": "Barclays Maintains Equal-Weight on Enbridge, Raises Price Target to C$59", "summary": "", "symbols": ["TSX:ENB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41881597/barclays-maintains-equal-weight-on-enbridge-raises-price-target-to-c-59", "tags": ["analyst_other", "price_target_up"]}
{"id": 41881673, "time": "2024-11-11 10:31:48", "headline": "BMO Capital Maintains Market Perform on Sunrun, Lowers Price Target to $11", "summary": "", "symbols": ["RUN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41881673/bmo-capital-maintains-market-perform-on-sunrun-lowers-price-target-to-11", "tags": ["analyst_other", "price_target_down"]}
{"id": 41881709, "time": "2024-11-11 10:33:01", "headline": "HC Wainwright & Co. Reiterates Neutral on CytoSorbents, Maintains $1 Price Target", "summary": "", "symbols": ["CTSO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41881709/hc-wainwright-co-reiterates-neutral-on-cytosorbents-maintains-1-price-target", "tags": ["analyst_other"]}
{"id": 41881741, "time": "2024-11-11 10:34:20", "headline": "Rapt Therapeutics Stock Plummets, Terminates Asthma Trial Due To Patient's Liver Injury", "summary": "RAPT Therapeutics stock falls after halting its zelnecirnon program following FDA clinical hold. Company shifts focus.", "symbols": ["RAPT"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41881741/rapt-therapeutics-stock-plummets-terminates-asthma-trial-due-to-patients-liver-injury", "tags": ["fda"]}
{"id": 41881754, "time": "2024-11-11 10:34:43", "headline": "1847 Holdings Shares Halted On Circuit Breaker To The Downside, Stock Now Down -39.9%", "summary": "", "symbols": ["EFSH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41881754/1847-holdings-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down-39-9", "tags": ["halt"]}
{"id": 41881758, "time": "2024-11-11 10:35:20", "headline": "Barclays Maintains Equal-Weight on HF Sinclair, Lowers Price Target to $42", "summary": "", "symbols": ["DINO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41881758/barclays-maintains-equal-weight-on-hf-sinclair-lowers-price-target-to-42", "tags": ["analyst_other", "price_target_down"]}
{"id": 41881790, "time": "2024-11-11 10:37:47", "headline": "Barclays Maintains Overweight on Howmet Aerospace, Raises Price Target to $130", "summary": "", "symbols": ["HWM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41881790/barclays-maintains-overweight-on-howmet-aerospace-raises-price-target-to-130", "tags": ["analyst_other", "price_target_up"]}
{"id": 41881793, "time": "2024-11-11 10:38:03", "headline": "TD Cowen Maintains Hold on Agilon Health, Lowers Price Target to $2", "summary": "", "symbols": ["AGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41881793/td-cowen-maintains-hold-on-agilon-health-lowers-price-target-to-2", "tags": ["analyst_other", "price_target_down"]}
{"id": 41881842, "time": "2024-11-11 10:39:24", "headline": "Veterans Deserve Access To Life-Changing Psychedelics Therapy: A Vital Solution For PTSD And Healing", "summary": "Veterans seeking PTSD relief face legal challenges in accessing psychedelic therapies. Will these treatments become available to those in need?", "symbols": [], "source": "benzinga", "author": "Juan Sp\u00ednelli", "url": "https://www.benzinga.com/24/11/41881842/why-do-veterans-deserve-access-to-psychedelic-therapy", "tags": []}
{"id": 41882012, "time": "2024-11-11 10:41:21", "headline": "TD Cowen Maintains Hold on Fortrea Holdings, Raises Price Target to $25", "summary": "", "symbols": ["FTRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882012/td-cowen-maintains-hold-on-fortrea-holdings-raises-price-target-to-25", "tags": ["analyst_other", "price_target_up"]}
{"id": 41882027, "time": "2024-11-11 10:41:31", "headline": "Evercore ISI Group Maintains In-Line on Hawaiian Electric Indus, Raises Price Target to $11", "summary": "", "symbols": ["HE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882027/evercore-isi-group-maintains-in-line-on-hawaiian-electric-indus-raises-price-target-to-11", "tags": ["analyst_other", "price_target_up"]}
{"id": 41882040, "time": "2024-11-11 10:41:49", "headline": "Barclays Maintains Overweight on JFrog, Lowers Price Target to $38", "summary": "", "symbols": ["FROG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882040/barclays-maintains-overweight-on-jfrog-lowers-price-target-to-38", "tags": ["analyst_other", "price_target_down"]}
{"id": 41882043, "time": "2024-11-11 10:44:28", "headline": "Barclays Maintains Underweight on Lumentum Holdings, Raises Price Target to $80", "summary": "", "symbols": ["LITE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882043/barclays-maintains-underweight-on-lumentum-holdings-raises-price-target-to-80", "tags": ["analyst_other", "price_target_up"]}
{"id": 41882070, "time": "2024-11-11 10:45:13", "headline": "A Look Into Advanced Drainage Systems Inc's Price Over Earnings", "summary": " ", "symbols": ["WMS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41882070/a-look-into-advanced-drainage-systems-incs-price-over-earnings", "tags": ["earnings"]}
{"id": 41882097, "time": "2024-11-11 10:46:24", "headline": "Barclays Maintains Overweight on Marathon Petroleum, Lowers Price Target to $159", "summary": "", "symbols": ["MPC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882097/barclays-maintains-overweight-on-marathon-petroleum-lowers-price-target-to-159", "tags": ["analyst_other", "price_target_down"]}
{"id": 41882159, "time": "2024-11-11 10:47:42", "headline": "Loop Capital Maintains Buy on Trade Desk, Raises Price Target to $145", "summary": "", "symbols": ["TTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882159/loop-capital-maintains-buy-on-trade-desk-raises-price-target-to-145", "tags": ["analyst_other", "price_target_up"]}
{"id": 41882160, "time": "2024-11-11 10:47:44", "headline": "Barclays Maintains Underweight on Molson Coors Beverage, Raises Price Target to $51", "summary": "", "symbols": ["TAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882160/barclays-maintains-underweight-on-molson-coors-beverage-raises-price-target-to-51", "tags": ["analyst_other", "price_target_up"]}
{"id": 41882214, "time": "2024-11-11 10:49:47", "headline": "Barclays Maintains Equal-Weight on Murphy Oil, Lowers Price Target to $37", "summary": "", "symbols": ["MUR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882214/barclays-maintains-equal-weight-on-murphy-oil-lowers-price-target-to-37", "tags": ["analyst_other", "price_target_down"]}
{"id": 41882233, "time": "2024-11-11 10:50:47", "headline": "Houston American Energy Shares Halted, News Pending", "summary": "", "symbols": ["HUSA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882233/houston-american-energy-shares-halted-news-pending", "tags": ["halt"]}
{"id": 41882328, "time": "2024-11-11 10:52:30", "headline": "TD Cowen Maintains Hold on Charles River, Raises Price Target to $227", "summary": "", "symbols": ["CRL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882328/td-cowen-maintains-hold-on-charles-river-raises-price-target-to-227", "tags": ["analyst_other", "price_target_up"]}
{"id": 41882329, "time": "2024-11-11 10:52:42", "headline": "Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal", "summary": "Evotec sees a 13.3% stock rise amid reports of Triton Partners eyeing a potential buyout after acquiring a 9.99% stake in the company.", "symbols": ["BMY", "EVO", "NVO"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41882329/private-equity-triton-partners-takes-around-10-stake-in-evotec-reportedly-mulls-potential-takeover-deal", "tags": ["merger", "contract"]}
{"id": 41882330, "time": "2024-11-11 10:52:46", "headline": "Raymond James Downgrades Bloomin Brands to Market Perform", "summary": "", "symbols": ["BLMN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882330/raymond-james-downgrades-bloomin-brands-to-market-perform", "tags": ["analyst_down"]}
{"id": 41882343, "time": "2024-11-11 10:53:43", "headline": "United Airlines Sees Over 6.2M Passengers Expected To Fly Between Nov 21-Dec 3, 2024; Co Added Nearly 400 Additional Flights A Day On Average; Nov 30 & Dec 1 To Be Busiest Travel Days With Over 530,000 People Flying United Each Day, Up 11% Vs Last Year; Anticipates 2024 Thanksgiving To Be Co's Busiest Thanksgiving Holiday Travel Period On Record", "summary": "", "symbols": ["UAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882343/united-airlines-sees-over-6-2m-passengers-expected-to-fly-between-nov-21-dec-3-2024-co-added-nearly", "tags": []}
{"id": 41882352, "time": "2024-11-11 10:54:10", "headline": "TD Cowen Maintains Hold on LanzaTech Global, Lowers Price Target to $2", "summary": "", "symbols": ["LNZA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882352/td-cowen-maintains-hold-on-lanzatech-global-lowers-price-target-to-2", "tags": ["analyst_other", "price_target_down"]}
{"id": 41882355, "time": "2024-11-11 10:54:25", "headline": "Barclays Maintains Equal-Weight on Phillips 66, Lowers Price Target to $124", "summary": "", "symbols": ["PSX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882355/barclays-maintains-equal-weight-on-phillips-66-lowers-price-target-to-124", "tags": ["analyst_other", "price_target_down"]}
{"id": 41882356, "time": "2024-11-11 10:54:40", "headline": "Aligos Therapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Up 29.7%", "summary": "", "symbols": ["ALGS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41882356/aligos-therapeutics-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-29-7", "tags": ["halt"]}
{"id": 41882368, "time": "2024-11-11 10:56:38", "headline": "Rocket Lab Stock Hits 52-Week High: What's Going On?", "summary": "Rocket Lab is scheduled to report\u00a0third-quarter financial results\u00a0after the market close on Tuesday. Analysts expect the company to report a loss of 11 cents per share and revenue of $102.28 million, according to estimates from\u00a0Benzinga Pro.", "symbols": ["RKLB"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/earnings/24/11/41882368/rocket-lab-stock-hits-52-week-high-whats-going-on", "tags": ["earnings", "why_moving"]}
{"id": 41882375, "time": "2024-11-11 10:56:53", "headline": "Barclays Maintains Equal-Weight on PTC Therapeutics, Raises Price Target to $43", "summary": "", "symbols": ["PTCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882375/barclays-maintains-equal-weight-on-ptc-therapeutics-raises-price-target-to-43", "tags": ["analyst_other", "price_target_up"]}
{"id": 41882406, "time": "2024-11-11 10:57:21", "headline": "iCAD Announces The FDA 510k Review Panel Has Rated ItsProFound Detection (V4.0) For Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer, Substantially Equivalent On November 8, 2024", "summary": "", "symbols": ["ICAD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41882406/icad-announces-the-fda-510k-review-panel-has-rated-itsprofound-detection-v4-0-for-radiological-co", "tags": ["fda"]}
{"id": 41882405, "time": "2024-11-11 10:57:21", "headline": "Why Bitcoin Cash Is Popping Off", "summary": "Bitcoin Cash (CRYPTO: BCH) is trading higher by 4.8% to $448.50 during Monday\u2019s session, and up 30% over the past week. The altcoin is spiking alongside Bitcoin, which reached a record $82,300. ", "symbols": ["BCHUSD"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/11/41882405/why-bitcoin-cash-is-popping-off-3", "tags": []}
{"id": 41882422, "time": "2024-11-11 10:58:16", "headline": "TD Cowen Maintains Buy on Calumet, Lowers Price Target to $26", "summary": "", "symbols": ["CLMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882422/td-cowen-maintains-buy-on-calumet-lowers-price-target-to-26", "tags": ["analyst_other", "price_target_down"]}
{"id": 41882424, "time": "2024-11-11 10:59:22", "headline": "Aligos Therapeutics Shares Resume Trade", "summary": "", "symbols": ["ALGS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41882424/aligos-therapeutics-shares-resume-trade", "tags": []}
{"id": 41882454, "time": "2024-11-11 11:00:31", "headline": "Peering Into Albemarle's Recent Short Interest", "summary": " ", "symbols": ["ALB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41882454/peering-into-albemarles-recent-short-interest", "tags": []}
{"id": 41882455, "time": "2024-11-11 11:00:31", "headline": "Cracking The Code: Understanding Analyst Reviews For RB Global", "summary": " ", "symbols": ["RBA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41882455/cracking-the-code-understanding-analyst-reviews-for-rb-global", "tags": []}
{"id": 41882457, "time": "2024-11-11 11:00:36", "headline": "(RIVN) - Analyzing Rivian Automotive's Short Interest", "summary": " ", "symbols": ["RIVN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41882457/rivn-analyzing-rivian-automotives-short-interest", "tags": []}
{"id": 41882459, "time": "2024-11-11 11:00:40", "headline": "Analyst Scoreboard: 38 Ratings For Salesforce", "summary": " ", "symbols": ["CRM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41882459/analyst-scoreboard-38-ratings-for-salesforce", "tags": []}
{"id": 41882460, "time": "2024-11-11 11:00:41", "headline": "Looking Into Novavax's Recent Short Interest", "summary": " ", "symbols": ["NVAX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41882460/looking-into-novavaxs-recent-short-interest", "tags": []}
{"id": 41882466, "time": "2024-11-11 11:00:49", "headline": "HC Wainwright & Co. Reiterates Buy on Cytokinetics, Maintains $120 Price Target", "summary": "", "symbols": ["CYTK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882466/hc-wainwright-co-reiterates-buy-on-cytokinetics-maintains-120-price-target", "tags": ["analyst_other"]}
{"id": 41882468, "time": "2024-11-11 11:00:51", "headline": "Critical Insights From Five9 Analyst Ratings: What You Need To Know", "summary": " ", "symbols": ["FIVN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41882468/critical-insights-from-five9-analyst-ratings-what-you-need-to-know", "tags": []}
{"id": 41882469, "time": "2024-11-11 11:00:55", "headline": "Watching Imunon; Zacks Small-Cap Research Gives Stock $8 Price Valuation", "summary": "", "symbols": ["IMNM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882469/watching-imunon-zacks-small-cap-research-gives-stock-8-price-valuation", "tags": []}
{"id": 41882471, "time": "2024-11-11 11:01:01", "headline": "Deep Dive Into Vale Stock: Analyst Perspectives (4 Ratings)", "summary": " ", "symbols": ["VALE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41882471/deep-dive-into-vale-stock-analyst-perspectives-4-ratings", "tags": []}
{"id": 41882472, "time": "2024-11-11 11:01:16", "headline": "Barclays Maintains Equal-Weight on Hershey, Lowers Price Target to $180", "summary": "", "symbols": ["HSY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882472/barclays-maintains-equal-weight-on-hershey-lowers-price-target-to-180", "tags": ["analyst_other", "price_target_down"]}
{"id": 41882509, "time": "2024-11-11 11:02:04", "headline": "Raymond James Maintains Outperform on Royal Gold, Raises Price Target to $186", "summary": "", "symbols": ["RGLD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882509/raymond-james-maintains-outperform-on-royal-gold-raises-price-target-to-186", "tags": ["analyst_other", "price_target_up"]}
{"id": 41882543, "time": "2024-11-11 11:03:33", "headline": "Insights into CureVac's Upcoming Earnings", "summary": " ", "symbols": ["CVAC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41882543/insights-into-curevacs-upcoming-earnings", "tags": ["earnings"]}
{"id": 41882545, "time": "2024-11-11 11:03:38", "headline": "Forecasting The Future: 4 Analyst Projections For Blue Bird", "summary": " ", "symbols": ["BLBD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41882545/forecasting-the-future-4-analyst-projections-for-blue-bird", "tags": []}
{"id": 41882550, "time": "2024-11-11 11:03:41", "headline": "Earnings Outlook For 23andMe Holding", "summary": " ", "symbols": ["ME"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41882550/earnings-outlook-for-23andme-holding", "tags": ["earnings", "guidance"]}
{"id": 41882552, "time": "2024-11-11 11:03:45", "headline": "Evaluating Dianthus Therapeutics: Insights From 5 Financial Analysts", "summary": " ", "symbols": ["DNTH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41882552/evaluating-dianthus-therapeutics-insights-from-5-financial-analysts", "tags": []}
{"id": 41882556, "time": "2024-11-11 11:03:50", "headline": "A Look at Mondee Hldgs's Upcoming Earnings Report", "summary": " ", "symbols": ["MOND"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41882556/a-look-at-mondee-hldgss-upcoming-earnings-report", "tags": ["earnings"]}
{"id": 41882559, "time": "2024-11-11 11:03:57", "headline": "OpenAI, Microsoft, Meta Advance New AI Tests As Transparency Concerns Grow", "summary": "Tech giants struggle to evaluate AI progress and advancements, raising concerns about transparency and standardized evaluations.", "symbols": ["GOOG", "META", "MSFT"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/media/24/11/41882559/openai-microsoft-meta-advance-new-ai-tests-as-transparency-concerns-grow", "tags": []}
{"id": 41882560, "time": "2024-11-11 11:03:57", "headline": "A Look at Beauty Health's Upcoming Earnings Report", "summary": " ", "symbols": ["SKIN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41882560/a-look-at-beauty-healths-upcoming-earnings-report", "tags": ["earnings"]}
{"id": 41882566, "time": "2024-11-11 11:04:06", "headline": "Earnings Outlook For SKYX Platforms", "summary": " ", "symbols": ["SKYX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41882566/earnings-outlook-for-skyx-platforms", "tags": ["earnings", "guidance"]}
{"id": 41882571, "time": "2024-11-11 11:04:15", "headline": "A Preview Of Alta Equipment Group's Earnings", "summary": " ", "symbols": ["ALTG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41882571/a-preview-of-alta-equipment-groups-earnings", "tags": ["earnings"]}
{"id": 41882576, "time": "2024-11-11 11:04:22", "headline": "Uncovering Potential: ePlus's Earnings Preview", "summary": " ", "symbols": ["PLUS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41882576/uncovering-potential-epluss-earnings-preview", "tags": ["earnings"]}
{"id": 41882578, "time": "2024-11-11 11:04:23", "headline": "Truist Securities Maintains Hold on BlackLine, Raises Price Target to $60", "summary": "", "symbols": ["BL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882578/truist-securities-maintains-hold-on-blackline-raises-price-target-to-60", "tags": ["analyst_other", "price_target_up"]}
{"id": 41882579, "time": "2024-11-11 11:04:29", "headline": "Examining the Future: Largo's Earnings Outlook", "summary": " ", "symbols": ["LGO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41882579/examining-the-future-largos-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41882589, "time": "2024-11-11 11:04:39", "headline": "A Look Ahead: Kopin's Earnings Forecast", "summary": " ", "symbols": ["KOPN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41882589/a-look-ahead-kopins-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 41882593, "time": "2024-11-11 11:04:48", "headline": "A Look Ahead: Longeveron's Earnings Forecast", "summary": " ", "symbols": ["LGVN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41882593/a-look-ahead-longeverons-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 41882591, "time": "2024-11-11 11:04:55", "headline": "Peanut The Squirrel's Coin PNUT Catapults 343% Higher To $420 Million Valuation: 'The Squirrel Who Saved The Election,' Quips Venture Capitalist", "summary": "Binance is facing backlash for listing Peanut the Squirrel (CRYPTO: PNUT), a meme coin on Solana (CRYPTO: SOL) inspired by the late", "symbols": ["ACTUSD", "SOLUSD", "UNIUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41882591/peanut-the-squirrels-coin-pnut-catapults-343-higher-to-420-million-valuation-the-squirrel-who-saved-the-election-quips-venture-capitalist", "tags": []}
{"id": 41882598, "time": "2024-11-11 11:04:56", "headline": "Insights into Iridex's Upcoming Earnings", "summary": " ", "symbols": ["IRIX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41882598/insights-into-iridexs-upcoming-earnings", "tags": ["earnings"]}
{"id": 41882602, "time": "2024-11-11 11:05:07", "headline": "Sangamo Therapeutics's Earnings Outlook", "summary": " ", "symbols": ["SGMO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41882602/sangamo-therapeuticss-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41882684, "time": "2024-11-11 11:08:14", "headline": "Sirius XM Holdings Option Alert: Jan 17 $30 Calls Sweep (54) Near The Ask: 2500 @ $1.193 Vs 15057 OI; Ref=$27.44", "summary": "", "symbols": ["SIRI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882684/sirius-xm-holdings-option-alert-jan-17-30-calls-sweep-54-near-the-ask-2500-1-193-vs-15057-oi-ref-27", "tags": []}
{"id": 41882757, "time": "2024-11-11 11:09:32", "headline": "Barclays Maintains Equal-Weight on Under Armour, Raises Price Target to $12", "summary": "", "symbols": ["UAA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882757/barclays-maintains-equal-weight-on-under-armour-raises-price-target-to-12", "tags": ["analyst_other", "price_target_up"]}
{"id": 41882780, "time": "2024-11-11 11:09:46", "headline": "Stifel Maintains Buy on Ameresco, Raises Price Target to $34", "summary": "", "symbols": ["AMRC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882780/stifel-maintains-buy-on-ameresco-raises-price-target-to-34", "tags": ["analyst_other", "price_target_up"]}
{"id": 41878130, "time": "2024-11-11 08:47:29", "headline": "Lakeside Holding shares are trading higher after the company announced it acquired Hupan Pharmaceutical.", "summary": "", "symbols": ["LSH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41878130/lakeside-holding-shares-are-trading-higher-after-the-company-announced-it-acquired-hupan-pharmaceuti", "tags": ["why_moving", "merger"]}
{"id": 41878261, "time": "2024-11-11 08:48:56", "headline": "Citius Pharmaceuticals shares are trading higher after the company announced results for its ongoing investigator-initiated  Phase I clinical trial evaluating the safety and efficacy of a combined regimen of pembrolizumab and LYMPHIR in patients with recurrent solid tumors.", "summary": "", "symbols": ["CTOR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41878261/citius-pharmaceuticals-shares-are-trading-higher-after-the-company-announced-results-for-its-ongoing", "tags": ["why_moving", "fda"]}
{"id": 41882801, "time": "2024-11-11 11:11:36", "headline": "HC Wainwright & Co. Reiterates Buy on Chimerix, Maintains $11 Price Target", "summary": "", "symbols": ["CMRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882801/hc-wainwright-co-reiterates-buy-on-chimerix-maintains-11-price-target", "tags": ["analyst_other"]}
{"id": 41882840, "time": "2024-11-11 11:12:00", "headline": "Italian Economy Stagnates As Manufacturing, Fashion Slow", "summary": " ", "symbols": ["PPRUY", "SFRGY", "STLA", "VWAGY"], "source": "benzinga", "author": "European Capital Insights", "url": "https://www.benzinga.com/markets/eurozone/24/11/41882840/italian-economy-stagnates-as-manufacturing-fashion-slow", "tags": []}
{"id": 41882844, "time": "2024-11-11 11:12:20", "headline": "Houston American Energy Corp. Announces It Has Closed A Private Placement Offering For The Issuance And Sale Of 2,180,180 Shares Of Common Stock To An Accredited Investor; CEO John F. Terwilliger To Be Stepping Down, Peter F. Longo To Serve As President And CEO, Effective On November 11, 2024", "summary": "", "symbols": ["HUSA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882844/houston-american-energy-corp-announces-it-has-closed-a-private-placement-offering-for-the-issuance-a", "tags": ["offering", "management"]}
{"id": 41882846, "time": "2024-11-11 11:12:29", "headline": "Barclays Maintains Overweight on Valero Energy, Lowers Price Target to $140", "summary": "", "symbols": ["VLO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882846/barclays-maintains-overweight-on-valero-energy-lowers-price-target-to-140", "tags": ["analyst_other", "price_target_down"]}
{"id": 41882847, "time": "2024-11-11 11:12:30", "headline": "Stifel Maintains Buy on Baxter Intl, Lowers Price Target to $38", "summary": "", "symbols": ["BAX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882847/stifel-maintains-buy-on-baxter-intl-lowers-price-target-to-38", "tags": ["analyst_other", "price_target_down"]}
{"id": 41882855, "time": "2024-11-11 11:13:33", "headline": "Barclays Maintains Equal-Weight on Victory Capital Holdings, Raises Price Target to $69", "summary": "", "symbols": ["VCTR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882855/barclays-maintains-equal-weight-on-victory-capital-holdings-raises-price-target-to-69", "tags": ["analyst_other", "price_target_up"]}
{"id": 41882860, "time": "2024-11-11 11:13:46", "headline": "Apple's Find My Enables Users To Share The Location Of Lost Items With Third Parties", "summary": "", "symbols": ["AAPL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882860/apples-find-my-enables-users-to-share-the-location-of-lost-items-with-third-parties", "tags": []}
{"id": 41882877, "time": "2024-11-11 11:15:06", "headline": "Stifel Maintains Hold on Home Depot, Raises Price Target to $400", "summary": "", "symbols": ["HD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882877/stifel-maintains-hold-on-home-depot-raises-price-target-to-400", "tags": ["analyst_other", "price_target_up"]}
{"id": 41882879, "time": "2024-11-11 11:15:26", "headline": "Decoding Robinhood Markets's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["HOOD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41882879/decoding-robinhood-marketss-options-activity-whats-the-big-picture", "tags": []}
{"id": 41882882, "time": "2024-11-11 11:15:36", "headline": "Vistra Unusual Options Activity For November 11", "summary": " ", "symbols": ["VST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41882882/vistra-unusual-options-activity-for-november-11", "tags": []}
{"id": 41882966, "time": "2024-11-11 11:17:40", "headline": "Reported November 10, 2024 'McKesson And Oracle Are Among The Final Bidders Vying To Acquire EMR Data Company Veradigm' - Axios", "summary": "", "symbols": ["MCK", "MDRX", "ORCL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41882966/reported-november-10-2024-mckesson-and-oracle-are-among-the-final-bidders-vying-to-acquire-emr-data", "tags": ["merger"]}
{"id": 41882969, "time": "2024-11-11 11:17:48", "headline": "Toyota To Make Strategic Shift In China, EVs", "summary": "\nToyota plans to produce 2.5M vehicles/year in China by 2030, while shifting development and production operations for greater efficiency.", "symbols": ["TM"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/24/11/41882969/toyota-eyes-3-million-cars-in-china-by-2030-cautions-against-us-electric-vehicle-mandates", "tags": []}
{"id": 41882974, "time": "2024-11-11 11:17:57", "headline": "Stifel Maintains Hold on Lowe's Companies, Raises Price Target to $260", "summary": "", "symbols": ["LOW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882974/stifel-maintains-hold-on-lowes-companies-raises-price-target-to-260", "tags": ["analyst_other", "price_target_up"]}
{"id": 41882987, "time": "2024-11-11 11:19:01", "headline": "Citigroup Maintains Buy on Air Products & Chemicals, Raises Price Target to $365", "summary": "", "symbols": ["APD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882987/citigroup-maintains-buy-on-air-products-chemicals-raises-price-target-to-365", "tags": ["analyst_other", "price_target_up"]}
{"id": 41882996, "time": "2024-11-11 11:19:23", "headline": "TD Cowen Maintains Hold on YETI Holdings, Lowers Price Target to $44", "summary": "", "symbols": ["YETI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41882996/td-cowen-maintains-hold-on-yeti-holdings-lowers-price-target-to-44", "tags": ["analyst_other", "price_target_down"]}
{"id": 41883001, "time": "2024-11-11 11:19:33", "headline": "Stock Of The Day: Micron Technology \u2013 The Best Traders Don't Guess", "summary": "There trends to be resistance at levels that have been resistance previously. There trends to be support at former support levels.", "symbols": ["MU"], "source": "benzinga", "author": "Mark Putrino", "url": "https://www.benzinga.com/trading-ideas/technicals/24/11/41883001/stock-of-the-day-micron-technology-the-best-traders-dont-guess", "tags": []}
{"id": 41883012, "time": "2024-11-11 11:20:14", "headline": "Stifel Maintains Buy on IGM Biosciences, Raises Price Target to $27", "summary": "", "symbols": ["IGMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883012/stifel-maintains-buy-on-igm-biosciences-raises-price-target-to-27", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883036, "time": "2024-11-11 11:21:51", "headline": "Stifel Maintains Buy on Mettler-Toledo Intl, Lowers Price Target to $1450", "summary": "", "symbols": ["MTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883036/stifel-maintains-buy-on-mettler-toledo-intl-lowers-price-target-to-1450", "tags": ["analyst_other", "price_target_down"]}
{"id": 41883042, "time": "2024-11-11 11:22:05", "headline": "Citigroup Maintains Buy on Airbnb, Raises Price Target to $158", "summary": "", "symbols": ["ABNB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883042/citigroup-maintains-buy-on-airbnb-raises-price-target-to-158", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883109, "time": "2024-11-11 11:23:00", "headline": "TD Cowen Maintains Hold on Monster Beverage, Raises Price Target to $55", "summary": "", "symbols": ["MNST"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883109/td-cowen-maintains-hold-on-monster-beverage-raises-price-target-to-55", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883115, "time": "2024-11-11 11:24:27", "headline": "Stifel Maintains Buy on Rivian Automotive, Lowers Price Target to $16", "summary": "", "symbols": ["RIVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883115/stifel-maintains-buy-on-rivian-automotive-lowers-price-target-to-16", "tags": ["analyst_other", "price_target_down"]}
{"id": 41883117, "time": "2024-11-11 11:25:19", "headline": "Wells Fargo Maintains Equal-Weight on Lamar Advertising, Lowers Price Target to $124", "summary": "", "symbols": ["LAMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883117/wells-fargo-maintains-equal-weight-on-lamar-advertising-lowers-price-target-to-124", "tags": ["analyst_other", "price_target_down"]}
{"id": 41883118, "time": "2024-11-11 11:25:28", "headline": "Houston American Energy Shares Resume Trade", "summary": "", "symbols": ["HUSA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41883118/houston-american-energy-shares-resume-trade", "tags": []}
{"id": 41883121, "time": "2024-11-11 11:25:52", "headline": "Stifel Maintains Hold on Schneider National, Raises Price Target to $27", "summary": "", "symbols": ["SNDR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883121/stifel-maintains-hold-on-schneider-national-raises-price-target-to-27", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883123, "time": "2024-11-11 11:26:40", "headline": "Wells Fargo Maintains Overweight on NRG Energy, Raises Price Target to $140", "summary": "", "symbols": ["NRG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883123/wells-fargo-maintains-overweight-on-nrg-energy-raises-price-target-to-140", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883144, "time": "2024-11-11 11:27:48", "headline": "Cava Earnings Preview: Can Q3 Continue The Growth Streak?", "summary": "CAVA Group Inc (NYSE: CAVA) to report Q3 earnings after strong Q2 performance. 35% increase in revenue, 14.4% same-restaurant sales growth, and aggressive expansion plans towards 1,000 US locations by 2032.", "symbols": ["CAVA"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/general/restaurants/24/11/41883144/cava-earnings-preview-can-q3-continue-the-growth-streak", "tags": ["earnings"]}
{"id": 41883145, "time": "2024-11-11 11:27:57", "headline": "Stifel Maintains Buy on Xponential Fitness, Raises Price Target to $20", "summary": "", "symbols": ["XPOF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883145/stifel-maintains-buy-on-xponential-fitness-raises-price-target-to-20", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883146, "time": "2024-11-11 11:27:57", "headline": "Wells Fargo Maintains Equal-Weight on Mettler-Toledo Intl, Lowers Price Target to $1350", "summary": "", "symbols": ["MTD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883146/wells-fargo-maintains-equal-weight-on-mettler-toledo-intl-lowers-price-target-to-1350", "tags": ["analyst_other", "price_target_down"]}
{"id": 41883155, "time": "2024-11-11 11:28:39", "headline": "Why Ethereum Classic Is Seeing Blue Skies", "summary": "Ethereum Classic (CRYPTO: ETC) is trading higher by 4.1% to $23.41 during Monday\u2019s session, and is up 30% over the past week, following a new all-time high for Bitcoin.", "symbols": ["ETCUSD"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/11/41883155/why-ethereum-classic-is-seeing-blue-skies-3", "tags": []}
{"id": 41883164, "time": "2024-11-11 11:29:40", "headline": "TD Cowen Maintains Buy on Lamar Advertising, Raises Price Target to $160", "summary": "", "symbols": ["LAMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883164/td-cowen-maintains-buy-on-lamar-advertising-raises-price-target-to-160", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883169, "time": "2024-11-11 11:30:17", "headline": "How Is The Market Feeling About Encompass Health?", "summary": " ", "symbols": ["EHC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41883169/how-is-the-market-feeling-about-encompass-health", "tags": []}
{"id": 41883170, "time": "2024-11-11 11:30:22", "headline": "How Is The Market Feeling About Southern?", "summary": " ", "symbols": ["SO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41883170/how-is-the-market-feeling-about-southern", "tags": []}
{"id": 41883173, "time": "2024-11-11 11:30:27", "headline": "How Is The Market Feeling About Quest Diagnostics?", "summary": " ", "symbols": ["DGX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41883173/how-is-the-market-feeling-about-quest-diagnostics", "tags": []}
{"id": 41883297, "time": "2024-11-11 11:31:18", "headline": "What's Going On With Dogecoin Rival Shiba Inu (SHIB)?", "summary": "Following Donald Trump\u2019s 2024 presidential win, Shiba Inu (CRYPTO: SHIB) has surged 67% to $0.00002837 over the past week, refle", "symbols": ["SHIBUSD"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/11/41883297/whats-going-on-with-dogecoin-rival-shiba-inu-shib", "tags": ["why_moving"]}
{"id": 41883299, "time": "2024-11-11 11:31:24", "headline": "Barrington Research Maintains Outperform on Warner Bros. Discovery, Maintains $12 Price Target", "summary": "", "symbols": ["WBD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883299/barrington-research-maintains-outperform-on-warner-bros-discovery-maintains-12-price-target", "tags": ["analyst_other"]}
{"id": 41883345, "time": "2024-11-11 11:32:52", "headline": "Barrington Research Maintains Outperform on Townsquare Media, Maintains $17 Price Target", "summary": "", "symbols": ["TSQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883345/barrington-research-maintains-outperform-on-townsquare-media-maintains-17-price-target", "tags": ["analyst_other"]}
{"id": 41883348, "time": "2024-11-11 11:33:08", "headline": "Donald Trump Can't Fire Gary Gensler, But Pro-Crypto Policies Means Industry Is On The Verge Of 'A Golden Era'", "summary": "Report highlights Trump&#39;s potential pro-crypto policies but he can&#39;t directly fire SEC chair Gensler. New appointees may ease regulatory landscape.", "symbols": [], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41883348/donald-trump-cant-fire-gary-gensler-but-pro-crypto-policies-means-industry-is-on-the-verge-of-a-golden-era", "tags": []}
{"id": 41883357, "time": "2024-11-11 11:34:31", "headline": "Taiwan Semiconductor Stock Drops as US Orders Halt on AI Chip Sales to China", "summary": "Taiwan Semiconductor faces new U.S. constraints, prohibiting advanced AI chip sales to China. Stock down, but company navigates between compliance and retaining business.", "symbols": ["ASML", "TSM"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41883357/taiwan-semiconductor-stock-drops-as-us-orders-halt-on-ai-chip-sales-to-china", "tags": []}
{"id": 41883359, "time": "2024-11-11 11:34:48", "headline": "CleanSpark Stock Resumes Trading: What's Going On?", "summary": "CleanSpark Inc (NASDAQ:CLSK) shares are trading higher Monday alongside several Bitcoin (CRYPTO: BTC) mining stocks as the price of Bitcoin soars to new all-time highs.", "symbols": ["BTCUSD", "CLSK"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/24/11/41883359/cleanspark-stock-resumes-trading-whats-going-on", "tags": ["why_moving"]}
{"id": 41883367, "time": "2024-11-11 11:35:01", "headline": "Susquehanna Maintains Positive on Airbnb, Raises Price Target to $160", "summary": "", "symbols": ["ABNB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883367/susquehanna-maintains-positive-on-airbnb-raises-price-target-to-160", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883383, "time": "2024-11-11 11:36:36", "headline": "RBC Capital Maintains Sector Perform on Advance Auto Parts, Lowers Price Target to $46", "summary": "", "symbols": ["AAP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883383/rbc-capital-maintains-sector-perform-on-advance-auto-parts-lowers-price-target-to-46", "tags": ["analyst_other", "price_target_down"]}
{"id": 41883395, "time": "2024-11-11 11:37:14", "headline": "Susquehanna Maintains Neutral on Applied Mat, Lowers Price Target to $170", "summary": "", "symbols": ["AMAT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883395/susquehanna-maintains-neutral-on-applied-mat-lowers-price-target-to-170", "tags": ["analyst_other", "price_target_down"]}
{"id": 41883399, "time": "2024-11-11 11:37:37", "headline": "DA Davidson Maintains Buy on Prestige Consumer, Maintains $95 Price Target", "summary": "", "symbols": ["PBH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883399/da-davidson-maintains-buy-on-prestige-consumer-maintains-95-price-target", "tags": ["analyst_other"]}
{"id": 41883406, "time": "2024-11-11 11:38:26", "headline": "Susquehanna Maintains Neutral on Bumble, Raises Price Target to $8", "summary": "", "symbols": ["BMBL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883406/susquehanna-maintains-neutral-on-bumble-raises-price-target-to-8", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883408, "time": "2024-11-11 11:38:41", "headline": "Watching Monolithic Power Systems; Shares Down -20% As Traders Circulate A Research Firm Contended In A Note To Investors That Performance Issues With The Co's Voltage Regulator Module/Power Management IC \"appear Likely To Severely Limit Or Eliminate\" Monolithic's Allocation In Nvidia's Blackwell", "summary": "", "symbols": ["MPWR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883408/watching-monolithic-power-systems-shares-down-20-as-traders-circulate-a-research-firm-contended-in-a", "tags": []}
{"id": 41883417, "time": "2024-11-11 11:38:44", "headline": "RBC Capital Maintains Sector Perform on Home Depot, Raises Price Target to $413", "summary": "", "symbols": ["HD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883417/rbc-capital-maintains-sector-perform-on-home-depot-raises-price-target-to-413", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883461, "time": "2024-11-11 11:39:37", "headline": "Susquehanna Maintains Neutral on Expedia Group, Raises Price Target to $190", "summary": "", "symbols": ["EXPE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883461/susquehanna-maintains-neutral-on-expedia-group-raises-price-target-to-190", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883464, "time": "2024-11-11 11:40:19", "headline": "Macquarie Maintains Outperform on DraftKings, Raises Price Target to $51", "summary": "", "symbols": ["DKNG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883464/macquarie-maintains-outperform-on-draftkings-raises-price-target-to-51", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883466, "time": "2024-11-11 11:41:19", "headline": "RBC Capital Maintains Sector Perform on APA, Lowers Price Target to $32", "summary": "", "symbols": ["APA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883466/rbc-capital-maintains-sector-perform-on-apa-lowers-price-target-to-32", "tags": ["analyst_other", "price_target_down"]}
{"id": 41883469, "time": "2024-11-11 11:41:29", "headline": "Susquehanna Maintains Neutral on Lyft, Raises Price Target to $18", "summary": "", "symbols": ["LYFT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883469/susquehanna-maintains-neutral-on-lyft-raises-price-target-to-18", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883577, "time": "2024-11-11 11:43:01", "headline": "Macquarie Maintains Underperform on Paramount Glb, Maintains $10 Price Target", "summary": "", "symbols": ["PARA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883577/macquarie-maintains-underperform-on-paramount-glb-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 41883578, "time": "2024-11-11 11:43:07", "headline": "RBC Capital Maintains Outperform on CarGurus, Raises Price Target to $42", "summary": "", "symbols": ["CARG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883578/rbc-capital-maintains-outperform-on-cargurus-raises-price-target-to-42", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883580, "time": "2024-11-11 11:43:25", "headline": "Susquehanna Maintains Neutral on Redfin, Raises Price Target to $10", "summary": "", "symbols": ["RDFN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883580/susquehanna-maintains-neutral-on-redfin-raises-price-target-to-10", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883586, "time": "2024-11-11 11:45:01", "headline": "Susquehanna Maintains Neutral on Zillow Gr, Raises Price Target to $75", "summary": "", "symbols": ["ZG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883586/susquehanna-maintains-neutral-on-zillow-gr-raises-price-target-to-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883587, "time": "2024-11-11 11:45:01", "headline": "Watching HP Inc.; Shares Spike Higher On Volume, Up 3.08%", "summary": "", "symbols": ["HPQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41883587/watching-hp-inc-shares-spike-higher-on-volume-up-3-08", "tags": []}
{"id": 41883588, "time": "2024-11-11 11:45:05", "headline": "BWS Financial Maintains Buy on Adeia, Maintains $16 Price Target", "summary": "", "symbols": ["ADEA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883588/bws-financial-maintains-buy-on-adeia-maintains-16-price-target", "tags": ["analyst_other"]}
{"id": 41883590, "time": "2024-11-11 11:45:31", "headline": "Behind the Scenes of Applied Mat's Latest Options Trends", "summary": " ", "symbols": ["AMAT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41883590/behind-the-scenes-of-applied-mats-latest-options-trends", "tags": []}
{"id": 41883591, "time": "2024-11-11 11:45:36", "headline": "Decoding McDonald's's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["MCD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41883591/decoding-mcdonaldss-options-activity-whats-the-big-picture", "tags": []}
{"id": 41883612, "time": "2024-11-11 11:46:49", "headline": "Money Flows Out Of Gold Into Bitcoin, Next Bitcoin Stop $100,000, Aggressive Buying In Tesla", "summary": "To gain an edge, this is what you need to know today.", "symbols": ["AAPL", "AMZN", "BTCUSD", "GLD", "GOOG", "IAU", "IBIT", "META", "MSFT", "NVDA", "QQQ", "SLV", "SPY", "TSLA", "USO"], "source": "benzinga", "author": "The Arora Report", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41883612/money-flows-out-of-gold-into-bitcoin-next-bitcoin-stop-100-000-aggressive-buying-in-tesla", "tags": []}
{"id": 41883635, "time": "2024-11-11 11:46:54", "headline": "Trump Looks To Undo Biden Climate Progress With Burgum As 'Energy Czar': Report", "summary": "Trump is reportedly considering North Dakota Governor Doug Burgum as the frontrunner for the energy czar position.\u00a0", "symbols": ["CVX", "IDRV", "LCID", "MSFT", "RIVN", "TEAM", "UCO", "XOM"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/24/11/41883635/trump-looks-to-undo-biden-climate-progress-with-burgum-as-energy-czar-report", "tags": []}
{"id": 41883694, "time": "2024-11-11 11:48:13", "headline": "Deutsche Bank Maintains Buy on Apollo Global Management, Raises Price Target to $163", "summary": "", "symbols": ["APO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883694/deutsche-bank-maintains-buy-on-apollo-global-management-raises-price-target-to-163", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883699, "time": "2024-11-11 11:48:25", "headline": "RBC Capital Maintains Outperform on Corteva, Lowers Price Target to $68", "summary": "", "symbols": ["CTVA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883699/rbc-capital-maintains-outperform-on-corteva-lowers-price-target-to-68", "tags": ["analyst_other", "price_target_down"]}
{"id": 41883703, "time": "2024-11-11 11:49:09", "headline": "Deutsche Bank Maintains Hold on Ares Management, Raises Price Target to $150", "summary": "", "symbols": ["ARES"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883703/deutsche-bank-maintains-hold-on-ares-management-raises-price-target-to-150", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883714, "time": "2024-11-11 11:50:12", "headline": "RBC Capital Maintains Outperform on Kodiak Gas Services, Raises Price Target to $40", "summary": "", "symbols": ["KGS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883714/rbc-capital-maintains-outperform-on-kodiak-gas-services-raises-price-target-to-40", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883715, "time": "2024-11-11 11:50:17", "headline": "Deutsche Bank Maintains Buy on Brookfield Asset Mgmt, Raises Price Target to $59", "summary": "", "symbols": ["BAM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883715/deutsche-bank-maintains-buy-on-brookfield-asset-mgmt-raises-price-target-to-59", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883735, "time": "2024-11-11 11:51:29", "headline": "Deutsche Bank Maintains Buy on Blackstone, Raises Price Target to $182", "summary": "", "symbols": ["BX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883735/deutsche-bank-maintains-buy-on-blackstone-raises-price-target-to-182", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883748, "time": "2024-11-11 11:51:54", "headline": "RBC Capital Maintains Sector Perform on Omega Healthcare Invts, Raises Price Target to $43", "summary": "", "symbols": ["OHI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883748/rbc-capital-maintains-sector-perform-on-omega-healthcare-invts-raises-price-target-to-43", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883758, "time": "2024-11-11 11:52:25", "headline": "Deutsche Bank Maintains Buy on KKR, Raises Price Target to $159", "summary": "", "symbols": ["KKR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883758/deutsche-bank-maintains-buy-on-kkr-raises-price-target-to-159", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883777, "time": "2024-11-11 11:53:51", "headline": "Deutsche Bank Maintains Buy on TPG, Raises Price Target to $69", "summary": "", "symbols": ["TPG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883777/deutsche-bank-maintains-buy-on-tpg-raises-price-target-to-69", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883780, "time": "2024-11-11 11:54:59", "headline": "Deutsche Bank Maintains Buy on Affiliated Managers Group, Raises Price Target to $208", "summary": "", "symbols": ["AMG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883780/deutsche-bank-maintains-buy-on-affiliated-managers-group-raises-price-target-to-208", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883785, "time": "2024-11-11 11:56:18", "headline": "Deutsche Bank Maintains Buy on BlackRock, Raises Price Target to $1133", "summary": "", "symbols": ["BLK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883785/deutsche-bank-maintains-buy-on-blackrock-raises-price-target-to-1133", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883786, "time": "2024-11-11 11:56:38", "headline": "RBC Capital Maintains Outperform on RB Global, Raises Price Target to $107", "summary": "", "symbols": ["RBA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883786/rbc-capital-maintains-outperform-on-rb-global-raises-price-target-to-107", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883802, "time": "2024-11-11 11:57:24", "headline": "Deutsche Bank Maintains Buy on Federated Hermes, Raises Price Target to $45", "summary": "", "symbols": ["FHI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883802/deutsche-bank-maintains-buy-on-federated-hermes-raises-price-target-to-45", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883803, "time": "2024-11-11 11:57:38", "headline": "Nvidia's Blackwell Chip Revenue Could Hit $6 Billion Next Quarter: Analyst", "summary": "Nvidia will report its third-quarter results next week and Morgan Stanley analyst Joseph Moore previews what&#39;s ahead for the company in 2025 and beyond.\u00a0Here&#39;s what to know:", "symbols": ["NVDA"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41883803/nvidias-blackwell-chip-revenue-could-hit-6-billion-next-quarter-analyst", "tags": ["earnings"]}
{"id": 41883816, "time": "2024-11-11 11:58:23", "headline": "Deutsche Bank Maintains Hold on Invesco, Raises Price Target to $19", "summary": "", "symbols": ["IVZ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883816/deutsche-bank-maintains-hold-on-invesco-raises-price-target-to-19", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883818, "time": "2024-11-11 11:59:08", "headline": "Deutsche Bank Maintains Hold on Janus Henderson Group, Raises Price Target to $44", "summary": "", "symbols": ["JHG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883818/deutsche-bank-maintains-hold-on-janus-henderson-group-raises-price-target-to-44", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883820, "time": "2024-11-11 12:00:01", "headline": "Trump Trade Sparks Biggest Financial Stock Inflows In 2 Years", "summary": "Financial stocks rally after Trump&#39;s return to White House; investors expect deregulation and tax cuts. Goldman Sachs predicts top picks in sector.", "symbols": ["ALLY", "APO", "ARES", "AXP", "BFH", "BX", "C", "CFG", "CG", "CMA", "COF", "EVR", "FCNCA", "FHB", "HBAN", "HIG", "JEF", "JPM", "KEY", "KKR", "KRE", "LPLA", "MC", "MS", "PIPR", "PJT", "PNC", "RF", "SNV", "SYF", "TFC", "TPG", "TRV", "TW", "WAL", "WFC", "WRB", "XLF", "ZION"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41883820/trump-trade-sparks-biggest-financial-stock-inflows-in-2-years", "tags": []}
{"id": 41883830, "time": "2024-11-11 12:00:06", "headline": "Deutsche Bank Maintains Hold on T. Rowe Price Gr, Raises Price Target to $120", "summary": "", "symbols": ["TROW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883830/deutsche-bank-maintains-hold-on-t-rowe-price-gr-raises-price-target-to-120", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883839, "time": "2024-11-11 12:00:13", "headline": "Unveiling 9 Analyst Insights On P10", "summary": " ", "symbols": ["PX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41883839/unveiling-9-analyst-insights-on-p10", "tags": []}
{"id": 41883840, "time": "2024-11-11 12:00:25", "headline": "Unveiling 7 Analyst Insights On Dana", "summary": " ", "symbols": ["DAN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41883840/unveiling-7-analyst-insights-on-dana", "tags": []}
{"id": 41883842, "time": "2024-11-11 12:00:31", "headline": "Beyond The Numbers: 5 Analysts Discuss Hawaiian Electric Indus Stock", "summary": " ", "symbols": ["HE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41883842/beyond-the-numbers-5-analysts-discuss-hawaiian-electric-indus-stock", "tags": []}
{"id": 41883843, "time": "2024-11-11 12:00:39", "headline": "Navigating 4 Analyst Ratings For Ocugen", "summary": " ", "symbols": ["OCGN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41883843/navigating-4-analyst-ratings-for-ocugen", "tags": []}
{"id": 41883844, "time": "2024-11-11 12:00:43", "headline": "CrowdStrike Holdings Unusual Options Activity For November 11", "summary": " ", "symbols": ["CRWD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41883844/crowdstrike-holdings-unusual-options-activity-for-november-11", "tags": []}
{"id": 41883852, "time": "2024-11-11 12:00:50", "headline": "Unveiling 4 Analyst Insights On Adeia", "summary": " ", "symbols": ["ADEA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41883852/unveiling-4-analyst-insights-on-adeia", "tags": []}
{"id": 41883866, "time": "2024-11-11 12:01:00", "headline": "The Analyst Verdict: NVIDIA In The Eyes Of 33 Experts", "summary": " ", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41883866/the-analyst-verdict-nvidia-in-the-eyes-of-33-experts", "tags": []}
{"id": 41883870, "time": "2024-11-11 12:01:08", "headline": "Exploring Dyadic International's Earnings Expectations", "summary": " ", "symbols": ["DYAI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41883870/exploring-dyadic-internationals-earnings-expectations", "tags": ["earnings"]}
{"id": 41883871, "time": "2024-11-11 12:01:13", "headline": "Alliance Global Partners Maintains Buy on Coda Octopus Group, Raises Price Target to $11", "summary": "", "symbols": ["CODA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883871/alliance-global-partners-maintains-buy-on-coda-octopus-group-raises-price-target-to-11", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883873, "time": "2024-11-11 12:01:17", "headline": "Deutsche Bank Maintains Hold on CME Gr, Lowers Price Target to $226", "summary": "", "symbols": ["CME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883873/deutsche-bank-maintains-hold-on-cme-gr-lowers-price-target-to-226", "tags": ["analyst_other", "price_target_down"]}
{"id": 41883874, "time": "2024-11-11 12:01:18", "headline": "A Look Ahead: eGain's Earnings Forecast", "summary": " ", "symbols": ["EGAN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41883874/a-look-ahead-egains-earnings-forecast", "tags": ["earnings", "guidance"]}
{"id": 41883876, "time": "2024-11-11 12:01:27", "headline": "Earnings Preview For US Energy", "summary": " ", "symbols": ["USEG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41883876/earnings-preview-for-us-energy", "tags": ["earnings"]}
{"id": 41883880, "time": "2024-11-11 12:01:34", "headline": "Insights Ahead: Agenus's Quarterly Earnings", "summary": " ", "symbols": ["AGEN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41883880/insights-ahead-agenuss-quarterly-earnings", "tags": ["earnings"]}
{"id": 41883883, "time": "2024-11-11 12:01:45", "headline": "Insights Ahead: FTC Solar's Quarterly Earnings", "summary": " ", "symbols": ["FTCI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41883883/insights-ahead-ftc-solars-quarterly-earnings", "tags": ["earnings"]}
{"id": 41883884, "time": "2024-11-11 12:01:55", "headline": "Uncovering Potential: Surgepays's Earnings Preview", "summary": " ", "symbols": ["SURG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41883884/uncovering-potential-surgepayss-earnings-preview", "tags": ["earnings"]}
{"id": 41883887, "time": "2024-11-11 12:02:04", "headline": "Earnings Preview: Ondas Holdings", "summary": " ", "symbols": ["ONDS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41883887/earnings-preview-ondas-holdings", "tags": ["earnings"]}
{"id": 41883893, "time": "2024-11-11 12:02:12", "headline": "Earnings Preview: Geovax Labs", "summary": " ", "symbols": ["GOVX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41883893/earnings-preview-geovax-labs", "tags": ["earnings"]}
{"id": 41883895, "time": "2024-11-11 12:02:18", "headline": "Deutsche Bank Maintains Hold on Intercontinental Exchange, Raises Price Target to $163", "summary": "", "symbols": ["ICE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883895/deutsche-bank-maintains-hold-on-intercontinental-exchange-raises-price-target-to-163", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883896, "time": "2024-11-11 12:02:19", "headline": "Insights into CXApp's Upcoming Earnings", "summary": " ", "symbols": ["CXAI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41883896/insights-into-cxapps-upcoming-earnings", "tags": ["earnings"]}
{"id": 41883897, "time": "2024-11-11 12:02:29", "headline": "Earnings Outlook For Lument Finance Trust", "summary": " ", "symbols": ["LFT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41883897/earnings-outlook-for-lument-finance-trust", "tags": ["earnings", "guidance"]}
{"id": 41883898, "time": "2024-11-11 12:02:41", "headline": "Acumen Pharmaceuticals Earnings Preview", "summary": " ", "symbols": ["ABOS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41883898/acumen-pharmaceuticals-earnings-preview", "tags": ["earnings"]}
{"id": 41883904, "time": "2024-11-11 12:02:49", "headline": "What's Next: Intrusion's Earnings Preview", "summary": " ", "symbols": ["INTZ"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41883904/whats-next-intrusions-earnings-preview", "tags": ["earnings"]}
{"id": 41883929, "time": "2024-11-11 12:03:59", "headline": "Benchmark Maintains Buy on Gray Television, Lowers Price Target to $8", "summary": "", "symbols": ["GTN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883929/benchmark-maintains-buy-on-gray-television-lowers-price-target-to-8", "tags": ["analyst_other", "price_target_down"]}
{"id": 41883953, "time": "2024-11-11 12:05:44", "headline": "Benchmark Maintains Buy on RCM Technologies, Raises Price Target to $37", "summary": "", "symbols": ["RCMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883953/benchmark-maintains-buy-on-rcm-technologies-raises-price-target-to-37", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883962, "time": "2024-11-11 12:06:02", "headline": "Deutsche Bank Maintains Hold on MarketAxess Holdings, Raises Price Target to $264", "summary": "", "symbols": ["MKTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883962/deutsche-bank-maintains-hold-on-marketaxess-holdings-raises-price-target-to-264", "tags": ["analyst_other", "price_target_up"]}
{"id": 41883988, "time": "2024-11-11 12:07:10", "headline": "Deutsche Bank Maintains Hold on Nasdaq, Raises Price Target to $80", "summary": "", "symbols": ["NDAQ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41883988/deutsche-bank-maintains-hold-on-nasdaq-raises-price-target-to-80", "tags": ["analyst_other", "price_target_up"]}
{"id": 41884031, "time": "2024-11-11 12:08:25", "headline": "Deutsche Bank Maintains Hold on Tradeweb Markets, Raises Price Target to $131", "summary": "", "symbols": ["TW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884031/deutsche-bank-maintains-hold-on-tradeweb-markets-raises-price-target-to-131", "tags": ["analyst_other", "price_target_up"]}
{"id": 41884117, "time": "2024-11-11 12:09:27", "headline": "Deutsche Bank Maintains Buy on Charles Schwab, Raises Price Target to $80", "summary": "", "symbols": ["SCHW"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884117/deutsche-bank-maintains-buy-on-charles-schwab-raises-price-target-to-80", "tags": ["analyst_other", "price_target_up"]}
{"id": 41884142, "time": "2024-11-11 12:10:15", "headline": "HSBC Upgrades Fortinet to Buy, Raises Price Target to $111", "summary": "", "symbols": ["FTNT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884142/hsbc-upgrades-fortinet-to-buy-raises-price-target-to-111", "tags": ["analyst_up", "price_target_up"]}
{"id": 41884147, "time": "2024-11-11 12:10:27", "headline": "Deutsche Bank Maintains Buy on Robinhood Markets, Raises Price Target to $32", "summary": "", "symbols": ["HOOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884147/deutsche-bank-maintains-buy-on-robinhood-markets-raises-price-target-to-32", "tags": ["analyst_other", "price_target_up"]}
{"id": 41884155, "time": "2024-11-11 12:11:33", "headline": "Deutsche Bank Maintains Buy on Bank of New York Mellon, Raises Price Target to $85", "summary": "", "symbols": ["BK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884155/deutsche-bank-maintains-buy-on-bank-of-new-york-mellon-raises-price-target-to-85", "tags": ["analyst_other", "price_target_up"]}
{"id": 41884190, "time": "2024-11-11 12:13:04", "headline": "Did Rockstar Drop GTA 6 Trailer Hint? Fans Spot Moon Clue Pointing To Nov. 22", "summary": "GTA fans believe Rockstar hinted at a GTA 6 trailer date through GTA Online&#39;s moon imagery, sparking speculation for a Nov. 22 release.", "symbols": ["TTWO"], "source": "benzinga", "author": "Franca Quarneti", "url": "https://www.benzinga.com/general/gaming/24/11/41884190/did-rockstar-drop-gta-6-trailer-hint-fans-spot-moon-clue-pointing-to-nov-22", "tags": []}
{"id": 41884191, "time": "2024-11-11 12:13:08", "headline": "Deutsche Bank Maintains Hold on Northern Trust, Raises Price Target to $108", "summary": "", "symbols": ["NTRS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884191/deutsche-bank-maintains-hold-on-northern-trust-raises-price-target-to-108", "tags": ["analyst_other", "price_target_up"]}
{"id": 41884192, "time": "2024-11-11 12:13:09", "headline": "Why Are Chip Stocks Trading Lower On Monday?", "summary": "Tech stocks trading lower after US instructs TSMC to stop supplying China with advanced chips. Monolithic Power Systems faces setback with Nvidia.", "symbols": ["AAPL", "AMD", "ARM", "AVGO", "CRDO", "INTC", "LSCC", "MCHP", "MPWR", "MRVL", "MTSI", "MU", "NVDA", "QCOM", "QRVO", "SMH", "SOXX", "TSM", "UMC"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/24/11/41884192/nvidia-intel-broadcom-stocks-drop-as-us-restricts-advanced-chip-sales-to-china", "tags": []}
{"id": 41884237, "time": "2024-11-11 12:14:19", "headline": "Deutsche Bank Maintains Hold on State Street, Raises Price Target to $95", "summary": "", "symbols": ["STT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884237/deutsche-bank-maintains-hold-on-state-street-raises-price-target-to-95", "tags": ["analyst_other", "price_target_up"]}
{"id": 41884250, "time": "2024-11-11 12:14:47", "headline": "Melius Research Maintains Buy on NVIDIA, Raises Price Target to $185", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884250/melius-research-maintains-buy-on-nvidia-raises-price-target-to-185", "tags": ["analyst_other", "price_target_up"]}
{"id": 41884252, "time": "2024-11-11 12:15:10", "headline": "A Look Into Essential Props Realty Inc's Price Over Earnings", "summary": " ", "symbols": ["EPRT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41884252/a-look-into-essential-props-realty-incs-price-over-earnings", "tags": ["earnings"]}
{"id": 41884313, "time": "2024-11-11 12:17:34", "headline": "Truist Securities Maintains Buy on Catalyst Pharmaceuticals, Raises Price Target to $36", "summary": "", "symbols": ["CPRX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884313/truist-securities-maintains-buy-on-catalyst-pharmaceuticals-raises-price-target-to-36", "tags": ["analyst_other", "price_target_up"]}
{"id": 41884314, "time": "2024-11-11 12:17:58", "headline": "Northcoast Research Upgrades Winnebago Industries to Buy", "summary": "", "symbols": ["WGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884314/northcoast-research-upgrades-winnebago-industries-to-buy", "tags": ["analyst_up"]}
{"id": 41884330, "time": "2024-11-11 12:19:06", "headline": "Truist Securities Maintains Buy on Fidelity National Finl, Raises Price Target to $70", "summary": "", "symbols": ["FNF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884330/truist-securities-maintains-buy-on-fidelity-national-finl-raises-price-target-to-70", "tags": ["analyst_other", "price_target_up"]}
{"id": 41884337, "time": "2024-11-11 12:20:21", "headline": "RF Lafferty Upgrades Lucid Gr to Buy, Announces $4 Price Target", "summary": "", "symbols": ["LCID"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884337/rf-lafferty-upgrades-lucid-gr-to-buy-announces-4-price-target", "tags": ["analyst_up"]}
{"id": 41884343, "time": "2024-11-11 12:21:22", "headline": "Enphase Unveils AI-Powered DIY Solar Permits: Details", "summary": "Enphase Energy introduces AI-powered DIY permit plan feature on its Solargraf platform, streamlining solar and battery installation process.", "symbols": ["ENPH", "QCLN", "TAN"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/mid-cap/24/11/41884343/enphase-unveils-ai-powered-diy-solar-permits-details", "tags": []}
{"id": 41884373, "time": "2024-11-11 12:24:51", "headline": "HC Wainwright & Co. Maintains Buy on Monopar Therapeutics, Raises Price Target to $22", "summary": "", "symbols": ["MNPR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884373/hc-wainwright-co-maintains-buy-on-monopar-therapeutics-raises-price-target-to-22", "tags": ["analyst_other", "price_target_up"]}
{"id": 41884382, "time": "2024-11-11 12:25:10", "headline": "'Wicked' Mistake For Toy Company Mattel: Why Parents Will Want To Check These Movie Dolls Before Buying", "summary": "Parents who bought &#34;Wicked&#34; dolls will want to check the boxes before handing them out to their children.", "symbols": ["CMCSA", "MAT"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/entertainment/24/11/41884382/wicked-mistake-for-toy-company-mattel-why-parents-will-want-to-check-these-movie-dolls-before-buying", "tags": []}
{"id": 41884411, "time": "2024-11-11 12:30:02", "headline": "Live On CNBC, Jim Lebenthal Announces Bought More AbbVie", "summary": "", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884411/live-on-cnbc-jim-lebenthal-announces-bought-more-abbvie", "tags": []}
{"id": 41884420, "time": "2024-11-11 12:30:14", "headline": "Peering Into TD Synnex's Recent Short Interest", "summary": " ", "symbols": ["SNX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41884420/peering-into-td-synnexs-recent-short-interest", "tags": []}
{"id": 41884421, "time": "2024-11-11 12:30:19", "headline": "Peering Into Arch Capital Group's Recent Short Interest", "summary": " ", "symbols": ["ACGL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41884421/peering-into-arch-capital-groups-recent-short-interest", "tags": []}
{"id": 41884422, "time": "2024-11-11 12:30:24", "headline": "Peering Into Pentair's Recent Short Interest", "summary": " ", "symbols": ["PNR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41884422/peering-into-pentairs-recent-short-interest", "tags": []}
{"id": 41884437, "time": "2024-11-11 12:30:50", "headline": "Chipotle Names Scott Boatwright CEO And Member Of The Board, Effective Immediately", "summary": "", "symbols": ["CMG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884437/chipotle-names-scott-boatwright-ceo-and-member-of-the-board-effective-immediately", "tags": ["management"]}
{"id": 41884491, "time": "2024-11-11 12:35:11", "headline": "10 Information Technology Stocks With Whale Alerts In Today's Session", "summary": " ", "symbols": ["AAPL", "CLSK", "CRM", "DELL", "MARA", "MSTR", "NVDA", "PLTR", "SOUN", "TSM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41884491/10-information-technology-stocks-with-whale-alerts-in-todays-session", "tags": []}
{"id": 41884494, "time": "2024-11-11 12:35:17", "headline": "10 Industrials Stocks With Whale Alerts In Today's Session", "summary": " ", "symbols": ["BA", "BE", "DAL", "HON", "NXT", "RKLB", "SPCE", "SYM", "UAL", "UBER"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41884494/10-industrials-stocks-with-whale-alerts-in-todays-session", "tags": []}
{"id": 41884495, "time": "2024-11-11 12:35:22", "headline": "10 Financials Stocks With Whale Alerts In Today's Session", "summary": " ", "symbols": ["ABR", "BAC", "COIN", "FUTU", "HOOD", "PYPL", "RKT", "SOFI", "SQ", "UPST"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41884495/10-financials-stocks-with-whale-alerts-in-todays-session", "tags": []}
{"id": 41884539, "time": "2024-11-11 12:38:15", "headline": "Apollo Expands Multi-Billion Partnership With Mubadala For Global Growth: Details", "summary": "Apollo Global Management (APO) extends partnership with Mubadala Investment Company to enhance global origination opportunities, strengthening its Capital Solutions business.", "symbols": ["APO", "FDFF", "LBO"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/contracts/24/11/41884539/apollo-expands-multi-billion-partnership-with-mubadala-for-global-growth-details", "tags": ["contract"]}
{"id": 41884540, "time": "2024-11-11 12:38:19", "headline": "Ascendiant Capital Maintains Buy on Verb Tech, Adjusts Price Target To $100 (1-200 Reverse Stock Split)", "summary": "", "symbols": ["VERB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884540/ascendiant-capital-maintains-buy-on-verb-tech-adjusts-price-target-to-100-1-200-reverse-stock-split", "tags": ["analyst_other"]}
{"id": 41884572, "time": "2024-11-11 12:39:08", "headline": "Home Depot Q3 Earnings Preview: Hurricane Impact, Home Repairs Top Themes To Watch", "summary": "Home Depot looks to turn the corner on revenue in the third quarter after missing analyst estimates in two straight quarters.", "symbols": ["HD", "LOW"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/trading-ideas/previews/24/11/41884572/home-depot-q3-earnings-preview-hurricane-impact-home-repairs-top-themes-to-watch", "tags": ["earnings"]}
{"id": 41884625, "time": "2024-11-11 12:42:40", "headline": "Medical Marijuana Shop Closes Down In South Dakota, What Went Wrong?", "summary": "The first store in South Dakota that kicked off medical cannabis sales in 2022 is closing its door to customers.Unity Rd. store, located at 404 West Opal Lane in the Sioux Falls suburb of Hartford, was opened on July 27, 2022.The store&#39;s closing follows South Dakota voters&#39; rejection of Measure 29 this past Tuesday.", "symbols": [], "source": "benzinga", "author": "Jelena Martinovic", "url": "https://www.benzinga.com/news/retail-sales/24/11/41884625/medical-marijuana-shop-closes-down-in-south-dakota-what-went-wrong", "tags": []}
{"id": 41884655, "time": "2024-11-11 12:44:01", "headline": "Bank Of America Predicts Positive Stock Re-Rating For Wells Fargo After Asset Cap Removal", "summary": "A meeting with Wells Fargo CEO Charlie Scharf strengthened analysts&#39; belief that the bank is on track to achieve high-teens ROTE.", "symbols": ["FTXO", "KBWB", "WFC"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/analyst-ratings/price-target/24/11/41884655/bank-of-america-predicts-positive-stock-re-rating-for-wells-fargo-after-asset-cap-removal", "tags": ["management"]}
{"id": 41884698, "time": "2024-11-11 12:44:28", "headline": "JD.com Reports Over 20% YoY Increase In Shoppers For Its 2024 Singles Day Grand Promotion", "summary": "", "symbols": ["JD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884698/jd-com-reports-over-20-yoy-increase-in-shoppers-for-its-2024-singles-day-grand-promotion", "tags": []}
{"id": 41884699, "time": "2024-11-11 12:44:50", "headline": "Ascendiant Capital Maintains Buy on NovaBay Pharmaceuticals, Adjusts Price Target To $0.85 (1-35 Reverse Stock Split)", "summary": "", "symbols": ["NBY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884699/ascendiant-capital-maintains-buy-on-novabay-pharmaceuticals-adjusts-price-target-to-0-85-1-35-revers", "tags": ["analyst_other"]}
{"id": 41884773, "time": "2024-11-11 12:47:36", "headline": "AstraZeneca Q3 Earnings Preview: Will Cancer, Heart Drugs Fuel Continued Growth?", "summary": "AstraZeneca is set to report its third-quarter 2024 earnings Tuesday morning. The company&#39;s Q2 performance suggests strong growth driven by its oncology and cardiovascular portfolios.", "symbols": ["AZN"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/general/biotech/24/11/41884773/astrazeneca-q3-earnings-preview-will-cancer-heart-drugs-fuel-continued-growth", "tags": ["earnings"]}
{"id": 41884785, "time": "2024-11-11 12:49:24", "headline": "Cboe Upgraded To Buy: Deutsche Bank Sees Strong Revenue Growth And Margin Gains Through 2025", "summary": "Deutsche Bank upgraded CBOE to Buy and raised price target to $222, citing strong revenue growth and market demand for index and volatility options.", "symbols": ["BCDF", "CBOE", "IAI"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/24/11/41884785/deutsche-bank-bullish-on-cboe-predicts-8-revenue-growth-by-2025-following-us-election-volatility", "tags": ["analyst_up", "earnings"]}
{"id": 41884798, "time": "2024-11-11 12:51:56", "headline": "AbbVie's Emraclidine For Schizophrenia 'Surprisingly Disappoints,' Analyst Says Pipeline Is Underappreciated", "summary": "AbbVie&#39;s emraclidine trials for schizophrenia fail, leading to stock decline, but analysts maintain confidence in the company&#39;s broader drug pipeline.", "symbols": ["ABBV", "BMY"], "source": "benzinga", "author": "Vandana Singh", "url": "https://www.benzinga.com/general/biotech/24/11/41884798/abbvies-emraclidine-for-schizophrenia-surprisingly-disappoints-analyst-says-pipeline-is-underappreciated", "tags": []}
{"id": 41884832, "time": "2024-11-11 12:52:38", "headline": "Piper Sandler Maintains Overweight on Monday.Com, Raises Price Target to $350", "summary": "", "symbols": ["MNDY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884832/piper-sandler-maintains-overweight-on-monday-com-raises-price-target-to-350", "tags": ["analyst_other", "price_target_up"]}
{"id": 41884858, "time": "2024-11-11 12:56:30", "headline": "Spirit Airlines Flight Bound For Port-au-Prince Diverts To Dominican Republic After Being Hit By Gunfire Over Haiti; Lands Safely", "summary": "", "symbols": ["SAVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884858/spirit-airlines-flight-bound-for-port-au-prince-diverts-to-dominican-republic-after-being-hit-by-gun", "tags": []}
{"id": 41884860, "time": "2024-11-11 12:57:29", "headline": "Psychedelic Mushrooms Market Poised For $3.3 Billion Surge By 2031", "summary": "Psychedelic mushrooms market to reach $3.3 billion by 2031, due to rising demand, regulatory changes &amp; growing psilocybin acceptance.", "symbols": [], "source": "benzinga", "author": "Juan Sp\u00ednelli", "url": "https://www.benzinga.com/news/retail-sales/24/11/41884860/psychedelic-mushrooms-market-poised-for-3-3-billion-surge-by-2031", "tags": []}
{"id": 41884861, "time": "2024-11-11 12:57:48", "headline": "HC Wainwright & Co. Maintains Buy on Cadrenal Therapeutics, Adjusts Price Target To $32 (1-15 Reverse Stock Split)", "summary": "", "symbols": ["CVKD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884861/hc-wainwright-co-maintains-buy-on-cadrenal-therapeutics-adjusts-price-target-to-32-1-15-reverse-stoc", "tags": ["analyst_other"]}
{"id": 41884878, "time": "2024-11-11 13:00:01", "headline": "CNBC Halftime Report Final Trades: Salesforce, Lockheed Martin, Interactive Brokers Group, iShares Core S&P Small-Cap ETF", "summary": "", "symbols": ["CRM", "IBKR", "IJR", "LMT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884878/cnbc-halftime-report-final-trades-salesforce-lockheed-martin-interactive-brokers-group-ishares-core", "tags": []}
{"id": 41884891, "time": "2024-11-11 13:00:11", "headline": "Shopify Stock Rides High Into Q3: Can Earnings Justify The Surge?", "summary": "Shopify is set to report Q3 earnings. Stock is up 47.31% in past year, 24.38% YTD. Analysts rate it a Buy with $78.93 target.", "symbols": ["SHOP"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/technicals/24/11/41884891/shopify-stock-rides-high-into-q3-can-earnings-justify-the-surge", "tags": ["earnings"]}
{"id": 41884892, "time": "2024-11-11 13:00:12", "headline": "A Look Into ARM Holdings Inc's Price Over Earnings", "summary": " ", "symbols": ["ARM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41884892/a-look-into-arm-holdings-incs-price-over-earnings", "tags": ["earnings"]}
{"id": 41884893, "time": "2024-11-11 13:00:14", "headline": "Breaking Down Omega Healthcare Invts: 6 Analysts Share Their Views", "summary": " ", "symbols": ["OHI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41884893/breaking-down-omega-healthcare-invts-6-analysts-share-their-views", "tags": []}
{"id": 41884894, "time": "2024-11-11 13:00:24", "headline": "A Closer Look at 13 Analyst Recommendations For HF Sinclair", "summary": " ", "symbols": ["DINO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41884894/a-closer-look-at-13-analyst-recommendations-for-hf-sinclair", "tags": []}
{"id": 41884900, "time": "2024-11-11 13:00:32", "headline": "The Analyst Landscape: 5 Takes On Tango Therapeutics", "summary": " ", "symbols": ["TNGX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41884900/the-analyst-landscape-5-takes-on-tango-therapeutics", "tags": []}
{"id": 41884908, "time": "2024-11-11 13:00:41", "headline": "Deep Dive Into Lamar Advertising Stock: Analyst Perspectives (4 Ratings)", "summary": " ", "symbols": ["LAMR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41884908/deep-dive-into-lamar-advertising-stock-analyst-perspectives-4-ratings", "tags": []}
{"id": 41884909, "time": "2024-11-11 13:00:41", "headline": "Boeing's Elizabeth Lund To Retire In December; Doug Ackerman Named Successor As VP Of Supply Chain And Fabrication Quality", "summary": "", "symbols": ["BA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41884909/boeings-elizabeth-lund-to-retire-in-december-doug-ackerman-named-successor-as-vp-of-supply-chain-and", "tags": []}
{"id": 41884911, "time": "2024-11-11 13:00:49", "headline": "The Analyst Verdict: Tradeweb Markets In The Eyes Of 12 Experts", "summary": " ", "symbols": ["TW"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41884911/the-analyst-verdict-tradeweb-markets-in-the-eyes-of-12-experts", "tags": []}
{"id": 41884914, "time": "2024-11-11 13:01:01", "headline": "Cracking The Code: Understanding Analyst Reviews For Pinterest", "summary": " ", "symbols": ["PINS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41884914/cracking-the-code-understanding-analyst-reviews-for-pinterest", "tags": []}
{"id": 41884921, "time": "2024-11-11 13:01:16", "headline": "Sky Harbour Group Earnings Preview", "summary": " ", "symbols": ["SKYH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41884921/sky-harbour-group-earnings-preview", "tags": ["earnings"]}
{"id": 41884924, "time": "2024-11-11 13:01:23", "headline": "Insights into SenesTech's Upcoming Earnings", "summary": " ", "symbols": ["SNES"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41884924/insights-into-senestechs-upcoming-earnings", "tags": ["earnings"]}
{"id": 41884925, "time": "2024-11-11 13:01:31", "headline": "Insights Ahead: OptiNose's Quarterly Earnings", "summary": " ", "symbols": ["OPTN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41884925/insights-ahead-optinoses-quarterly-earnings", "tags": ["earnings"]}
{"id": 41884928, "time": "2024-11-11 13:01:39", "headline": "Earnings Outlook For Pangaea Logistics Solns", "summary": " ", "symbols": ["PANL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41884928/earnings-outlook-for-pangaea-logistics-solns", "tags": ["earnings", "guidance"]}
{"id": 41884931, "time": "2024-11-11 13:01:49", "headline": "Insights into Atara Biotherapeutics's Upcoming Earnings", "summary": " ", "symbols": ["ATRA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41884931/insights-into-atara-biotherapeuticss-upcoming-earnings", "tags": ["earnings"]}
{"id": 41884943, "time": "2024-11-11 13:01:58", "headline": "Preview: Aemetis's Earnings", "summary": " ", "symbols": ["AMTX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41884943/preview-aemetiss-earnings", "tags": ["earnings"]}
{"id": 41884947, "time": "2024-11-11 13:02:06", "headline": "Earnings Outlook For Lisata Therapeutics", "summary": " ", "symbols": ["LSTA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41884947/earnings-outlook-for-lisata-therapeutics", "tags": ["earnings", "guidance"]}
{"id": 41884955, "time": "2024-11-11 13:02:13", "headline": "Earnings Preview: Sadot Group", "summary": " ", "symbols": ["SDOT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41884955/earnings-preview-sadot-group", "tags": ["earnings"]}
{"id": 41884956, "time": "2024-11-11 13:02:22", "headline": "Earnings Preview: Aris Water Solutions", "summary": " ", "symbols": ["ARIS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41884956/earnings-preview-aris-water-solutions", "tags": ["earnings"]}
{"id": 41884959, "time": "2024-11-11 13:02:30", "headline": "Earnings Outlook For Eton Pharmaceuticals", "summary": " ", "symbols": ["ETON"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41884959/earnings-outlook-for-eton-pharmaceuticals", "tags": ["earnings", "guidance"]}
{"id": 41884964, "time": "2024-11-11 13:02:40", "headline": "What to Expect from OncoCyte's Earnings", "summary": " ", "symbols": ["OCX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41884964/what-to-expect-from-oncocytes-earnings", "tags": ["earnings"]}
{"id": 41884968, "time": "2024-11-11 13:02:47", "headline": "Earnings Outlook For Eyenovia", "summary": " ", "symbols": ["EYEN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41884968/earnings-outlook-for-eyenovia", "tags": ["earnings", "guidance"]}
{"id": 41885062, "time": "2024-11-11 13:05:51", "headline": "Paramount Revenue Is Down: Analyst Remains Optimistic That 'Gladiator II' And 'Sonic 3' Can Help", "summary": "Paramount&#39;s TV Media revenue declined 6% to $4.3 billion, with ad revenue dropping 2% year-over-year.", "symbols": ["PARA"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/general/entertainment/24/11/41885062/paramount-revenue-is-down-analyst-remains-optimistic-that-gladiator-ii-and-sonic-3-can-help", "tags": ["earnings"]}
{"id": 41885215, "time": "2024-11-11 13:10:39", "headline": "Jefferies Maintains Buy on Global Ship Lease, Maintains $29 Price Target", "summary": "", "symbols": ["GSL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885215/jefferies-maintains-buy-on-global-ship-lease-maintains-29-price-target", "tags": ["analyst_other"]}
{"id": 41885228, "time": "2024-11-11 13:11:35", "headline": "HC Wainwright & Co. Maintains Buy on Nkarta, Lowers Price Target to $18", "summary": "", "symbols": ["NKTX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885228/hc-wainwright-co-maintains-buy-on-nkarta-lowers-price-target-to-18", "tags": ["analyst_other", "price_target_down"]}
{"id": 41885256, "time": "2024-11-11 13:12:14", "headline": "FOXO Technologies Shares Halted To The Downside; Stock Now Up 45.16%", "summary": "", "symbols": ["FOXO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41885256/foxo-technologies-shares-halted-to-the-downside-stock-now-up-45-16", "tags": ["halt"]}
{"id": 41885258, "time": "2024-11-11 13:12:55", "headline": "Barrington Research Maintains Outperform on Superior Gr of Cos, Raises Price Target to $21", "summary": "", "symbols": ["SGC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885258/barrington-research-maintains-outperform-on-superior-gr-of-cos-raises-price-target-to-21", "tags": ["analyst_other", "price_target_up"]}
{"id": 41885314, "time": "2024-11-11 13:15:15", "headline": "Needham Maintains Buy on nLight, Raises Price Target to $16", "summary": "", "symbols": ["LASR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885314/needham-maintains-buy-on-nlight-raises-price-target-to-16", "tags": ["analyst_other", "price_target_up"]}
{"id": 41885315, "time": "2024-11-11 13:15:22", "headline": "Blackstone Unusual Options Activity For November 11", "summary": " ", "symbols": ["BX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41885315/blackstone-unusual-options-activity-for-november-11", "tags": []}
{"id": 41885386, "time": "2024-11-11 13:17:13", "headline": "BWS Financial Maintains Buy on Interparfums, Maintains $172 Price Target", "summary": "", "symbols": ["IPAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885386/bws-financial-maintains-buy-on-interparfums-maintains-172-price-target", "tags": ["analyst_other"]}
{"id": 41885393, "time": "2024-11-11 13:18:14", "headline": "Germany's Govt. Coalition Crisis, Is Cannabis Reform At Risk?", "summary": "Germany&#39;s political crisis puts recent cannabis reforms at risk. Industry leaders weigh in on the potential impact of a conservative gov...", "symbols": [], "source": "benzinga", "author": "Rolando Garc\u00eda", "url": "https://www.benzinga.com/government/regulations/24/11/41885393/germanys-govt-coalition-crisis-is-cannabis-reform-at-risk", "tags": []}
{"id": 41885404, "time": "2024-11-11 13:18:39", "headline": "Benchmark Maintains Buy on Diodes, Lowers Price Target to $75", "summary": "", "symbols": ["DIOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885404/benchmark-maintains-buy-on-diodes-lowers-price-target-to-75", "tags": ["analyst_other", "price_target_down"]}
{"id": 41885411, "time": "2024-11-11 13:19:57", "headline": "Nasdaq Moves Lower; Canaan Shares Surge", "summary": " ", "symbols": ["CAN", "CERO", "EFSH", "MARA", "MNDY", "RAPT", "SPNS"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/24/11/41885411/nasdaq-moves-lower-canaan-shares-surge", "tags": []}
{"id": 41885415, "time": "2024-11-11 13:20:13", "headline": "HC Wainwright & Co. Reiterates Neutral on Ventyx Biosciences, Maintains $6 Price Target", "summary": "", "symbols": ["VTYX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885415/hc-wainwright-co-reiterates-neutral-on-ventyx-biosciences-maintains-6-price-target", "tags": ["analyst_other"]}
{"id": 41884236, "time": "2024-11-11 12:13:54", "headline": "EXCLUSIVE: Persistence Pays Off For Only Cannabis Distributor In Bavaria's Developing Market", "summary": "Drapalin Pharmaceuticals GmbH, Bavaria&#39;s sole licensed cannabis distributor, has transformed Germany&#39;s cannabis market with strategic growth", "symbols": [], "source": "benzinga", "author": "Rolando Garc\u00eda", "url": "https://www.benzinga.com/government/regulations/24/11/41884236/exclusive-persistence-pays-off-for-only-cannabis-distributor-in-bavarias-developing-market", "tags": []}
{"id": 41885443, "time": "2024-11-11 13:21:42", "headline": "This GeoVax Labs Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Monday", "summary": " ", "symbols": ["GOVX", "MRCY", "SKT", "TLSI", "UEIC"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/analyst-ratings/price-target/24/11/41885443/this-geovax-labs-analyst-begins-coverage-on-a-bullish-note-here-are-top-initiations-for-monday", "tags": ["analyst_init"]}
{"id": 41885451, "time": "2024-11-11 13:21:50", "headline": "Dogwifhat Chases After Dogecoin, Shiba Inu With 12% Rally: 'The Hat Stays On Till $25,' Claims Bullish Trader", "summary": "Dogwifhat (CRYPTO: WIF) has rallied 12% on Monday, sparking predictions of a potential bull run from traders.", "symbols": ["WIFUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41885451/dogwifhat-chases-after-dogecoin-shiba-inu-with-12-rally-the-hat-stays-on-till-25-claims-bullish-trader", "tags": []}
{"id": 41885456, "time": "2024-11-11 13:21:59", "headline": "DA Davidson Maintains Buy on Coty, Lowers Price Target to $12.5", "summary": "", "symbols": ["COTY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885456/da-davidson-maintains-buy-on-coty-lowers-price-target-to-12-5", "tags": ["analyst_other", "price_target_down"]}
{"id": 41885469, "time": "2024-11-11 13:22:21", "headline": "Google News Executive Shailesh Prakash Resigns After Two Years; Played Key Role In Relations With News Publishers, Sources Say", "summary": "", "symbols": ["GOOG", "GOOGL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885469/google-news-executive-shailesh-prakash-resigns-after-two-years-played-key-role-in-relations-with-new", "tags": ["management"]}
{"id": 41885472, "time": "2024-11-11 13:22:49", "headline": "HC Wainwright & Co. Maintains Buy on Imunon, Lowers Price Target to $12", "summary": "", "symbols": ["IMNN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885472/hc-wainwright-co-maintains-buy-on-imunon-lowers-price-target-to-12", "tags": ["analyst_other", "price_target_down"]}
{"id": 41885482, "time": "2024-11-11 13:23:27", "headline": "Barrington Research Maintains Outperform on Dave, Maintains $65 Price Target", "summary": "", "symbols": ["DAVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885482/barrington-research-maintains-outperform-on-dave-maintains-65-price-target", "tags": ["analyst_other"]}
{"id": 41885487, "time": "2024-11-11 13:24:11", "headline": "Barrington Research Maintains Outperform on DHI Group, Maintains $7 Price Target", "summary": "", "symbols": ["DHX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885487/barrington-research-maintains-outperform-on-dhi-group-maintains-7-price-target", "tags": ["analyst_other"]}
{"id": 41885488, "time": "2024-11-11 13:24:14", "headline": "What's Going On With Shopify Stock Monday?", "summary": "Shopify Inc. (NYSE:SHOP) shares are trending and moving higher on Monday. The company is due to release earnings before the market opens on Tuesday. Here&#39;s what you need to know.", "symbols": ["SHOP"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/news/earnings/24/11/41885488/whats-going-on-with-shopify-stock-monday", "tags": ["earnings", "why_moving"]}
{"id": 41885516, "time": "2024-11-11 13:25:24", "headline": "Barrington Research Maintains Outperform on PowerFleet, Maintains $10 Price Target", "summary": "", "symbols": ["AIOT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885516/barrington-research-maintains-outperform-on-powerfleet-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 41885523, "time": "2024-11-11 13:26:10", "headline": "HC Wainwright & Co. Maintains Buy on NextCure, Lowers Price Target to $4", "summary": "", "symbols": ["NXTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885523/hc-wainwright-co-maintains-buy-on-nextcure-lowers-price-target-to-4", "tags": ["analyst_other", "price_target_down"]}
{"id": 41885544, "time": "2024-11-11 13:28:10", "headline": "Barrington Research Maintains Outperform on Information Servs Gr, Raises Price Target to $3.75", "summary": "", "symbols": ["III"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885544/barrington-research-maintains-outperform-on-information-servs-gr-raises-price-target-to-3-75", "tags": ["analyst_other", "price_target_up"]}
{"id": 41885561, "time": "2024-11-11 13:28:40", "headline": "HC Wainwright & Co. Maintains Buy on Sandstorm Gold, Raises Price Target to $12", "summary": "", "symbols": ["SAND"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885561/hc-wainwright-co-maintains-buy-on-sandstorm-gold-raises-price-target-to-12", "tags": ["analyst_other", "price_target_up"]}
{"id": 41885562, "time": "2024-11-11 13:29:19", "headline": "FOXO Technologies Shares Resumed Trade", "summary": "", "symbols": ["FOXO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41885562/foxo-technologies-shares-resume-trade", "tags": []}
{"id": 41885573, "time": "2024-11-11 13:30:41", "headline": "Spotlight on Visa: Analyzing the Surge in Options Activity", "summary": " ", "symbols": ["V"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41885573/spotlight-on-visa-analyzing-the-surge-in-options-activity", "tags": []}
{"id": 41885574, "time": "2024-11-11 13:30:46", "headline": "Unpacking the Latest Options Trading Trends in Bank of America", "summary": " ", "symbols": ["BAC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41885574/unpacking-the-latest-options-trading-trends-in-bank-of-america", "tags": []}
{"id": 41885576, "time": "2024-11-11 13:30:59", "headline": "HC Wainwright & Co. Reiterates Buy on Akero Therapeutics, Maintains $50 Price Target", "summary": "", "symbols": ["AKRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885576/hc-wainwright-co-reiterates-buy-on-akero-therapeutics-maintains-50-price-target", "tags": ["analyst_other"]}
{"id": 41885591, "time": "2024-11-11 13:31:36", "headline": "'Blackstone Nears Deal To Buy American Industrial Partners Stake' - Bloomberg News", "summary": "", "symbols": ["BX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/m-a/24/11/41885591/blackstone-nears-deal-to-buy-american-industrial-partners-stake-bloomberg-news", "tags": ["contract"]}
{"id": 41885594, "time": "2024-11-11 13:31:42", "headline": "Bumble Catalysts Show Efficiency Gains, But Analyst Flags Growth Risks", "summary": "BofA analyst reiterates underperform rating on Bumble with a $5.75 price target, citing OPEX efficiency improvements, in-line revenue, and cautious outlook.", "symbols": ["BMBL"], "source": "benzinga", "author": "Anusuya Lahiri", "url": "https://www.benzinga.com/24/11/41885594/bumble-catalysts-show-efficiency-gains-strong-repurchases-but-analyst-nagle-flags-growth-risks", "tags": ["analyst_other", "earnings", "guidance"]}
{"id": 41885656, "time": "2024-11-11 13:33:04", "headline": "HC Wainwright & Co. Maintains Buy on Tourmaline Bio, Raises Price Target to $49", "summary": "", "symbols": ["TRML"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885656/hc-wainwright-co-maintains-buy-on-tourmaline-bio-raises-price-target-to-49", "tags": ["analyst_other", "price_target_up"]}
{"id": 41885673, "time": "2024-11-11 13:34:54", "headline": "Needham Reiterates Hold on Neurocrine Biosciences", "summary": "", "symbols": ["NBIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885673/needham-reiterates-hold-on-neurocrine-biosciences", "tags": ["analyst_other"]}
{"id": 41885710, "time": "2024-11-11 13:36:48", "headline": "'Amazon confirms employee data stolen after hacker claims MOVEit breach' - TechCrunch", "summary": "", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885710/amazon-confirms-employee-data-stolen-after-hacker-claims-moveit-breach-techcrunch", "tags": []}
{"id": 41885759, "time": "2024-11-11 13:39:27", "headline": "Spotify's Q3 Countdown: Analysts Suggest 10% Climb On Bullish Momentum", "summary": "Spotify is to report Q3 earnings on Tuesday. Analysts see 10% upside with target price of $356.56. MACD supports bullish trend. RSI near overbought territory.", "symbols": ["SPOT"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/technicals/24/11/41885759/spotifys-q3-countdown-analysts-suggest-10-climb-on-bullish-momentum", "tags": ["earnings"]}
{"id": 41885777, "time": "2024-11-11 13:40:09", "headline": "How Trump's Tax Cuts, Tariffs, 'Animal Spirits' Could Shape S&P 500 Earnings", "summary": "Trump&#39;s pro-business policies, including tax cuts and deregulation, could drive S&amp;P 500 earnings higher by 11% in 2025 and 7% in 2026, but tariffs on Chinese imports pose a downside risk.", "symbols": ["SPY"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/government/regulations/24/11/41885777/how-trumps-tax-cuts-tariffs-animal-spirits-could-shape-sp-500-earnings", "tags": ["earnings"]}
{"id": 41885889, "time": "2024-11-11 13:46:10", "headline": "JP Morgan Downgrades RAPT Therapeutics to Underweight", "summary": "", "symbols": ["RAPT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885889/jp-morgan-downgrades-rapt-therapeutics-to-underweight", "tags": ["analyst_down"]}
{"id": 41885894, "time": "2024-11-11 13:46:52", "headline": "This Is What Whales Are Betting On AbbVie", "summary": " ", "symbols": ["ABBV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41885894/this-is-what-whales-are-betting-on-abbvie", "tags": []}
{"id": 41885895, "time": "2024-11-11 13:46:57", "headline": "What the Options Market Tells Us About United Airlines Holdings", "summary": " ", "symbols": ["UAL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41885895/what-the-options-market-tells-us-about-united-airlines-holdings", "tags": []}
{"id": 41885969, "time": "2024-11-11 13:48:24", "headline": "What's Going On With Bristol-Myers Squibb Shares Monday?", "summary": "Bristol-Myers Squibb Co (NYSE:BMY) shares are trading higher Monday. The stock appears to be reacting positively after AbbVie Inc (NYSE:ABBV) announced that its Phase 2 EMPOWER trials did not meet their primary endpoints.", "symbols": ["ABBV", "BMY"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41885969/whats-going-on-with-bristol-myers-squibb-shares-monday", "tags": ["why_moving", "fda"]}
{"id": 41885991, "time": "2024-11-11 13:48:53", "headline": "Loop Capital Maintains Buy on Advanced Drainage Systems, Lowers Price Target to $170", "summary": "", "symbols": ["WMS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41885991/loop-capital-maintains-buy-on-advanced-drainage-systems-lowers-price-target-to-170", "tags": ["analyst_other", "price_target_down"]}
{"id": 41886017, "time": "2024-11-11 13:50:17", "headline": "Loop Capital Maintains Buy on ARM Holdings, Raises Price Target to $180", "summary": "", "symbols": ["ARM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41886017/loop-capital-maintains-buy-on-arm-holdings-raises-price-target-to-180", "tags": ["analyst_other", "price_target_up"]}
{"id": 41886029, "time": "2024-11-11 13:52:28", "headline": "Loop Capital Maintains Buy on AppLovin, Raises Price Target to $385", "summary": "", "symbols": ["APP"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41886029/loop-capital-maintains-buy-on-applovin-raises-price-target-to-385", "tags": ["analyst_other", "price_target_up"]}
{"id": 41886047, "time": "2024-11-11 13:54:07", "headline": "Lake Street Maintains Buy on PAR Technology, Raises Price Target to $77", "summary": "", "symbols": ["PAR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41886047/lake-street-maintains-buy-on-par-technology-raises-price-target-to-77", "tags": ["analyst_other", "price_target_up"]}
{"id": 41886058, "time": "2024-11-11 13:55:27", "headline": "Donald Trump Victory Week (Nov 4-8): These Large Cap Stocks Were Biggest Gainers", "summary": "Top-performing large-cap stocks last week: APP (+82.27%), TEM (+49.03%), COIN (+45.35%), ALAB (+42.57%), PLTR (+41.0%), AXON (+39.76%), DOCS (+39.29%), TSLA (+32.28%), HOOD (+25.58%), RDDT (+23.64%).", "symbols": ["ALAB", "APP", "AXON", "COIN", "DOCS", "HOOD", "PLTR", "RDDT", "TEM", "TSLA"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/large-cap/24/11/41886058/donald-trump-victory-week-nov-4-8-these-large-cap-stocks-were-biggest-gainers", "tags": []}
{"id": 41886108, "time": "2024-11-11 13:58:43", "headline": "Scotiabank Maintains Sector Outperform on Pacific Biosciences, Lowers Price Target to $6", "summary": "", "symbols": ["PACB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41886108/scotiabank-maintains-sector-outperform-on-pacific-biosciences-lowers-price-target-to-6", "tags": ["analyst_other", "price_target_down"]}
{"id": 41886130, "time": "2024-11-11 14:00:13", "headline": "Analyst Scoreboard: 13 Ratings For Valero Energy", "summary": " ", "symbols": ["VLO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41886130/analyst-scoreboard-13-ratings-for-valero-energy", "tags": []}
{"id": 41886131, "time": "2024-11-11 14:00:15", "headline": "How Is The Market Feeling About Lantheus Holdings?", "summary": " ", "symbols": ["LNTH"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41886131/how-is-the-market-feeling-about-lantheus-holdings", "tags": []}
{"id": 41886133, "time": "2024-11-11 14:00:21", "headline": "Deep Dive Into Applied Mat Stock: Analyst Perspectives (15 Ratings)", "summary": " ", "symbols": ["AMAT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41886133/deep-dive-into-applied-mat-stock-analyst-perspectives-15-ratings", "tags": []}
{"id": 41886134, "time": "2024-11-11 14:00:21", "headline": "Looking Into Grand Canyon Education's Recent Short Interest", "summary": " ", "symbols": ["LOPE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41886134/looking-into-grand-canyon-educations-recent-short-interest", "tags": []}
{"id": 41886136, "time": "2024-11-11 14:00:26", "headline": "(PGR) - Analyzing Progressive's Short Interest", "summary": " ", "symbols": ["PGR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41886136/pgr-analyzing-progressives-short-interest", "tags": []}
{"id": 41886137, "time": "2024-11-11 14:00:29", "headline": "Key Takeaways From Lyft Analyst Ratings", "summary": " ", "symbols": ["LYFT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41886137/key-takeaways-from-lyft-analyst-ratings", "tags": []}
{"id": 41886138, "time": "2024-11-11 14:00:42", "headline": "Critical Insights From Solventum Analyst Ratings: What You Need To Know", "summary": " ", "symbols": ["SOLV"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41886138/critical-insights-from-solventum-analyst-ratings-what-you-need-to-know", "tags": []}
{"id": 41886140, "time": "2024-11-11 14:00:52", "headline": "Analyst Ratings For Hamilton Lane", "summary": " ", "symbols": ["HLNE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41886140/analyst-ratings-for-hamilton-lane", "tags": []}
{"id": 41886150, "time": "2024-11-11 14:01:06", "headline": "17 Analysts Assess Intercontinental Exchange: What You Need To Know", "summary": " ", "symbols": ["ICE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41886150/17-analysts-assess-intercontinental-exchange-what-you-need-to-know", "tags": []}
{"id": 41886163, "time": "2024-11-11 14:01:29", "headline": "A Look at VerifyMe's Upcoming Earnings Report", "summary": " ", "symbols": ["VRME"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41886163/a-look-at-verifymes-upcoming-earnings-report", "tags": ["earnings"]}
{"id": 41886165, "time": "2024-11-11 14:01:39", "headline": "An Overview of Shimmick's Earnings", "summary": " ", "symbols": ["SHIM"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41886165/an-overview-of-shimmicks-earnings", "tags": ["earnings"]}
{"id": 41886166, "time": "2024-11-11 14:01:46", "headline": "Earnings Preview For Paltalk", "summary": " ", "symbols": ["PALT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41886166/earnings-preview-for-paltalk", "tags": ["earnings"]}
{"id": 41886171, "time": "2024-11-11 14:01:52", "headline": "Spirit Airlines Says Flight To Port-au-Prince Was Diverted To Santiago, Dominican Republic; Aircraft Presented Damage Consistent With Gunfire; One Flight Attendant Injured, No Guests; Suspended Service At Port-au-Prince And Cap-Haitien Pending Further Evaluation; Plane Has Been Taken Out Of Service, Airline Arranging For Different Aircraft To Return Passengers To Fort Lauderdale", "summary": "", "symbols": ["SAVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41886171/spirit-airlines-says-flight-to-port-au-prince-was-diverted-to-santiago-dominican-republic-aircraft-p", "tags": []}
{"id": 41886174, "time": "2024-11-11 14:01:54", "headline": "Preview: Rockwell Medical's Earnings", "summary": " ", "symbols": ["RMTI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41886174/preview-rockwell-medicals-earnings", "tags": ["earnings"]}
{"id": 41886182, "time": "2024-11-11 14:02:07", "headline": "Xtant Medical Hldgs's Earnings Outlook", "summary": " ", "symbols": ["XTNT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41886182/xtant-medical-hldgss-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41886187, "time": "2024-11-11 14:02:16", "headline": "Cherry Hill Mortgage's Earnings Outlook", "summary": " ", "symbols": ["CHMI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41886187/cherry-hill-mortgages-earnings-outlook", "tags": ["earnings", "guidance"]}
{"id": 41886191, "time": "2024-11-11 14:02:24", "headline": "What's Next: Adams Resources & Energy's Earnings Preview", "summary": " ", "symbols": ["AE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41886191/whats-next-adams-resources-energys-earnings-preview", "tags": ["earnings"]}
{"id": 41886198, "time": "2024-11-11 14:02:35", "headline": "An Overview of Kingstone Companies's Earnings", "summary": " ", "symbols": ["KINS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41886198/an-overview-of-kingstone-companiess-earnings", "tags": ["earnings"]}
{"id": 41886199, "time": "2024-11-11 14:02:41", "headline": "Earnings Preview: Oncolytics Biotech", "summary": " ", "symbols": ["ONCY"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41886199/earnings-preview-oncolytics-biotech", "tags": ["earnings"]}
{"id": 41886231, "time": "2024-11-11 14:04:26", "headline": "UBS Maintains Buy on NVIDIA, Raises Price Target to $185", "summary": "", "symbols": ["NVDA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41886231/ubs-maintains-buy-on-nvidia-raises-price-target-to-185", "tags": ["analyst_other", "price_target_up"]}
{"id": 41886265, "time": "2024-11-11 14:05:40", "headline": "UBS Downgrades Pacific Biosciences to Neutral, Announces $2 Price Target", "summary": "", "symbols": ["PACB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41886265/ubs-downgrades-pacific-biosciences-to-neutral-announces-2-price-target", "tags": ["analyst_down"]}
{"id": 41886262, "time": "2024-11-11 14:05:27", "headline": "Home Depot's Bullish Streak Confronts Q3 Earnings Expectations", "summary": "The Home Depot reports Q3 earnings on Tuesday. Wall Street expects $3.64 EPS and $39.17B in revenue. Stock is up 42.56% in the past year.", "symbols": ["HD"], "source": "benzinga", "author": "Surbhi Jain", "url": "https://www.benzinga.com/trading-ideas/technicals/24/11/41886262/home-depots-bullish-streak-confronts-q3-earnings-expectations", "tags": ["earnings"]}
{"id": 41886426, "time": "2024-11-11 14:10:54", "headline": "BWS Financial Maintains Buy on Ubiquiti, Raises Price Target to $385", "summary": "", "symbols": ["UI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41886426/bws-financial-maintains-buy-on-ubiquiti-raises-price-target-to-385", "tags": ["analyst_other", "price_target_up"]}
{"id": 41886430, "time": "2024-11-11 14:11:16", "headline": "Small Caps, Financials Rally As Bitcoin Blasts Past $85,000: What's Driving Markets Monday?", "summary": "The \u201cTrump-related everything rally\u201d reignited across markets on Monday, with heightened focus on last week&#39;s top performers like small caps, financials, Tesla Inc. (NASDAQ:TSLA), and cryptocurrencies, all surging as the ", "symbols": ["AMDY", "ARMK", "BTCUSD", "COIN", "CSLK", "DIA", "IWM", "KRE", "MARA", "QQQ", "RIOT", "SPY", "TSLA", "TSM", "XLB", "XLF", "XLK", "XLU"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/economics/macro-economic-events/24/11/41886430/small-caps-financials-rally-as-bitcoin-blasts-past-85000-whats-driving-markets-monday", "tags": []}
{"id": 41886523, "time": "2024-11-11 14:16:49", "headline": "Peter Schiff: US Bitcoin Reserve Could 'Destroy Dollar,' Predicts It's 'Highly Unlikely' To Happen", "summary": "Renowned economist Peter Schiff has issued a stark warning about the U.S.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41886523/peter-schiff-us-bitcoin-reserve-could-destroy-dollar-predicts-its-highly-unlikely-to-happen", "tags": []}
{"id": 41886594, "time": "2024-11-11 14:19:12", "headline": "American Airlines, JetBlue Suspend Flights To Haiti Through Thursday After Spirit Airlines Flight Hit By Gunfire", "summary": "", "symbols": ["AAL", "JBLU", "SAVE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41886594/american-airlines-jetblue-suspend-flights-to-haiti-through-thursday-after-spirit-airlines-flight-hit", "tags": []}
{"id": 41886609, "time": "2024-11-11 14:25:20", "headline": "Will GOP Gov-Elect Jenniffer Gonz\u00e1lez Fuel Puerto Rico's Cannabis Industry Potential?", "summary": "Puerto Rico cannabis industry growth could accelerate under new Governor Gonz\u00e1lez, boosting exports, patient access, and regulatory support.", "symbols": [], "source": "benzinga", "author": "Patricio Liddle", "url": "https://www.benzinga.com/government/regulations/24/11/41886609/will-gop-gov-elect-jenniffer-gonzalez-fuel-puerto-ricos-cannabis-industry-potential", "tags": []}
{"id": 41886639, "time": "2024-11-11 14:29:01", "headline": "CERo Therapeutics Stock Is Soaring Monday: What's Going On?", "summary": "CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares are moving higher Monday after the company presented preclinical data for its lead compound. ", "symbols": ["CERO"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41886639/cero-therapeutics-stock-is-soaring-monday-whats-going-on", "tags": ["why_moving"]}
{"id": 41886657, "time": "2024-11-11 14:30:36", "headline": "A Closer Look at AstraZeneca's Options Market Dynamics", "summary": " ", "symbols": ["AZN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41886657/a-closer-look-at-astrazenecas-options-market-dynamics", "tags": []}
{"id": 41886688, "time": "2024-11-11 14:31:54", "headline": "Crude Oil Down 3%; Aramark Posts Upbeat Earnings", "summary": " ", "symbols": ["ARMK", "CAN", "CERO", "EFSH", "MARA", "RAPT", "SPNS"], "source": "benzinga", "author": "Avi Kapoor", "url": "https://www.benzinga.com/news/earnings/24/11/41886688/crude-oil-down-3-aramark-posts-upbeat-earnings", "tags": ["earnings"]}
{"id": 41886697, "time": "2024-11-11 14:32:36", "headline": "Why Trump's Win Has 2 Market Experts Betting On Small Caps, Financials", "summary": "Tom Lee of Fundstrat discusses trade ideas following Trump&#39;s victory. Fellow analyst Ryan Detrick agrees with Lee&#39;s picks, citing small-cap and cyclical stocks.", "symbols": ["IAT", "IWM", "SPY", "XLF", "XLI"], "source": "benzinga", "author": "Hayden Buckfire", "url": "https://www.benzinga.com/24/11/41886697/two-ideas-famed-stock-market-forecasters-agree-on-for-2025", "tags": []}
{"id": 41886800, "time": "2024-11-11 14:43:13", "headline": "U.S. Election Stress Fuels Demand For Psychedelic-Assisted Therapy", "summary": "Post-election stress has driven a surge in Americans seeking psychedelic therapy for relief, with clinics reporting record appointments.", "symbols": [], "source": "benzinga", "author": "Juan Sp\u00ednelli", "url": "https://www.benzinga.com/general/health-care/24/11/41886800/u-s-election-stress-fuels-demand-for-psychedelic-assisted-therapy", "tags": []}
{"id": 41886816, "time": "2024-11-11 14:45:30", "headline": "Unpacking the Latest Options Trading Trends in Shopify", "summary": " ", "symbols": ["SHOP"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41886816/unpacking-the-latest-options-trading-trends-in-shopify", "tags": []}
{"id": 41886898, "time": "2024-11-11 14:47:39", "headline": "Move Over Dogecoin And Shiba Inu\u2014This Dogcoin Is An 'Underrated, Non-Consensus Play,' According To A Millionaire Trader", "summary": "Floki (CRYPTO: FLOKI), dubbed as an \u201cunderrated\u201d meme coin by traders, could catch up to Dogecoin\u2019s (CRYPTO: DOGE) gains soon, according to sentiment o", "symbols": ["DOGEUSD", "FLOKIUSD", "SHIBUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41886898/move-over-dogecoin-and-shiba-inu-this-dogcoin-is-an-underrated-non-consensus-play-according-to-a-millionaire-trader", "tags": []}
{"id": 41886925, "time": "2024-11-11 14:52:06", "headline": "California Cannabis Industry Titans Headline Benzinga's Anaheim Event Tues. Nov. 12", "summary": "Join top cannabis experts in Anaheim this Tuesday, Nov 12 at Benzinga&#39;s California Market Spotlight. Register now!", "symbols": ["GLASF", "GRAM", "PLNH"], "source": "benzinga", "author": "Javier Hasse", "url": "https://www.benzinga.com/news/events/24/11/41886925/california-cannabis-industry-titans-headline-benzingas-anaheim-event-tues-nov-12", "tags": []}
{"id": 41886929, "time": "2024-11-11 14:52:15", "headline": "NIO Option Alert: Sweep Of 47 Feb 21 $8 Calls Near Ask, 3,117 Contracts At $0.25 Against 11,952 Open Interest; Earnings On Nov. 20", "summary": "", "symbols": ["NIO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/trading-ideas/24/11/41886929/nio-option-alert-sweep-of-47-feb-21-8-calls-near-ask-3-117-contracts-at-0-25-against-11-952-open-in", "tags": ["earnings"]}
{"id": 41886972, "time": "2024-11-11 15:00:13", "headline": "Looking Into Academy Sports's Recent Short Interest", "summary": " ", "symbols": ["ASO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41886972/looking-into-academy-sportss-recent-short-interest", "tags": []}
{"id": 41886973, "time": "2024-11-11 15:00:15", "headline": "Key Takeaways From Fidelity National Finl Analyst Ratings", "summary": " ", "symbols": ["FNF"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41886973/key-takeaways-from-fidelity-national-finl-analyst-ratings", "tags": []}
{"id": 41886974, "time": "2024-11-11 15:00:19", "headline": "(HMC) - Analyzing Honda Motor Co's Short Interest", "summary": " ", "symbols": ["HMC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41886974/hmc-analyzing-honda-motor-cos-short-interest", "tags": []}
{"id": 41886975, "time": "2024-11-11 15:00:22", "headline": "Analyst Expectations For Air Products & Chemicals's Future", "summary": " ", "symbols": ["APD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41886975/analyst-expectations-for-air-products-chemicalss-future", "tags": []}
{"id": 41886976, "time": "2024-11-11 15:00:24", "headline": "(AIG) - Analyzing American Intl Gr's Short Interest", "summary": " ", "symbols": ["AIG"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41886976/aig-analyzing-american-intl-grs-short-interest", "tags": []}
{"id": 41886982, "time": "2024-11-11 15:00:30", "headline": "Navigating 4 Analyst Ratings For Ubiquiti", "summary": " ", "symbols": ["UI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41886982/navigating-4-analyst-ratings-for-ubiquiti", "tags": []}
{"id": 41886985, "time": "2024-11-11 15:00:45", "headline": "The Analyst Verdict: Bank of New York Mellon In The Eyes Of 12 Experts", "summary": " ", "symbols": ["BK"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41886985/the-analyst-verdict-bank-of-new-york-mellon-in-the-eyes-of-12-experts", "tags": []}
{"id": 41876779, "time": "2024-11-11 08:04:41", "headline": "Aramark shares are trading higher after the company reported better-than-expected Q4 financial results and announced a $500 million share repurchase program. Also, the company approved a 11% increase to its quarterly dividend.", "summary": "", "symbols": ["ARMK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41876779/aramark-shares-are-trading-higher-after-the-company-reported-better-than-expected-q4-financial-resul", "tags": ["why_moving", "buyback", "dividend"]}
{"id": 41886986, "time": "2024-11-11 15:00:56", "headline": "Key Takeaways From APA Analyst Ratings", "summary": " ", "symbols": ["APA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41886986/key-takeaways-from-apa-analyst-ratings", "tags": []}
{"id": 41886989, "time": "2024-11-11 15:01:03", "headline": "Unveiling 12 Analyst Insights On Northern Trust", "summary": " ", "symbols": ["NTRS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41886989/unveiling-12-analyst-insights-on-northern-trust", "tags": []}
{"id": 41877070, "time": "2024-11-11 08:11:05", "headline": "Tempus AI shares are trading lower after Stifel downgraded the stock from Buy to Hold.", "summary": "", "symbols": ["TEM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/wiim/24/11/41877070/tempus-ai-shares-are-trading-lower-after-stifel-downgraded-the-stock-from-buy-to-hold", "tags": ["analyst_down", "why_moving"]}
{"id": 41887127, "time": "2024-11-11 15:11:34", "headline": "What's Going On With Destiny Tech100 Stock Monday?", "summary": "", "symbols": ["DXYZ"], "source": "benzinga", "author": "Dylan Berman", "url": "https://www.benzinga.com/general/space/24/11/41887127/whats-going-on-with-destiny-tech100-stock-monday", "tags": ["why_moving"]}
{"id": 41887136, "time": "2024-11-11 15:12:04", "headline": "SNL Parodies Elon Musk And Donald Trump After 2024 Election: Billionaire Says Show Is 'Out Of Touch With Reality'", "summary": "", "symbols": ["CMCSA", "DOGEUSD"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/general/entertainment/24/11/41887136/snl-parodies-elon-musk-and-donald-trump-after-2024-election-billionaire-says-show-is-out-of-touch-with-reality", "tags": []}
{"id": 41887155, "time": "2024-11-11 15:15:37", "headline": "Looking Into Kinder Morgan's Recent Short Interest", "summary": " ", "symbols": ["KMI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41887155/looking-into-kinder-morgans-recent-short-interest", "tags": []}
{"id": 41887156, "time": "2024-11-11 15:15:42", "headline": "How Is The Market Feeling About Axis Capital Holdings?", "summary": " ", "symbols": ["AXS"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41887156/how-is-the-market-feeling-about-axis-capital-holdings", "tags": []}
{"id": 41887157, "time": "2024-11-11 15:15:47", "headline": "Looking Into Westinghouse Air Brake's Recent Short Interest", "summary": " ", "symbols": ["WAB"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/short-sellers/24/11/41887157/looking-into-westinghouse-air-brakes-recent-short-interest", "tags": []}
{"id": 41887262, "time": "2024-11-11 15:19:22", "headline": "The Week Kamala Harris Lost (Nov 4-8), These Large Cap Stocks Lost Big", "summary": "Kamala Harris lost 2024 US election, 10 large-cap stocks performed poorly: Moderna, Honda, Akamai, ADS, AstraZeneca, Pinterest, MercadoLibre, First Solar, POSCO, Floor &amp; Decor", "symbols": ["AKAM", "AZN", "FND", "FSLR", "HMC", "MELI", "MRNA", "PINS", "PKX", "WMS"], "source": "benzinga", "author": "Lekha Gupta", "url": "https://www.benzinga.com/news/large-cap/24/11/41887262/the-week-kamala-harris-lost-nov-4-8-these-large-cap-stocks-lost-big", "tags": []}
{"id": 41887278, "time": "2024-11-11 15:21:55", "headline": "Royal Caribbean Stock Hit A New All-Time High Today: What's Going On?", "summary": "Royal Caribbean shares are trading higher by 3.7% Monday afternoon. Tigress Financial maintained its Buy rating on the stock and raised its price target from $210 to $270 a share.", "symbols": ["RCL"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/11/41887278/royal-caribbean-stock-hit-a-new-all-time-high-today-whats-going-on", "tags": ["why_moving"]}
{"id": 41887293, "time": "2024-11-11 15:24:30", "headline": "Bitcoin SV Is Up 35% Over The Past Week: What's Going On?", "summary": "Bitcoin SV (CRYPTO: BSV) is trading higher by 35% to $61.71 over the past week following Donald Trump\u2019s 2024 presidential win and ", "symbols": ["BSVUSD"], "source": "benzinga", "author": "Henry Khederian", "url": "https://www.benzinga.com/news/24/11/41887293/bitcoin-sv-is-up-35-over-the-past-week-whats-going-on", "tags": ["why_moving"]}
{"id": 41887346, "time": "2024-11-11 15:30:39", "headline": "Decoding Novo Nordisk's Options Activity: What's the Big Picture?", "summary": " ", "symbols": ["NVO"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/options/24/11/41887346/decoding-novo-nordisks-options-activity-whats-the-big-picture", "tags": []}
{"id": 41887375, "time": "2024-11-11 15:33:34", "headline": "Tevogen Bio Shares Are On The Rise Monday: What's Going On?", "summary": "Tevogen Bio Holdings Inc. (NASDAQ: TVGN) shares are trading higher Monday, potentially driven by momentum from a late-Friday announcement regarding operational updates. Here&#39;s what you need to know.", "symbols": ["TVGN"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41887375/tevogen-bio-shares-are-on-the-rise-monday-whats-going-on", "tags": ["why_moving"]}
{"id": 41887406, "time": "2024-11-11 15:38:19", "headline": "Bitcoin Shatters $87,000 All-Time High, Ethereum Up 5%, Dogecoin Blasts Through $0.30 For 20% Gain In Memorable Monday Trading Session", "summary": "Cryptocurrency markets are skyrocketing, with Bitcoin setting repeated all-time high marks on Monday.", "symbols": ["BTCUSD", "BTTUSD", "CROUSD", "DOGEUSD", "ETHUSD", "SHIBUSD", "SOLUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41887406/bitcoin-shatters-87000-all-time-high-ethereum-up-5-dogecoin-blasts-through-0-30-for-20-gain-in-memorable-monday-trading-session", "tags": []}
{"id": 41887408, "time": "2024-11-11 15:39:08", "headline": "Nintendo Sues Streamer Over Pirated Games, Claims 'Millions Of Dollars' In Lost Revenue", "summary": "Nintendo sues streamer Jesse Keighin for pirating unreleased games, seeking takedowns and up to $150K per violation under copyright laws.", "symbols": ["NTDOY"], "source": "benzinga", "author": "Franca Quarneti", "url": "https://www.benzinga.com/general/gaming/24/11/41887408/nintendo-sues-streamer-over-pirated-games-claims-millions-dollars-lost-revenue", "tags": ["earnings"]}
{"id": 41887505, "time": "2024-11-11 15:45:14", "headline": "Price Over Earnings Overview: Amazon.com", "summary": " ", "symbols": ["AMZN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/news/24/11/41887505/price-over-earnings-overview-amazon-com", "tags": ["earnings"]}
{"id": 41887642, "time": "2024-11-11 15:58:42", "headline": "Bond ETFs Slide As Fed Cuts Clash With Trump's Fiscal Agenda", "summary": "U.S. bond market faces volatility as Trump&#39;s policies could push yields up. Fed&#39;s rate cuts may not ease borrowing costs.", "symbols": ["AGG", "BND", "BNDX", "GOVT", "JNK", "LQD", "SPAB", "TLT", "VCIT", "VCSH"], "source": "benzinga", "author": "Michael Cohen", "url": "https://www.benzinga.com/markets/bonds/24/11/41887642/bond-etfs-slide-as-fed-cuts-clash-with-trumps-fiscal-agenda", "tags": []}
{"id": 41887687, "time": "2024-11-11 16:00:22", "headline": "Breaking Down Hain Celestial Group: 5 Analysts Share Their Views", "summary": " ", "symbols": ["HAIN"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41887687/breaking-down-hain-celestial-group-5-analysts-share-their-views", "tags": []}
{"id": 41887688, "time": "2024-11-11 16:00:31", "headline": "Unveiling 6 Analyst Insights On Ameresco", "summary": " ", "symbols": ["AMRC"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41887688/unveiling-6-analyst-insights-on-ameresco", "tags": []}
{"id": 41887689, "time": "2024-11-11 16:00:41", "headline": "Assessing Interparfums: Insights From 5 Financial Analysts", "summary": " ", "symbols": ["IPAR"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41887689/assessing-interparfums-insights-from-5-financial-analysts", "tags": []}
{"id": 41887690, "time": "2024-11-11 16:00:48", "headline": "Where Bumble Stands With Analysts", "summary": " ", "symbols": ["BMBL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41887690/where-bumble-stands-with-analysts", "tags": []}
{"id": 41887693, "time": "2024-11-11 16:01:01", "headline": "Lipella Pharmaceuticals Will Be Issued U.S. Patent Number 12,138,345 Tomorrow Titled \"DELIVERY OF AGENTS USING METASTABLE LIPOSOMES (FOR THE TREATMENT OF BLADDER CONDITIONS)\".", "summary": "", "symbols": ["LIPO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41887693/lipella-pharmaceuticals-will-be-issued-u-s-patent-number-12-138-345-tomorrow-titled-delivery-of-a", "tags": []}
{"id": 41887695, "time": "2024-11-11 16:01:01", "headline": "Cracking The Code: Understanding Analyst Reviews For PowerFleet", "summary": " ", "symbols": ["AIOT"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41887695/cracking-the-code-understanding-analyst-reviews-for-powerfleet", "tags": []}
{"id": 41887699, "time": "2024-11-11 16:01:03", "headline": "Earnings Outlook For Novavax", "summary": " ", "symbols": ["NVAX"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/earnings/24/11/41887699/earnings-outlook-for-novavax", "tags": ["earnings", "guidance"]}
{"id": 41887710, "time": "2024-11-11 16:01:16", "headline": "Demystifying Dave: Insights From 5 Analyst Reviews", "summary": " ", "symbols": ["DAVE"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/analyst-ratings/24/11/41887710/demystifying-dave-insights-from-5-analyst-reviews", "tags": []}
{"id": 41887709, "time": "2024-11-11 16:01:19", "headline": "Prices Up 50%, Wages 'Barely Moved,' Says PharmaCann Worker And New Teamster Member", "summary": " ", "symbols": [], "source": "benzinga", "author": "Nina Zdinjak", "url": "https://www.benzinga.com/markets/cannabis/24/11/41887709/prices-up-50-wages-barely-moved-says-pharmacann-worker-and-new-teamster-member", "tags": []}
{"id": 41887728, "time": "2024-11-11 16:02:04", "headline": "Kura Sushi USA Commences  Public Offering Of Shares Of Its Class A Common Stock; No Terms Disclosed", "summary": "", "symbols": ["KRUS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41887728/kura-sushi-usa-commences-public-offering-of-shares-of-its-class-a-common-stock-no-terms-disclosed", "tags": ["offering"]}
{"id": 41887743, "time": "2024-11-11 16:03:31", "headline": "Arcturus Therapeutics Receives FDA Clearance To Begin H5N1 Pandemic Flu Vaccine Clinical Trial", "summary": "", "symbols": ["ARCT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41887743/arcturus-therapeutics-receives-fda-clearance-to-begin-h5n1-pandemic-flu-vaccine-clinical-trial", "tags": ["fda"]}
{"id": 41887751, "time": "2024-11-11 16:03:31", "headline": "Stereotaxis Q3 2024 GAAP EPS $(0.08) Misses $(0.05) Estimate, Sales $9.196M Beat $7.100M Estimate", "summary": "", "symbols": ["STXS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41887751/stereotaxis-q3-2024-gaap-eps-0-08-misses-0-05-estimate-sales-9-196m-beat-7-100m-estimate", "tags": ["earnings"]}
{"id": 41887746, "time": "2024-11-11 16:03:33", "headline": "Neurogene Reports Interim Efficacy Data From First 4 Low-Dose Pediatric Participants In NGN-401 Gene Therapy Clinical Trial For Rett Syndrome; Low-Dose NGN-401 Well-Tolerated With Favorable Safety Profile; All Participants Experienced A 2-Point Improvement In The Clinician-Rated Clinical Global Impression-improvement Scale From Baseline", "summary": "", "symbols": ["NGNE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41887746/neurogene-reports-interim-efficacy-data-from-first-4-low-dose-pediatric-participants-in-ngn-401-g", "tags": ["fda"]}
{"id": 41887748, "time": "2024-11-11 16:04:38", "headline": "Luminar Announces New Development Contract With A Japanese Automaker, Also Announces Additional Model Win With Volvo Cars", "summary": "", "symbols": ["LAZR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41887748/luminar-announces-new-development-contract-with-a-japanese-automaker-also-announces-additional-model", "tags": ["contract"]}
{"id": 41887765, "time": "2024-11-11 16:04:45", "headline": "Assertio Holdings Q3 2024 Adj. EPS $0.03 Beats $(0.05) Estimate, Sales $29.204M Beat $28.869M Estimate", "summary": "", "symbols": ["ASRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41887765/assertio-holdings-q3-2024-adj-eps-0-03-beats-0-05-estimate-sales-29-204m-beat-28-869m-estimate", "tags": ["earnings"]}
{"id": 41887846, "time": "2024-11-11 16:06:41", "headline": "Spyre Therapeutics To Host Conference Call And Webcast To Report Interim Results From Phase 1 Healthy Volunteer Trial For SPY001, Its Novel Half-Life Extended Anti-\u03b14\u03b27 Antibody For The Treatment For Inflammatory Bowel Disease On November 12, 2024 At 8:00am ET", "summary": "", "symbols": ["SYRE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41887846/spyre-therapeutics-to-host-conference-call-and-webcast-to-report-interim-results-from-phase-1-hea", "tags": ["fda"]}
{"id": 41887840, "time": "2024-11-11 16:07:11", "headline": "Mineralys Therapeutics Q3 2024 GAAP EPS $(1.13) Misses $(0.83) Estimate", "summary": "", "symbols": ["MLYS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41887840/mineralys-therapeutics-q3-2024-gaap-eps-1-13-misses-0-83-estimate", "tags": ["earnings"]}
{"id": 41887856, "time": "2024-11-11 16:08:01", "headline": "DoubleDown Interactive Q3 Sales $83.00M Miss $85.43M Estimate", "summary": "", "symbols": ["DDI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41887856/doubledown-interactive-q3-sales-83-00m-miss-85-43m-estimate", "tags": []}
{"id": 41887866, "time": "2024-11-11 16:08:02", "headline": "Nevro Q3 EPS $(0.41) Beats $(0.76) Estimate, Sales $96.91M Beat $93.07M Estimate", "summary": "", "symbols": ["NVRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41887866/nevro-q3-eps-0-41-beats-0-76-estimate-sales-96-91m-beat-93-07m-estimate", "tags": ["earnings"]}
{"id": 41887871, "time": "2024-11-11 16:08:17", "headline": "Intevac Q3 2024 Adj. EPS $(0.08) Beats $(0.15) Estimate, Sales $28.505M Beat $11.500M Estimate", "summary": "", "symbols": ["IVAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41887871/intevac-q3-2024-adj-eps-0-08-beats-0-15-estimate-sales-28-505m-beat-11-500m-estimate", "tags": ["earnings"]}
{"id": 41887867, "time": "2024-11-11 16:08:37", "headline": "Zeta Global Holdings Q3 Sales $268.295M Beat $252.479M Estimate", "summary": "", "symbols": ["ZETA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41887867/zeta-global-holdings-q3-sales-268-295m-beat-252-479m-estimate", "tags": []}
{"id": 41887868, "time": "2024-11-11 16:08:45", "headline": "Beyond Air Q2 EPS $(0.28), Inline, Sales $798.00K Miss $1.04M Estimate", "summary": "", "symbols": ["XAIR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41887868/beyond-air-q2-eps-0-28-inline-sales-798-00k-miss-1-04m-estimate", "tags": ["earnings"]}
{"id": 41887898, "time": "2024-11-11 16:09:27", "headline": "12 Information Technology Stocks Moving In Monday's Pre-Market Session", "summary": " ", "symbols": ["ARBB", "BTBT", "CISO", "FOXO", "MARA", "MFH", "MNDY", "MPWR", "PERF", "SGN", "SMCI", "UI"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/11/41887898/12-information-technology-stocks-moving-in-mondays-pre-market-session", "tags": ["why_moving"]}
{"id": 41887899, "time": "2024-11-11 16:09:34", "headline": "12 Industrials Stocks Moving In Monday's Pre-Market Session", "summary": " ", "symbols": ["AMBI", "AWX", "BTM", "CRGO", "FGI", "HOVR", "KULR", "LICY", "NCL", "PMEC", "SKYH", "SPPL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/11/41887899/12-industrials-stocks-moving-in-mondays-pre-market-session", "tags": ["why_moving"]}
{"id": 41887925, "time": "2024-11-11 16:09:39", "headline": "12 Health Care Stocks Moving In Monday's Pre-Market Session", "summary": " ", "symbols": ["ABBV", "CERO", "DWTX", "EVO", "FRES", "NUWE", "RAPT", "RDNT", "REVB", "SNES", "TIVC", "VIGL"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/11/41887925/12-health-care-stocks-moving-in-mondays-pre-market-session", "tags": ["why_moving"]}
{"id": 41887927, "time": "2024-11-11 16:09:45", "headline": "12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session", "summary": " ", "symbols": ["AZI", "BQ", "CANG", "GOEV", "HLLY", "HOFV", "LINC", "LVLU", "SBET", "VEEE", "VMAR", "YTRA"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/movers/24/11/41887927/12-consumer-discretionary-stocks-moving-in-mondays-pre-market-session", "tags": ["why_moving"]}
{"id": 41887920, "time": "2024-11-11 16:10:02", "headline": "Live Nation Entertainment Q3 2024 GAAP EPS $1.66, Inline, Sales $7.651B Miss $7.774B Estimate", "summary": "", "symbols": ["LYV"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41887920/live-nation-entertainment-q3-2024-gaap-eps-1-66-inline-sales-7-651b-miss-7-774b-estimate", "tags": ["earnings"]}
{"id": 41887966, "time": "2024-11-11 16:10:49", "headline": "Assured Guaranty Q3 2024 Adj EPS $1.44 Beats $1.35 Estimate, Sales $202.00M Beat $201.38M Estimate", "summary": "", "symbols": ["AGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41887966/assured-guaranty-q3-2024-adj-eps-1-44-beats-1-35-estimate-sales-202-00m-beat-201-38m-estimate", "tags": ["earnings"]}
{"id": 41887983, "time": "2024-11-11 16:11:34", "headline": "Nevro Sees FY24 Revenue $400M-$405M Vs $402.55M Est.", "summary": "", "symbols": ["NVRO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41887983/nevro-sees-fy24-revenue-400m-405m-vs-402-55m-est", "tags": ["earnings"]}
{"id": 41887984, "time": "2024-11-11 16:11:37", "headline": "Invizyne Technologies Announced Its $15M IPO With An $8 Per Share Price", "summary": "", "symbols": ["IZTC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41887984/invizyne-technologies-announced-its-15m-ipo-with-an-8-per-share-price", "tags": []}
{"id": 41887985, "time": "2024-11-11 16:11:52", "headline": "LivaNova Announces Its OSPREY Trial Met Its Primary Safety And Efficacy Endpoints", "summary": "", "symbols": ["LIVN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41887985/livanova-announces-its-osprey-trial-met-its-primary-safety-and-efficacy-endpoints", "tags": ["fda"]}
{"id": 41887987, "time": "2024-11-11 16:11:54", "headline": "Endeavor Group Agrees To Sell OpenBet And IMG ARENA To OB Global Holdings LLC In Management Buyout Backed By Ariel Emanuel For Approximately $450M", "summary": "", "symbols": ["EDR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41887987/endeavor-group-agrees-to-sell-openbet-and-img-arena-to-ob-global-holdings-llc-in-management-buyout-b", "tags": ["merger"]}
{"id": 41887993, "time": "2024-11-11 16:12:09", "headline": "Quince Therapeutics Presents Safety Data From Prior Phase 3 ATTeST Clinical Trial At 53rd Child Neurology Society Annual Meeting", "summary": "", "symbols": ["QNCX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41887993/quince-therapeutics-presents-safety-data-from-prior-phase-3-attest-clinical-trial-at-53rd-child-n", "tags": ["fda"]}
{"id": 41887996, "time": "2024-11-11 16:13:20", "headline": "IAC Announced It Is Considering A Spin-Off Of Its Ownership Stake In Angi Inc. To Its Shareholders.", "summary": "", "symbols": ["ANGI", "IAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41887996/iac-announced-it-is-considering-a-spin-off-of-its-ownership-stake-in-angi-inc-to-its-shareholders", "tags": []}
{"id": 41887998, "time": "2024-11-11 16:13:25", "headline": "James River Gr Hldgs Q3 2024 GAAP EPS $(1.10) Misses $(0.25) Estimate, Sales $191.497M Beat $146.557M Estimate", "summary": "", "symbols": ["JRVR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41887998/james-river-gr-hldgs-q3-2024-gaap-eps-1-10-misses-0-25-estimate-sales-191-497m-beat-146-557m-estima", "tags": ["earnings"]}
{"id": 41887999, "time": "2024-11-11 16:13:30", "headline": "Bitfarms Reschedules Q3 2024 Conference Call To November 13th, 2024", "summary": "", "symbols": ["BITF", "TSX:BITF"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41887999/bitfarms-reschedules-q3-2024-conference-call-to-november-13th-2024", "tags": []}
{"id": 41888000, "time": "2024-11-11 16:13:51", "headline": "Bridger Aerospace Gr Q3 2024 GAAP EPS $0.31 Misses $0.46 Estimate, Sales $64.507M Beat $57.500M Estimate", "summary": "", "symbols": ["BAER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41888000/bridger-aerospace-gr-q3-2024-gaap-eps-0-31-misses-0-46-estimate-sales-64-507m-beat-57-500m-estimate", "tags": ["earnings"]}
{"id": 41888022, "time": "2024-11-11 16:15:29", "headline": "Bridger Aerospace Gr Raises FY2024 Sales Guidance from $70.00M-86.00M to $90.00M-95.00M", "summary": "", "symbols": ["BAER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888022/bridger-aerospace-gr-raises-fy2024-sales-guidance-from-70-00m-86-00m-to-90-00m-95-00m", "tags": ["guidance"]}
{"id": 41888023, "time": "2024-11-11 16:15:33", "headline": "Angi Q3 2024 GAAP EPS $0.07 Beats $0.00 Estimate, Sales $296.700M Beat $296.517M Estimate", "summary": "", "symbols": ["ANGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41888023/angi-q3-2024-gaap-eps-0-07-beats-0-00-estimate-sales-296-700m-beat-296-517m-estimate", "tags": ["earnings"]}
{"id": 41888026, "time": "2024-11-11 16:15:43", "headline": "Marpai Q3 EPS $(0.30) Up From $(1.10) YoY, Sales $7.01M Miss $8.46M Estimate", "summary": "", "symbols": ["MRAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41888026/marpai-q3-eps-0-30-up-from-1-10-yoy-sales-7-01m-miss-8-46m-estimate", "tags": ["earnings"]}
{"id": 41888032, "time": "2024-11-11 16:15:59", "headline": "Nvidia CEO Jensen Huang Doesn't Wear A Watch After A Gardner Taught Him The Secret Of Time", "summary": "Nvidia CEO Jensen Huang shared a story of why he doesn&#39;t wear a watch during a 2023 interview. Here&#39;s the unique reason why.", "symbols": ["NVDA"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/24/11/41888032/nvidia-ceo-jensen-huang-said-nvidia-has-no-long-term-strategy-how-this-philosophy-is-similar-to-his-reason-to-not-wear-a-watch", "tags": ["management"]}
{"id": 41888047, "time": "2024-11-11 16:16:36", "headline": "STRATTEC Appoints Matthew Pauli As Senior Vice President, CFO, Effective November 13, 2024", "summary": "", "symbols": ["STRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888047/strattec-appoints-matthew-pauli-as-senior-vice-president-cfo-effective-november-13-2024", "tags": ["management"]}
{"id": 41888048, "time": "2024-11-11 16:16:55", "headline": "Aterian Q3 2024 GAAP EPS $(0.25) Beats $(0.55) Estimate, Sales $26.239M Beat $26.014M Estimate", "summary": "", "symbols": ["ATER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41888048/aterian-q3-2024-gaap-eps-0-25-beats-0-55-estimate-sales-26-239m-beat-26-014m-estimate", "tags": ["earnings"]}
{"id": 41888107, "time": "2024-11-11 16:17:20", "headline": "HOOKIPA Pharma Presented Updated Phase 2 Data From A Study Evaluating Eseba-vec In Combination With Pembrolizumab As Front Line Therapy In The Setting Of Human Papillomavirus Type 16 Positive Relapsed Or Metastatic Head And Neck Squamous Cell Carcinoma At SITC 2024", "summary": "", "symbols": ["HOOK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41888107/hookipa-pharma-presented-updated-phase-2-data-from-a-study-evaluating-eseba-vec-in-combination-wi", "tags": ["fda"]}
{"id": 41888122, "time": "2024-11-11 16:18:18", "headline": "Enerpac Tool Group Announced It Has Appointed Matthew Pauli As CFO, Effective November 13, 2024", "summary": "", "symbols": ["EPAC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888122/enerpac-tool-group-announced-it-has-appointed-matthew-pauli-as-cfo-effective-november-13-2024", "tags": ["management"]}
{"id": 41888123, "time": "2024-11-11 16:18:30", "headline": "Johnson & Johnson Today Announces That The U.S. FDA Has Granted Nipocalimab Breakthrough Therapy Designation For The Treatment Of Adults Living With Moderate-To-Severe Sj\u00f6gren's Disease, A Debilitating And Chronic Autoantibody Disease With High Prevalence, For Which No Approved Advanced Treatments Are Available", "summary": "", "symbols": ["JNJ"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41888123/johnson-johnson-today-announces-that-the-u-s-fda-has-granted-nipocalimab-breakthrough-therapy-des", "tags": ["fda"]}
{"id": 41888125, "time": "2024-11-11 16:19:09", "headline": "Gatos Silver Q3 2024 GAAP EPS $0.14 Beats $0.13 Estimate, Sales $93.800M", "summary": "", "symbols": ["GATO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41888125/gatos-silver-q3-2024-gaap-eps-0-14-beats-0-13-estimate-sales-93-800m", "tags": ["earnings"]}
{"id": 41888216, "time": "2024-11-11 16:19:42", "headline": "RMR Gr Q4 Adj $0.34 Misses $0.38 Estimate, Sales $212.30M Miss $220.35M Estimate", "summary": "", "symbols": ["RMR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41888216/rmr-gr-q4-adj-0-34-misses-0-38-estimate-sales-212-30m-miss-220-35m-estimate", "tags": []}
{"id": 41888220, "time": "2024-11-11 16:20:15", "headline": "DoubleDown Interactive Q3 EPADS $0.51 Misses $0.56 Estimate, Sales $83.00M Miss $85.43M Estimate", "summary": "", "symbols": ["DDI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41888220/doubledown-interactive-q3-eps-0-51-misses-0-56-estimate-sales-83-00m-miss-85-43m-estimate", "tags": []}
{"id": 41888241, "time": "2024-11-11 16:22:11", "headline": "Robinhood Markets Reports October 2024 Operating Data; Funded Customers At The End Of October Were 24.4M Up ~90K From September 2024, Up Over 1M YoY; Assets Under Custody At The End Of October Were $159.7B", "summary": "", "symbols": ["HOOD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888241/robinhood-markets-reports-october-2024-operating-data-funded-customers-at-the-end-of-october-were-24", "tags": []}
{"id": 41888242, "time": "2024-11-11 16:22:13", "headline": "Zeta Global Holdings Sees Q4 Revenue $293.0M-$297.0M Vs $268.821M Est.", "summary": "", "symbols": ["ZETA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888242/zeta-global-holdings-sees-q4-revenue-293-0m-297-0m-vs-268-821m-est", "tags": ["earnings"]}
{"id": 41888250, "time": "2024-11-11 16:22:21", "headline": "Aterian Sees Q4 Sales $22.500M-25.500M vs $23.89M Est", "summary": "", "symbols": ["ATER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888250/aterian-sees-q4-sales-22-500m-25-500m-vs-23-89m-est", "tags": []}
{"id": 41888251, "time": "2024-11-11 16:22:25", "headline": "Zeta Global Holdings Sees FY24 Revenue $984.1M-$988.1M Vs $942.892M Est.", "summary": "", "symbols": ["ZETA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888251/zeta-global-holdings-sees-fy24-revenue-984-1m-988-1m-vs-942-892m-est", "tags": ["earnings"]}
{"id": 41888287, "time": "2024-11-11 16:24:52", "headline": "Net Power Ended Q3 2024 With ~$580M Of Total Cash, Cash Equivalents And Investments, As Compared To ~$609M In Q2 2024", "summary": "", "symbols": ["NPWR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41888287/net-power-ended-q3-2024-with-580m-of-total-cash-cash-equivalents-and-investments-as-compared-to-609", "tags": []}
{"id": 41888299, "time": "2024-11-11 16:25:53", "headline": "Great Elm Group Q1 EPS $0.08, Same YoY, Sales $3.99M Up From $3.31M YoY", "summary": "", "symbols": ["GEG"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41888299/great-elm-group-q1-eps-0-08-same-yoy-sales-3-99m-up-from-3-31m-yoy", "tags": ["earnings"]}
{"id": 41888302, "time": "2024-11-11 16:26:22", "headline": "CORRECTION: Strattec Security Appointed Matthew Pauli As CFO, Effective Nov. 13, 2024", "summary": "", "symbols": ["EPAC", "STRT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888302/correction-strattec-security-appointed-matthew-pauli-as-cfo-effective-nov-13-2024", "tags": ["management"]}
{"id": 41888532, "time": "2024-11-11 16:31:39", "headline": "DBV Technologies Plans To Change Ratio From 1 ADS to 1 Ordinary Share To 1 ADS To 5 Ordinary Shares", "summary": "", "symbols": ["DBVT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888532/dbv-technologies-plans-to-change-ratio-from-1-ads-to-1-ordinary-share-to-1-ads-to-5-ordinary-shares", "tags": []}
{"id": 41888556, "time": "2024-11-11 16:32:41", "headline": "QuickLogic Q3 2024 Adj. EPS $(0.06) Misses $(0.05) Estimate, Sales $4.273M Beat $4.200M Estimate", "summary": "", "symbols": ["QUIK"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41888556/quicklogic-q3-2024-adj-eps-0-06-misses-0-05-estimate-sales-4-273m-beat-4-200m-estimate", "tags": ["earnings"]}
{"id": 41888558, "time": "2024-11-11 16:33:04", "headline": "FGI Industries Q3 2024 Adj. EPS $(0.01) Misses $0.03 Estimate, Sales $36.099M Beat $30.686M Estimate", "summary": "", "symbols": ["FGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41888558/fgi-industries-q3-2024-adj-eps-0-01-misses-0-03-estimate-sales-36-099m-beat-30-686m-estimate", "tags": ["earnings"]}
{"id": 41888562, "time": "2024-11-11 16:33:56", "headline": "XBP Europe And Exela Technologies' Reaktr Business Unit Announces The Availability Of SecAi On Oracle Cloud Infrastructure", "summary": "", "symbols": ["XBP", "XELA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888562/xbp-europe-and-exela-technologies-reaktr-business-unit-announces-the-availability-of-secai-on-oracle", "tags": []}
{"id": 41888564, "time": "2024-11-11 16:35:02", "headline": "FGI Industries Raises FY2024 Sales Guidance from $115.00M-128.00M to $127.00M-$131.00M  VS Est. 122.49M", "summary": "", "symbols": ["FGI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888564/fgi-industries-raises-fy2024-sales-guidance-from-115-00m-128-00m-to-127-00m-131-00m-vs-est-122-49m", "tags": ["guidance"]}
{"id": 41888567, "time": "2024-11-11 16:35:16", "headline": "American Vanguard Q3 2024 GAAP EPS $(0.92) May Not Be Comparable To $(0.10) Estimate", "summary": "", "symbols": ["AVD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41888567/american-vanguard-q3-2024-gaap-eps-0-92-may-not-be-comparable-to-0-10-estimate", "tags": ["earnings"]}
{"id": 41888582, "time": "2024-11-11 16:36:44", "headline": "American Vanguard Says Board Is Actively Engaged In Recruiting CEO To Build Upon Transformation Momentum", "summary": "", "symbols": ["AVD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888582/american-vanguard-says-board-is-actively-engaged-in-recruiting-ceo-to-build-upon-transformation-mome", "tags": ["management"]}
{"id": 41888584, "time": "2024-11-11 16:37:01", "headline": "Clearwater Analytics Launches Secondary Offering Of 25M Shares", "summary": "", "symbols": ["CWAN"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888584/clearwater-analytics-launches-secondary-offering-of-25m-shares", "tags": ["offering"]}
{"id": 41888590, "time": "2024-11-11 16:37:44", "headline": "American Vanguard Reiterates Full Year 2024 Revenue (Down 2% To Flat, Excluding Product Recall Charge) And Adjusted EBITDA ($40M - $50M) Targets", "summary": "", "symbols": ["AVD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888590/american-vanguard-reiterates-full-year-2024-revenue-down-2-to-flat-excluding-product-recall-charge-a", "tags": ["analyst_other", "earnings"]}
{"id": 41888594, "time": "2024-11-11 16:38:30", "headline": "Zevra Therapeutics To Present Relevant Data Of Swallow Domain In Niemann-Pick Disease Type C Clinical Severity Scale At 53rd Child Neurology Society Annual Meeting", "summary": "", "symbols": ["ZVRA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/general/biotech/24/11/41888594/zevra-therapeutics-to-present-relevant-data-of-swallow-domain-in-niemann-pick-disease-type-c-clin", "tags": ["fda"]}
{"id": 41888597, "time": "2024-11-11 16:39:28", "headline": "Investors Title Company Announced A Special Cash Dividend Of $14.00 Per Share To Shareholders Of Record On December 2, 2024 And Payable On December 16, 2024", "summary": "", "symbols": ["ITIC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888597/investors-title-company-announced-a-special-cash-dividend-of-14-00-per-share-to-shareholders-of-reco", "tags": ["dividend"]}
{"id": 41888686, "time": "2024-11-11 16:39:44", "headline": "Bitcoin Blasts Through $88,000 As Market 'Euphoria,' Regulatory Optimism Take Hold", "summary": "Even as Bitcoin (CRYPTO: BTC) crossed $88,000, up nearly 11% in 24 hours and over 30% the past week, experts say that &#34;euphoria has set into the market,&#34; suggesting prices cou", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41888686/bitcoin-blasts-through-87000-as-market-euphoria-regulatory-optimism-take-hold", "tags": []}
{"id": 41888869, "time": "2024-11-11 16:48:23", "headline": "Chardan Capital Maintains Buy on Solid Biosciences, Maintains $15 Price Target", "summary": "", "symbols": ["SLDB"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888869/chardan-capital-maintains-buy-on-solid-biosciences-maintains-15-price-target", "tags": ["analyst_other"]}
{"id": 41888870, "time": "2024-11-11 16:48:26", "headline": "American Vanguard Q3 2024 Sales $118.31M Miss $139.20M Estimate", "summary": "", "symbols": ["AVD"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41888870/american-vanguard-q3-2024-sales-118-31m-miss-139-20m-estimate", "tags": []}
{"id": 41888873, "time": "2024-11-11 16:48:35", "headline": "Luminar Technologies Stock Is Rising After Hours: What's Driving The Action?", "summary": "Luminar Technologies provided a business update for the third quarter after the bell on Monday. Here&#39;s a look at what you need to know.", "symbols": ["LAZR"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/news/earnings/24/11/41888873/luminar-technologies-stock-is-rising-after-hours-whats-driving-the-action", "tags": []}
{"id": 41888531, "time": "2024-11-11 16:31:19", "headline": "Live Nation Q3 Earnings: Revenue Miss, EPS In Line, Shares Climb As 'Momentum Continues To Build'", "summary": "Live Nation reported third-quarter revenue of $7.65 billion, beating analyst estimates of $7.77 billion, according to Benzinga Pro. The Ticketmaster parent company reported third-quarter earnings of $1.66 per share, in line with analyst estimates.", "symbols": ["LYV"], "source": "benzinga", "author": "Adam Eckert", "url": "https://www.benzinga.com/general/entertainment/24/11/41888531/live-nation-q3-earnings-revenue-miss-eps-in-line-shares-climb-as-momentum-continues-to-build", "tags": ["earnings"]}
{"id": 41888881, "time": "2024-11-11 16:49:21", "headline": "Team Lowers FY2024 Sales Guidance from $850.00M-900.00M to $845.00M-860.00M", "summary": "", "symbols": ["TISI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888881/team-lowers-fy2024-sales-guidance-from-850-00m-900-00m-to-845-00m-860-00m", "tags": ["guidance"]}
{"id": 41888882, "time": "2024-11-11 16:49:26", "headline": "Team Q3 Adj $(2.84) Down From $(2.01) YoY, Sales $210.76M Up From $206.72M YoY", "summary": "", "symbols": ["TISI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41888882/team-q3-adj-2-84-down-from-2-01-yoy-sales-210-76m-up-from-206-72m-yoy", "tags": []}
{"id": 41888909, "time": "2024-11-11 16:50:45", "headline": "Chardan Capital Maintains Buy on Rocket Pharmaceuticals, Maintains $62 Price Target", "summary": "", "symbols": ["RCKT"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888909/chardan-capital-maintains-buy-on-rocket-pharmaceuticals-maintains-62-price-target", "tags": ["analyst_other"]}
{"id": 41888920, "time": "2024-11-11 16:52:53", "headline": "Barrington Research Maintains Outperform on Lincoln Educational Servs, Raises Price Target to $20", "summary": "", "symbols": ["LINC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888920/barrington-research-maintains-outperform-on-lincoln-educational-servs-raises-price-target-to-20", "tags": ["analyst_other", "price_target_up"]}
{"id": 41888921, "time": "2024-11-11 16:53:17", "headline": "Easy Income Portfolio: Post-Election Update and Strategy Overview", "summary": " ", "symbols": [], "source": "benzinga", "author": "Tim Melvin", "url": "https://www.benzinga.com/24/11/41888921/easy-income-portfolio-post-election-update-and-strategy-overview", "tags": []}
{"id": 41888938, "time": "2024-11-11 16:54:24", "headline": "Tigress Financial Maintains Strong Buy on Norwegian Cruise Line, Raises Price Target to $36", "summary": "", "symbols": ["NCLH"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888938/tigress-financial-maintains-strong-buy-on-norwegian-cruise-line-raises-price-target-to-36", "tags": ["analyst_other", "price_target_up"]}
{"id": 41888948, "time": "2024-11-11 16:56:24", "headline": "Macquarie Maintains Outperform on Madison Square Garden, Lowers Price Target to $45", "summary": "", "symbols": ["MSGE"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41888948/macquarie-maintains-outperform-on-madison-square-garden-lowers-price-target-to-45", "tags": ["analyst_other", "price_target_down"]}
{"id": 41888984, "time": "2024-11-11 17:00:43", "headline": "Archrock Q3 Adj $0.28 Beats $0.27 Estimate, Sales $292.16M Beat $286.19M Estimate", "summary": "", "symbols": ["AROC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41888984/archrock-q3-adj-0-28-beats-0-27-estimate-sales-292-16m-beat-286-19m-estimate", "tags": []}
{"id": 41889003, "time": "2024-11-11 17:02:14", "headline": "Dayforce Reveals Key Investments Intended To Supercharge Next Evolution Of Its Partner Ecosystem", "summary": "", "symbols": ["DAY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889003/dayforce-reveals-key-investments-intended-to-supercharge-next-evolution-of-its-partner-ecosystem", "tags": []}
{"id": 41889004, "time": "2024-11-11 17:02:14", "headline": "Yalla Group Sees Q4 Sales $77.000M-$84.000M vs $86.60M Est", "summary": "", "symbols": ["YALA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889004/yalla-group-sees-q4-sales-77-000m-84-000m-vs-86-60m-est", "tags": []}
{"id": 41889015, "time": "2024-11-11 17:03:19", "headline": "Archrock Sees FY24 Net Income $157M-$167M; Adj. EBITDA $575M-$585M; Contracts Operations Revenue $970M-$980M; Aftermarket Services Revenue $180M-$185M", "summary": "", "symbols": ["AROC"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889015/archrock-sees-fy24-net-income-157m-167m-adj-ebitda-575m-585m-contracts-operations-revenue-970m-980m", "tags": ["earnings"]}
{"id": 41888750, "time": "2024-11-11 16:41:57", "headline": "Gold ETF Hit With $1 Billion Outflow: Investors Dump Safe Haven Asset After Trump Win", "summary": "The SPDR Gold Trust (NYSE:GLD) witnessed its biggest weekly outflow in over two years driven by a post-election shift in sentiment following Donald Trump&#39;s election victory. ", "symbols": ["BTCUSD", "GLD"], "source": "benzinga", "author": "Piero Cingari", "url": "https://www.benzinga.com/etfs/specialty-etfs/24/11/41888750/gold-etf-hit-with-1-billion-outflow-investors-dump-safe-haven-asset-after-trump-win", "tags": []}
{"id": 41889032, "time": "2024-11-11 17:06:15", "headline": "D. Boral Capital Maintains Buy on Annovis Bio, Maintains $21 Price Target", "summary": "", "symbols": ["ANVS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889032/d-boral-capital-maintains-buy-on-annovis-bio-maintains-21-price-target", "tags": ["analyst_other"]}
{"id": 41889038, "time": "2024-11-11 17:07:19", "headline": "Organogenesis Reports Outcome Of Interim Analysis Of Second Phase 3 Randomized Control Trial Of ReNu, A Cryopreserved Amniotic Suspension Allograft, For Management Of Symptoms Associated With Knee Osteoarthritis", "summary": "", "symbols": ["ORGO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889038/organogenesis-reports-outcome-of-interim-analysis-of-second-phase-3-randomized-control-trial-of-renu", "tags": ["fda"]}
{"id": 41889039, "time": "2024-11-11 17:07:55", "headline": "What's Going On With Nano Nuclear Energy Stock?", "summary": "Nano Nuclear Energy Inc. (NASDAQ: NNE) shares pulled back Monday after rallying more than 25% last week. Here&#39;s what you need to know.", "symbols": ["NNE"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/trading-ideas/movers/24/11/41889039/whats-going-on-with-nano-nuclear-energy-stock-3", "tags": ["why_moving"]}
{"id": 41889050, "time": "2024-11-11 17:09:16", "headline": "Occidental Petroleum Earnings Preview: What Investors Are Watching, Including Debt Levels", "summary": "Occidental Petroleum is set to report its third-quarter results on Tuesday after the closing bell. Here&#39;s a preview of what to expect.", "symbols": ["OXY"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/earnings/24/11/41889050/occidental-petroleum-earnings-preview-what-investors-are-watching-including-debt-levels", "tags": ["earnings"]}
{"id": 41889105, "time": "2024-11-11 17:10:49", "headline": "D. Boral Capital Maintains Buy on CARISMA Therapeutics, Maintains $24 Price Target", "summary": "", "symbols": ["CARM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889105/d-boral-capital-maintains-buy-on-carisma-therapeutics-maintains-24-price-target", "tags": ["analyst_other"]}
{"id": 41889139, "time": "2024-11-11 17:11:46", "headline": "Talos Energy Q3 2024 Adj. EPS $(0.14) Misses $(0.06) Estimate, Sales $509.286M Beat $500.140M Estimate", "summary": "", "symbols": ["TALO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41889139/talos-energy-q3-2024-adj-eps-0-14-misses-0-06-estimate-sales-509-286m-beat-500-140m-estimate", "tags": ["earnings"]}
{"id": 41889157, "time": "2024-11-11 17:14:59", "headline": "Enstar Group Subsidiary Enters Adverse Development Cover Reinsurance Agreement With Certain Subsidiaries Of James River Group", "summary": "", "symbols": ["ESGR", "JRVR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889157/enstar-group-subsidiary-enters-adverse-development-cover-reinsurance-agreement-with-certain-subsidia", "tags": ["contract"]}
{"id": 41889158, "time": "2024-11-11 17:15:01", "headline": "Yalla Group Q3 2024 Adj. EPS $0.24, Sales $88.922M Beat $82.785M Estimate", "summary": "", "symbols": ["YALA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41889158/yalla-group-q3-2024-adj-eps-0-24-sales-88-922m-beat-82-785m-estimate", "tags": ["earnings"]}
{"id": 41889166, "time": "2024-11-11 17:15:32", "headline": "D. Boral Capital Maintains Buy on Humacyte, Maintains $25 Price Target", "summary": "", "symbols": ["HUMA"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889166/d-boral-capital-maintains-buy-on-humacyte-maintains-25-price-target", "tags": ["analyst_other"]}
{"id": 41889239, "time": "2024-11-11 17:18:20", "headline": "D. Boral Capital Maintains Buy on Anixa Biosciences, Maintains $10 Price Target", "summary": "", "symbols": ["ANIX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889239/d-boral-capital-maintains-buy-on-anixa-biosciences-maintains-10-price-target", "tags": ["analyst_other"]}
{"id": 41889267, "time": "2024-11-11 17:20:24", "headline": "D. Boral Capital Maintains Buy on Citius Pharma, Maintains $6 Price Target", "summary": "", "symbols": ["CTXR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889267/d-boral-capital-maintains-buy-on-citius-pharma-maintains-6-price-target", "tags": ["analyst_other"]}
{"id": 41889299, "time": "2024-11-11 17:24:00", "headline": "Talos Energy 2024 production guidance improved to 91.0 \u2013 94.0 Mboe/d, with reduced capital expenditures guidance to $510 - $530 million.", "summary": "", "symbols": ["TALO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889299/talos-energy-2024-production-guidance-improved-to-91-0-94-0-mboed-with-reduced-capital-expenditures", "tags": ["guidance"]}
{"id": 41889305, "time": "2024-11-11 17:26:02", "headline": "Cuba Reeling After Hurricane Rafael, Two Earthquakes: What You Need To Know", "summary": "Hurricane Rafael, 17th named storm of 2024 season, hits Cuba as category 3 storm. Two earthquakes impact country, worsen power issues and economic crisis.", "symbols": [], "source": "benzinga", "author": "Hayden Buckfire", "url": "https://www.benzinga.com/news/global/24/11/41889305/cuba-reeling-after-hurricane-rafael-two-earthquakes-what-you-need-to-know", "tags": []}
{"id": 41889339, "time": "2024-11-11 17:31:31", "headline": "23andMe Plans Restructuring To Streamline Operations; Reduces Workforce By Roughly 40%, Expects Annualized Cost Savings Of More Than $35M", "summary": "", "symbols": ["ME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889339/23andme-plans-restructuring-to-streamline-operations-reduces-workforce-by-roughly-40-expects-annuali", "tags": []}
{"id": 41889344, "time": "2024-11-11 17:32:38", "headline": "23andMe Discontinues Development Of Therapeutics Division And Begins Strategic Alternatives Process For All In-house Therapeutic Programs", "summary": "", "symbols": ["ME"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889344/23andme-discontinues-development-of-therapeutics-division-and-begins-strategic-alternatives-process", "tags": []}
{"id": 41889365, "time": "2024-11-11 17:34:32", "headline": "Jefferies Maintains Buy on Delta Air Lines, Raises Price Target to $72", "summary": "", "symbols": ["DAL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889365/jefferies-maintains-buy-on-delta-air-lines-raises-price-target-to-72", "tags": ["analyst_other", "price_target_up"]}
{"id": 41889368, "time": "2024-11-11 17:35:58", "headline": "Teradyne Plans To Repurchase Up To Additional $100M Of Common Stock In The Remainder Of 2024 As Part Of Its Previously Announced $2B Share Repurchase Program", "summary": "", "symbols": ["TER"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889368/teradyne-plans-to-repurchase-up-to-additional-100m-of-common-stock-in-the-remainder-of-2024-as-part", "tags": ["buyback"]}
{"id": 41889486, "time": "2024-11-11 17:40:11", "headline": "Leerink Partners Maintains Outperform on Tectonic Therapeutic, Raises Price Target to $69", "summary": "", "symbols": ["TECX"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889486/leerink-partners-maintains-outperform-on-tectonic-therapeutic-raises-price-target-to-69", "tags": ["analyst_other", "price_target_up"]}
{"id": 41889518, "time": "2024-11-11 17:45:54", "headline": "Shopify Q3 Earnings Preview: Stock Hits 52-Week Highs, Analysts Expect Second Best Revenue Quarterly Total In Company History", "summary": "Shopify analysts expect the company to post strong Q3 revenue growth and have one of its best ever quarters for overall revenue.", "symbols": ["PYPL", "SHOP"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/news/earnings/24/11/41889518/shopify-q3-earnings-preview-stock-hits-52-week-highs-analysts-expect-second-best-revenue-quarterly-total-in-company-history", "tags": ["earnings"]}
{"id": 41889433, "time": "2024-11-11 17:37:31", "headline": "U.S. Central Command Confirms Strikes On Iranian-Linked Targets In Syria", "summary": "U.S. Central Command (CENTCOM) said its forces launched strikes on nine targets in two locations in Syria on Monday. The strikes targeted groups associated with Iran in response to multiple attacks on U.S. personnel and allies in the region over the past 24 hours. Here&#39;s what to know: ", "symbols": [], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/global/24/11/41889433/u-s-central-command-confirms-strikes-on-iranian-linked-targets-in-syria", "tags": []}
{"id": 41889577, "time": "2024-11-11 17:51:01", "headline": "Loop Capital Initiates Coverage On NXP Semiconductors with Buy Rating, Announces Price Target of $300", "summary": "", "symbols": ["NXPI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889577/loop-capital-initiates-coverage-on-nxp-semiconductors-with-buy-rating-announces-price-target-of-300", "tags": ["analyst_init"]}
{"id": 41889607, "time": "2024-11-11 17:52:46", "headline": "Loop Capital Initiates Coverage On ON Semiconductor with Buy Rating, Announces Price Target of $95", "summary": "", "symbols": ["ON"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889607/loop-capital-initiates-coverage-on-on-semiconductor-with-buy-rating-announces-price-target-of-95", "tags": ["analyst_init"]}
{"id": 41889609, "time": "2024-11-11 17:53:36", "headline": "The Colorado City That Legalized And Banned Cannabis At The Same Time", "summary": "Colorado Springs voters approved two conflicting cannabis measures, simultaneously legalizing and banning recreational sales.", "symbols": [], "source": "benzinga", "author": "Rolando Garc\u00eda", "url": "https://www.benzinga.com/24/11/41889609/the-city-that-legalized-and-banned-cannabisat-the-same-time", "tags": []}
{"id": 41889626, "time": "2024-11-11 17:54:41", "headline": "Loop Capital Initiates Coverage On Synopsys with Buy Rating, Announces Price Target of $675", "summary": "", "symbols": ["SNPS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889626/loop-capital-initiates-coverage-on-synopsys-with-buy-rating-announces-price-target-of-675", "tags": ["analyst_init"]}
{"id": 41889634, "time": "2024-11-11 17:55:58", "headline": "Loop Capital Initiates Coverage On Cadence Design Sys with Buy Rating, Announces Price Target of $360", "summary": "", "symbols": ["CDNS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889634/loop-capital-initiates-coverage-on-cadence-design-sys-with-buy-rating-announces-price-target-of-360", "tags": ["analyst_init"]}
{"id": 41889635, "time": "2024-11-11 17:57:30", "headline": "Loop Capital Initiates Coverage On Qorvo with Hold Rating, Announces Price Target of $73", "summary": "", "symbols": ["QRVO"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889635/loop-capital-initiates-coverage-on-qorvo-with-hold-rating-announces-price-target-of-73", "tags": ["analyst_init"]}
{"id": 41889638, "time": "2024-11-11 17:59:16", "headline": "Loop Capital Initiates Coverage On Skyworks Solutions with Hold Rating, Announces Price Target of $90", "summary": "", "symbols": ["SWKS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889638/loop-capital-initiates-coverage-on-skyworks-solutions-with-hold-rating-announces-price-target-of-90", "tags": ["analyst_init"]}
{"id": 41889652, "time": "2024-11-11 18:00:49", "headline": "Loop Capital Initiates Coverage On Qualcomm with Hold Rating, Announces Price Target of $180", "summary": "", "symbols": ["QCOM"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889652/loop-capital-initiates-coverage-on-qualcomm-with-hold-rating-announces-price-target-of-180", "tags": ["analyst_init"]}
{"id": 41889654, "time": "2024-11-11 18:01:54", "headline": "MediciNova Says Notified By Sanofi That Sanofi/Novartis Litigation Was Settled; Says It Is Entitled To Receive Certain Amount Of Monetary Damages Through This Settlement", "summary": "", "symbols": ["MNOV", "SNY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889654/medicinova-says-notified-by-sanofi-that-sanofinovartis-litigation-was-settled-says-it-is-entitled-to", "tags": ["legal"]}
{"id": 41889672, "time": "2024-11-11 18:04:17", "headline": "Loop Capital Initiates Coverage On Marvell Tech with Hold Rating, Announces Price Target of $95", "summary": "", "symbols": ["MRVL"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889672/loop-capital-initiates-coverage-on-marvell-tech-with-hold-rating-announces-price-target-of-95", "tags": ["analyst_init"]}
{"id": 41889679, "time": "2024-11-11 18:06:01", "headline": "Loop Capital Initiates Coverage On Rambus with Buy Rating, Announces Price Target of $70", "summary": "", "symbols": ["RMBS"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889679/loop-capital-initiates-coverage-on-rambus-with-buy-rating-announces-price-target-of-70", "tags": ["analyst_init"]}
{"id": 41889692, "time": "2024-11-11 18:09:36", "headline": "Loop Capital Initiates Coverage On Monolithic Power Systems with Hold Rating, Announces Price Target of $660", "summary": "", "symbols": ["MPWR"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/24/11/41889692/loop-capital-initiates-coverage-on-monolithic-power-systems-with-hold-rating-announces-price-target", "tags": ["analyst_init"]}
{"id": 41889726, "time": "2024-11-11 18:10:44", "headline": "Momentus Shares Moved Higher On Monday: What Happened?", "summary": "Shares of Momentus Inc. (NASDAQ: MNTS) traded higher on Monday, adding to gains of nearly 17% over the past week. The momentum appears to be linked to political developments. Here&#39;s what you need to know.", "symbols": ["MNTS"], "source": "benzinga", "author": "Vaishali Prayag", "url": "https://www.benzinga.com/general/space/24/11/41889726/momentus-shares-moved-higher-on-monday-what-happened", "tags": []}
{"id": 41889729, "time": "2024-11-11 18:11:10", "headline": "Avalon Labs Launches BTC-Backed Stablecoin USDa To Unlock Bitcoin Liquidity In DeFi, CeFi", "summary": "Avalon Labs on Monday announced the launch of USDa, a Bitcoin (CRYPTO: BTC)-backed stablecoin designed to enable Bitcoin holders to unlock liquidity without selling their holdings.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41889729/avalon-labs-launches-btc-backed-stablecoin-usda-to-unlock-bitcoin-liquidity-in-defi-cefi", "tags": []}
{"id": 41889838, "time": "2024-11-11 18:25:12", "headline": "Polymarket Bettors Say 60% Likelihood Bitcoin Crosses $100K This Year", "summary": "The odds of Bitcoin (CRYPTO: BTC) reaching $100,000 by the end of 2024 have surged, with bettors on Polymarket currently assigning a 60% probability to the milestone.\n\n\n\nThis confidence follows Bitcoin&#39;s new all-time high of $87,293 on Monday afternoon, according to data from CoinGecko.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Murtuza Merchant", "url": "https://www.benzinga.com/general/sports-betting/24/11/41889838/polymarket-bettors-say-60-likelihood-bitcoin-crosses-100k-this-year", "tags": []}
{"id": 41889849, "time": "2024-11-11 18:29:42", "headline": "Relaxation Emerges As Strongest Predictor Of Psychedelic Therapy Benefits, Study", "summary": "Study reveals relaxation, not mystical experiences, as the main factor in the success of psychedelic therapy for treatment-resistant depression.", "symbols": [], "source": "benzinga", "author": "Juan Sp\u00ednelli", "url": "https://www.benzinga.com/24/11/41889849/relaxation-not-mystical-visions-key-to-psychedelic-therapys-success-new-study-shows", "tags": []}
{"id": 41889911, "time": "2024-11-11 18:34:15", "headline": "What's Going On With China-Based Stocks Alibaba, JD.com, PDD Holdings, Baidu, Nio?", "summary": "Shares of U.S.- listed, China-based stocks ended the session mixed on Monday amid more Chinese stimulus measures and uncertainty surrounding potentially higher tariffs from the incoming Trump administration.", "symbols": ["BABA", "BIDU", "JD", "NIO", "PDD"], "source": "benzinga", "author": "Erica Kollmann", "url": "https://www.benzinga.com/news/global/24/11/41889911/whats-going-on-with-china-based-stocks-alibaba-jd-com-pdd-holdings-baidu-nio", "tags": ["why_moving"]}
{"id": 41890024, "time": "2024-11-11 18:50:42", "headline": "Much Wow! Dogecoin Is Now Larger Than Ford, Adidas, Lululemon, Roblox: 15 Companies Worth Less Than Meme Crypto", "summary": "Meme cryptocurrency Dogecoin (CRYPTO: DOGE) is soaring in price and valuation, up more than 80% in the past week and setting new 52-week highs.", "symbols": ["ADDYY", "BTCUSD", "DAL", "DOGEUSD", "F", "HEINY", "HMC", "KDP", "KHC", "KR", "LULU", "NDAQ", "OXY", "RBLX", "VWAGY", "YUM"], "source": "benzinga", "author": "Chris Katje", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41890024/much-wow-dogecoin-is-now-larger-than-ford-adidas-lululemon-roblox-15-companies-worth-less-than-meme-crypto", "tags": []}
{"id": 41890223, "time": "2024-11-11 19:25:18", "headline": "IAC Considers A Spin-Off Of Angi After Q3 Report", "summary": "IAC considering spin-off of Angi Inc., a pioneer in home services. Angi&#39;s Q3 earnings beat estimates, with 20% decrease in sales compared to last year.", "symbols": ["ANGI", "IAC"], "source": "benzinga", "author": "Benzinga News-desk", "url": "https://www.benzinga.com/trading-ideas/24/11/41890223/iac-considers-a-spin-off-of-angi-after-q3-report", "tags": ["earnings"]}
{"id": 41890232, "time": "2024-11-11 19:26:43", "headline": "UK Relaxes Hemp Rules, Skips Raising THC Limits Or Cutting Licensing Fees", "summary": " ", "symbols": [], "source": "benzinga", "author": "Nina Zdinjak", "url": "https://www.benzinga.com/markets/cannabis/24/11/41890232/uk-relaxes-hemp-rules-skips-raising-thc-limits-or-cutting-licensing-fees", "tags": []}
{"id": 41890244, "time": "2024-11-11 19:29:04", "headline": "Elizabeth Warren Says Trump And His Transition Team Are Already Crossing Legal Boundaries: 'I Would Know Because I Wrote The Law'", "summary": "Elizabeth Warren accused Donald Trump and his transition team of violating legal requirements for preventing conflicts of interest, as Trump has yet to sign mandatory ethics agreements.", "symbols": ["DJT"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/24/11/41890244/elizabeth-warren-says-trump-and-his-transition-team-are-already-crossing-legal-boundaries-i-would-know-because-i-wrote-the-law", "tags": []}
{"id": 41890414, "time": "2024-11-11 19:50:04", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["JTAI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41890414/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 41890415, "time": "2024-11-11 19:50:04", "headline": "Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending", "summary": "", "symbols": ["SISI"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/24/11/41890415/trading-halt-halted-at-7-50-00-p-m-et-trading-halt-halt-news-pending", "tags": ["halt"]}
{"id": 41890526, "time": "2024-11-11 20:15:43", "headline": "Tradepulse Power Inflow Alert: Coinbase Global Inc. Receives Alert And Rises 4.9% After Signal", "summary": " ", "symbols": ["COIN"], "source": "benzinga", "author": "Finit", "url": "https://www.benzinga.com/signals/24/11/41890526/tradepulse-power-inflow-alert-coinbase-global-inc-receives-alert-and-rises-4-9-after-signal", "tags": []}
{"id": 41890600, "time": "2024-11-11 20:21:14", "headline": "Anthony Scaramucci Optimistic On US Strategic Bitcoin Reserve: 'Trump's Victory Accelerated The Cycle'", "summary": "Anthony Scaramucci, CEO of\u00a0SkyBridge Capital, expressed confidence that the U.S. would establish a Strategic Bitcoin (CRYPTO: BTC) Reserve, leading to increased allocations and price increases for the leading cryptocurrency.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/24/11/41890600/anthony-scaramucci-optimistic-of-a-us-strategic-bitcoin-reserve-trumps-victory-accelerated-the-cycle", "tags": ["management"]}
{"id": 41890694, "time": "2024-11-11 20:44:51", "headline": "Jim Cramer Says Salesforce Agentforce Is The Best Use Of AI He Has Seen: 'Makes Sense That The Stock Has Gone Up So Much'", "summary": "Cramer took to X to express his admiration for Salesforce&#39;s Agentforce, calling it &#34;pretty revolutionary.&#34; He also noted that the stock&#39;s significant rise was a logical outcome of this groundbreaking AI application.", "symbols": ["CRM"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/24/11/41890694/jim-cramer-says-salesforce-agentforce-is-the-best-use-of-ai-he-has-seen-makes-sense-that-the-stock-has-gone-up-so-much", "tags": []}
{"id": 41890755, "time": "2024-11-11 20:48:58", "headline": "Microstrategy, Marathon Digital Holdings, Coinbase, Cleanspark, And Tesla: 5 Stocks On Investors' Radars Today Amid Bitcoin Buzz", "summary": "The U.S. stock market displayed a robust performance today, with the Dow Jones index soaring by over 300 points. The NASDAQ and the S&amp;P 500 indices also posted gains, rising by almost 0.1% and 0.1% respectively.", "symbols": ["BTCUSD", "CLSK", "COIN", "MARA", "MSTR", "TSLA"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/24/11/41890755/microstrategy-marathon-digital-holdings-coinbase-cleanspark-and-tesla-5-stocks-on-investors-radars-today-amid-bitcoin-buzz", "tags": []}
{"id": 41890759, "time": "2024-11-11 20:49:21", "headline": "Polish Parliamentary Committee Sends Cannabis Decriminalization Petition To Prime Minister", "summary": " ", "symbols": [], "source": "benzinga", "author": "Nina Zdinjak", "url": "https://www.benzinga.com/markets/cannabis/24/11/41890759/polish-parliamentary-committee-sends-cannabis-decriminalization-petition-to-prime-minister", "tags": []}
{"id": 41890944, "time": "2024-11-11 21:32:01", "headline": "Tesla The 'Most Undervalued AI Name In The Market In Our View,' Says Dan Ives \u2014 Trump's Win A 'Game Changer'", "summary": "Tesla&#39;s stock has surged more than 40% since Donald Trump&#39;s election win, with analyst Dan Ives calling it a game changer for the company&#39;s AI and autonomous driving prospects, and raising the price target to $400.", "symbols": ["TSLA"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/markets/24/11/41890944/tesla-the-most-undervalued-ai-name-in-the-market-in-our-view-says-dan-ives-trumps-win-a-game-changer", "tags": []}
{"id": 41890968, "time": "2024-11-11 21:36:38", "headline": "Bitcoin Hovers Around $90K, Ethereum, Dogecoin Extend Trump Victory Rally: How Long Before BTC Hits $100,000? Analysts Reveal", "summary": "Leading cryptocurrencies catapulted Monday as the rally sparked by Donald Trump\u2019s victory entered top gear.", "symbols": ["BTC", "BTCUSD", "DOGEUSD", "ETHUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/24/11/41890968/bitcoin-kisses-89500-ethereum-dogecoin-extend-trump-victory-rally-how-long-before-btc-hits-100000-analysts-reveal", "tags": []}
{"id": 41891026, "time": "2024-11-11 21:50:30", "headline": "Palantir Overtakes Lockheed Martin In Market Cap, How Does The 'Messi Of AI' Stack Up Against The Traditional Defense Player", "summary": "The data analytics company&#39;s market value reached $137.17 billion, surpassing Lockheed Martin&#39;s $135.25 billion, reflecting Palantir&#39;s growth in artificial intelligence and data analytics within modern defense and security operations.", "symbols": ["AMZN", "LMT", "META", "PLTR"], "source": "benzinga", "author": "Kaustubh Bagalkote", "url": "https://www.benzinga.com/markets/equities/24/11/41891026/palantir-overtakes-lockheed-martin-in-market-cap-how-does-the-messi-of-ai-stack-up-against-the-traditional-defense-player", "tags": []}
{"id": 41891184, "time": "2024-11-11 22:44:48", "headline": "Tesla Stock Has Spiked Over 60% Since Earnings, Gene Munster Says These 2 Key Catalysts Will Spur Future Growth For EV Giant", "summary": "Tesla has witnessed a remarkable 63% surge in its stock value since the release of its earnings report in October. This significant growth is attributed to the company&#39;s delivery expansion and the potential of its autonomous driving technology, according to a prominent analyst.", "symbols": ["TSLA"], "source": "benzinga", "author": "Benzinga Neuro", "url": "https://www.benzinga.com/markets/equities/24/11/41891184/tesla-stock-has-spiked-over-60-since-earnings-gene-munster-says-these-2-key-catalysts-will-spur-future-growth-for-ev-giant", "tags": ["earnings"]}
{"id": 41891221, "time": "2024-11-11 22:50:48", "headline": "Peter Schiff Says He Would Have 'Loaded Up' On Bitcoin Had He Known That The BTC Bubble Would 'Get This Big'", "summary": "Renowned economist and Bitcoin (CRYPTO: BTC) critic Peter Schiff said he would have bought the leading cryptocurrency far earlier had he anticipated the \u201cbubble\u201d to grow as big as it is currently.", "symbols": ["BTCUSD"], "source": "benzinga", "author": "Aniket Verma", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41891221/peter-schiff-says-he-would-have-loaded-up-on-bitcoin-had-he-known-that-the-btc-bubble-would-get-this-big", "tags": []}
{"id": 41891237, "time": "2024-11-11 22:58:51", "headline": "Apple's Smart Camera Coming In 2026, Cupertino Eyeing 'Tens of Millions' In Annual Shipments, Says Top Supply Chain Analyst", "summary": "Apple plans to launch its first smart home IP camera in 2026, aiming for tens of millions in annual shipments and leveraging seamless integration with its product ecosystem, according to analyst Ming-Chi Kuo.", "symbols": ["AAPL"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/tech/24/11/41891237/apples-smart-camera-coming-in-2026-cupertino-eyeing-tens-of-millions-in-annual-shipments-says-top-supply-chain-analyst", "tags": []}
{"id": 41891126, "time": "2024-11-11 22:27:55", "headline": "Amazon's New Smart Eyeglasses For Drivers Aim To Shave Seconds Off Deliveries \u2014 But There's More Than What Meets The Eye (UPDATED)", "summary": "Amazon is developing smart eyeglasses for its delivery drivers, designed to provide turn-by-turn navigation and improve efficiency, but faces challenges with battery life and potential delays.", "symbols": ["AMZN", "WMT"], "source": "benzinga", "author": "Ananya Gairola", "url": "https://www.benzinga.com/media/24/11/41891126/amazons-new-smart-eyeglasses-for-drivers-aim-to-shave-seconds-off-deliveries-but-theres-more-than-what-meets-the-eye", "tags": []}
{"id": 41891565, "time": "2024-11-11 23:57:29", "headline": "VAALCO Energy Q3 2024 Adj. EPS $0.08 Misses $0.14 Estimate, Sales $140.334M Beat $135.317M Estimate", "summary": "", "symbols": ["EGY"], "source": "benzinga", "author": "Benzinga Newsdesk", "url": "https://www.benzinga.com/news/earnings/24/11/41891565/vaalco-energy-q3-2024-adj-eps-0-08-misses-0-14-estimate-sales-140-334m-beat-135-317m-estimate", "tags": ["earnings"]}
{"id": 41888910, "time": "2024-11-11 16:50:54", "headline": "The Perfect Stock Portfolio", "summary": " While this will probably drive our lawyers crazy, the Perfect Stock Portfolio is a group of stocks that fit the definition of the ideal stock that I have developed over my career.", "symbols": [], "source": "benzinga", "author": "Tim Melvin", "url": "https://www.benzinga.com/24/11/41888910/the-perfect-stock-portfolio", "tags": []}
{"id": 41887610, "time": "2024-11-11 15:41:26", "headline": "Bitcoin Shatters $87,000 All-Time High, Ethereum Up 5%, Dogecoin Blasts Through 30 Cents For 20% Gain In Memorable Monday Trading Session", "summary": "Cryptocurrency markets are skyrocketing, with Bitcoin setting repeated all-time high marks on Monday.", "symbols": ["BTCUSD", "BTTUSD", "CROUSD", "DOGEUSD", "ETHUSD", "SHIBUSD", "SOLUSD"], "source": "benzinga", "author": "Khyathi Dalal", "url": "https://www.benzinga.com/markets/cryptocurrency/24/11/41887610/bitcoin-shatters-87000-all-time-high-ethereum-up-5-dogecoin-blasts-through-0-30-for-20-gain-in-memorable-monday-trading-session", "tags": []}
{"id": 41879935, "time": "2024-11-11 10:00:14", "headline": "Dogecoin's Price Increased More Than 20% Within 24 hours", "summary": "Over the past 24 hours, Dogecoin&#39;s (CRYPTO: DOGE) price rose 20.3% to $0.29. This continues its positive trend over the past week where it has experienced a 84.0% gain, moving from $0.16 to its current price. As it stands right now, the coin&#39;s all-time high is $0.73. ", "symbols": ["DOGEUSD"], "source": "benzinga", "author": "Benzinga Insights", "url": "https://www.benzinga.com/insights/cryptocurrency/24/11/41879935/test0-28942583368918406-dogecoins-price-increased-more-than-20-within-24-hours", "tags": []}
